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1.  Overview 
The United States Census Bureau (USCB) estimated the world population to number 7.152 
billion in April 2014.1 Facing this immense number and keeping in mind, that the world 
population will reach eight billion by 2027, a tremendous increase in global energy 
consumption is obvious. Besides the need to invent novel energy producing processes, the 
development of energy saving techniques offers the greatest chances to meet our energy needs 
in the long run. In the field of industrial and pharmaceutical chemistry, one of the most 
important branches of the German economy, catalysis is one of the key technologies to save 
energy. Modern research in catalysis has to achieve many aspects, such as broad applicability, 
high selectivity, environmental sustainability and cost effectiveness. Organometallic 
chemistry has shown in the past that it is able to fulfill most of these criteria and a variety of 
powerful concepts have been developed and reported within the last 40 years.2 Just in 2010, 
the importance of organometallic chemistry was once more highlighted by awarding the 
Nobel price in Chemistry to Richard F. Heck, Ei-ichi Negishi and Akira Suzuki for their work 
on palladium-catalyzed cross-coupling reactions.3 Even if palladium-based catalysts have 
certainly revolutionized organic syntheses, its potential to furnish even more complex 
molecules has certainly not been exploit yet.4 Nevertheless, palladium has some drawbacks 
that cannot be ignored in our modern society of the 21st century. Besides the fact, that 
palladium is a rare and expensive metal,5 it is also toxicologically very critical. Also, one 
must consider that palladium-salts undergo catalytic coupling reactions in general in the 
presence of ligands, that could be even more expensive and toxic, than the palladium-salt 
itself. Interestingly, very abundant and low-toxic alternative transition metals, such as iron or 
cobalt were shown to react without the need of additional ligands in exceptional reaction rates 
at low temperatures, often even surpassing related palladium-catalyzed coupling reactions.6 
                                                 
1
 www.census.gov; April 4th 2014. 
2
 Halpern, J. Pure Appl. Chem. 2001, 73, 209. 
3
 www.nobelprize.org/nobel_prizes/chemistry/laureates/2010; April 4th 2014. 
4
 (a) Cross-Coupling reactions. A Practical Guide; Miyaura, N., Ed.; Springer, Berlin, 2002. (b) Metal-
Catalyzed Cross-Coupling Reactions; de Meijere, A., Diederich, F., Eds.; Wiley-VCH, Weinheim, 2004. (c) 
Organotransition Metal Chemistry; Hartwig, J. F., Ed.; University Science Books, Sausalito, California, 2010. 
5
 One ounce (about 31 gramm) of palladium-metal costs 555 € (www.wallstreet-
online.de/rohstoffe/palladiumpreis, April 4th 2014). 
6
 (a) Bolm, C.; Legros, J.; Le Paih, J.; Zani, L. Chem. Rev. 2004, 104, 6217. (b) Shinokuo, H.; Oshima, K. Eur. J. 
Org. Chem. 2004, 2081. (c) Yorimitsu, H.; Oshima, K. Pure Appl. Chem. 2006, 78, 441. (d) Iron Catalysis in 
Organic Chemistry: Reactions and Applications; Plietker, B., Ed.; Wiley-VCH, Weinheim, 2008. (e) Enthaler, 
S.; Junge, K.; Beller, M. Angew. Chem. Int. Ed. 2008, 47, 3317. (f) Sherry, B. D.; Fürstner, A. Acc. Chem. Res. 
2008, 41, 1500. (g) Bolm, C. Nature Chem. 2009, 1, 420. (h) Fürstner, A. Angew. Chem. Int. Ed. 2009, 48, 1364. 
(i) Czaplik, W. M.; Mayer, M.; Cvengros, J.; Jacobi von Wangelin, A. ChemSusChem 2009, 2, 396. (j) 
Nakamura, E.; Yoshikai, N. J. Org. Chem. 2010, 75, 6061. (k) Sun, C.-L.; Li, B.-J.; Shi, Z.-J. Chem. Rev. 2011, 
111, 1293. 
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The replacement of palladium in transition metal catalyzed reactions by alternative metals like 
iron or cobalt is certainly one of the big challenges for organometallic chemists of the 21st 
century. 
 
 
2. Preparation of Functionalized Organometallic Reagents 
2.1. Introduction 
The cradle of organometallic chemistry is a Paris military pharmacy in 1760. It was there that 
Cadet worked on sympathetic inks based on cobalt salts. For their preparation, he used cobalt 
minerals which contain arsenic.7 In 1827, Zeise isolated Na[PtCl3C2H4], called Zeise`s salt, 
the first olefin complex in history.8 Another milestone in organometallic chemistry was the 
first synthesis of diethyl zinc by Frankland in 1849.9 He prepared diethyl zinc by reaction of 
zinc metal with ethyliodide. About 50 years later, Grignard prepared organomagnesium 
compounds for the very first time and paved the way for modern organometallic chemistry.10 
Today, almost all metals play a more or less important role in organometallic chemistry. The 
polarity of the carbon-metal bond of an organometallic reagent displays its reactivity.11 
Therefore, organolithium reagents feature very high reactivity due to their strongly polarized 
carbon-lithium bond. This high reactivity makes organolithium reagents very nucleophilic, 
but also incompatible with sensitive functional groups.12 In contrast, organoboron reagents 
possess almost covalent carbon-boron bonds and require harsh reaction conditions or 
sophisticated catalytic systems for successful reactions with appropriate electrophiles.13 
Organomagnesium, -copper and -zinc reagents are a good balance between these two 
extremes, as they show high reactivity and broad functional group compatibility.11,14 
There exist various ways to prepare organometallic reagents. In this work, the attention should 
be focused on oxidative insertion of magnesium metal into organic halides, halogen-
magnesium exchange reactions and direct metalation. 
 
 
                                                 
7
 Organometallics; Elschenbroich, C., Ed.; Wiley-VCH, Weinheim, 1992. 
8
 (a) Zeise, W. C. Poggendorf`s Ann. Phys. 1827, 9, 632. (b) Zeise, W. C. Poggendorf`s Ann. Phys. 1831, 21, 
497. (c) Zeise, W. C. Poggendorf`s Ann. Phys. 1837, 40, 234. 
9
 (a) Frankland, E. Ann. Chem. 1849, 71, 171. (b) Frankland, E. Ann. Chem. 1849, 71, 213. 
10
 Grignard, V. Compt. Rend. Acad. Sci. Paris, 1900, 130, 1322. 
11
 Handbook of Functionalized Organometallics, Knochel, P., Ed.; Wiley-VCH, Weinheim, 2005. 
12
 Wu. G.; Huang, M. Chem. Rev. 2006, 106, 2596. 
13
 Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457. 
14
 Knochel, P.; Dohle, W.; Gommermann, N.; Kneisel, F. F.; Kopp, F.; Korn, T.; Sapountzis, I.; Vu, V. A. 
Angew. Chem. Int. Ed. 2003, 42, 4302. 
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2.2. Oxidative Insertion of Magnesium Metal into Organic Halides 
The most common preparation method for organomagnesium compounds is the direct 
insertion of magnesium metal into organic halides.15 Even if the entire mechanism of this 
reaction has still not been elucidated completely, radical pathways are generally accepted.16 
The direct insertion of magnesium metal into organic halides usually proceeds under reflux 
conditions, which limits its functional group compatibility and its application in plant scale, 
due to safety issues.17 Rieke and coworkers observed that the reaction of lithium naphthalide 
with magnesium salts furnishes highly reactive magnesium powder (Mg*; so called Rieke 
magnesium) that can undergo oxidative insertion reactions into organic halides at very low 
temperatures, tolerating many sensitive functional groups, such as esters or nitriles (Scheme 
1).18 
 
 
Scheme 1. Low-temperature formation of functionalized Grignard reagents. 
 
Even if this method proved to be very efficient for the preparation of functionalized Grignard 
reagents, it still has some drawbacks, namely cryogenic conditions and separate preparation of 
the highly active magnesium. Knochel and coworkers could bypass these drawbacks elegantly 
by adding stoichiometric amounts of LiCl to the insertion reaction of magnesium metal into 
organic halides.19 LiCl not only accelerates the insertion progress significantly, it also leads to 
higher solubility and reactivity of the organomagnesium reagent in organic solvents.20 Using 
                                                 
15
 Handbook of Grignard Reagents, Silverman, G. S.; Rakita, P. E., Eds.; Marcel Dekker, New York, 2000. 
16
 (a) Walborsky, H. M. Acc. Chem. Res. 1990, 23, 286. (b) Garst, J. F. Acc. Chem. Res. 1991, 24, 95. (c) Garst, 
J. F.; Soriaga, M. P. Coord. Chem. Rev. 2004, 248, 623. 
17
 Jones, M. C. Plant and Operations Progress, 1989, 8, 200. 
18
 (a) Rieke, R. D. Science, 1989, 246, 1260. (b) Rieke, R. D.; Hanson, M. V. Tetrahedron 1997, 53, 1925. (c) 
Lee, J.; Velarde-Ortiz, R.; Guijarro, A.; Wurst, J. R.; Rieke, R. D. J. Org. Chem. 2000, 65, 5428. (d) Rieke, R. D. 
Aldrichchim. Acta 2000, 33, 52. 
19
 (a) Piller, F. M.; Appukkuttan, P.; Gavryushin, A.; Helm, M.; Knochel, P. Angew. Chem. Int. Ed. 2008, 47, 
6802. (b) Piller, F. M.; Metzger, A.; Schade, M. A.; Haag, B. A.; Gavryushin, A.; Knochel, P. Chem. Eur. J. 
2009, 15, 7192. 
20
 Solvents and Solvent Effects in Organic Chemistry, Reichardt, C., Ed.; Wiley-VCH, Weinheim, 2003. 
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this LiCl-mediated magnesium insertion, functionalized aryl and heteroaryl magnesium 
compounds can be prepared under mild reaction conditions in high yields (Scheme 2). 
 
 
Scheme 2. LiCl-mediated insertion of magnesium metal into (hetero)aromatic halides. 
 
Knochel and coworkers could also perform highly regioselective magnesium-directed 
insertion reactions using this LiCl-mediated insertion reaction. Reaction of tert-butyl (2,4-
dibromophenyl) carbonate with Mg/LiCl (THF, -20 °C) led to magnesium insertion 
exclusively in the para-position (Scheme 3). Related Zn insertion reactions provide the 
respective ortho-metalated compound.21 This behavior can be explained by assuming that zinc 
insertion requires coordination to the directing group, whereas magnesium metal, which has a 
much stronger reducing power, does not need this ortho-coordination site and prefers to insert 
into the least sterically hindered carbon-bromine bond.19 
 
 
Scheme 3. Regioselective LiCl-mediated magnesium insertion. 
 
 
 
                                                 
21
 Boudet, N.; Sase, S.; Sinha, P.; Liu, C.-Y.; Krasovskiy, A.; Knochel, P. J. Am. Chem. Soc. 2007, 129, 12358. 
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2.3. Halogen-Magnesium Exchange Reaction 
An alternative, very straightforward way to prepare organomagnesium reagents from the 
respective halides is to use another organomagnesium reagent that undergoes a halogen-
magnesium exchange reaction with the halide. The driving force for this kind of 
transformation is the higher stability of the produced organomagnesium compound compared 
to the exchange reagent itself. The order of stability of organometallic reagents with respect to 
the hybridization of the connected carbon atom is the following: Csp > Csp2vinyl > Csp2aryl > 
Csp3primary > Csp3secondary.22 The first example of a bromine-magnesium exchange reaction was 
reported by Prévost in 1931.23 Cinnamyl bromide was reacted with ethylmagnesium bromide 
to furnish cinnamylmagnesium bromide in low yield (Scheme 4).  
 
 
Scheme 4. First example of halogen-magnesium exchange reaction. 
 
Over the last decades, this kind of reaction was studied intensively and nowadays several 
applications, even on industrial scale exist.14 Even if the detailed mechanism of these halogen-
magnesium exchange reactions is still not completely understood, a halogen ate complex is 
assumed to be operative in this process.24 The nature of the halide and the electronic 
properties of the organic substrate play important roles for the rate of halogen-magnesium 
exchange reactions.25 In general, iodides undergo the halogen-magnesium exchange reaction 
faster than bromides, and bromides exchange faster than chlorides. Furthermore, the rate is 
higher, if the organic substrate bears electron-withdrawing groups. Knochel and coworkers 
could establish the reagents iPrMgBr and PhMgCl as widely used halogen-metal exchange 
reactions in organic synthesis.14,26 These reagents tolerate various functional groups and allow 
the preparation of a broad range of organomagnesium reagents from the respective iodides 
(Scheme 5). 
 
                                                 
22
 Hauk, D.; Lang, S.; Murso, A. Org. Process Res. Dev. 2006, 10, 733. 
23
 Prévost, C. Bull. Soc. Chim. Fr. 1931, 49, 1372. 
24
 (a) Hoffmann, R. W.; Brönstrup, M.; Müller, M. Org. Lett. 2003, 5, 313. (b) Böhm, V. P. W.; Schulze, V.; 
Brönstrup, M.; Müller, M.; Hoffmann, R. W. Organometallics 2003, 22, 2925. 
25
 Tamborski, C.; Moore, G. J. J. Organomet. Chem. 1971, 26, 153. 
26
 (a) Boymond, L.; Rottländer, M.; Cahiez, G.; Knochel, P. Angew. Chem. Int. Ed. 1998, 37, 1701. (b) 
Sapountzis, I.; Knochel, P. Angew. Chem. Int. Ed. 2002, 41, 1610. 
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Scheme 5. Examples of halogen-magnesium exchange reactions using iPrMgBr and PhMgCl. 
 
Knochel further improved the halogen-magnesium exchange reaction by introducing the so 
called Turbo-Grignard reagent iPrMgCl·LiCl. Stoichiometric amounts of LiCl are able to 
break aggregates of iPrMgCl and lead to an increased reactivity and solubility of the Grignard 
reagent by formation of a magnesium-lithium ate complexe (Scheme 6).27 
 
 
Scheme 6. Effect of LiCl on iPrMgCl aggregates. 
 
Using the Turbo-Grignard reagent iPrMgCl·LiCl, now highly functionalized aromatic and 
heteroaromatic bromides undergo very efficiently the halogen-magnesium exchange reaction 
to furnish the corresponding magnesiated reagents (Scheme 7).28 
 
 
Scheme 7. Bromine-magnesium exchange reactions using iPrMgCl·LiCl. 
 
                                                 
27
 Krasovskiy, A.; Knochel, P. Angew. Chem. Int. Ed. 2004, 43, 3333.  
28
 Barl, N. M.; Werner, V., Sämann, C.; Knochel, P. Heterocycles, 2014, 88, 827. 
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2.4. Directed Metalation 
A third way to produce magnesiated compounds involves the direct metalation of organic 
substrates. No halide like iodide or bromide is necessary for this kind of reaction. Simply a  
C-H bond having a pka-value lower than the metalation agent is required for this reaction to 
be operative. Historically, lithium-reagents like nBuLi29 or EtLi30 have been used to metalate 
organic substrates. In the following decades, less nucleophilic sterically hindered lithium 
amide bases like LDA and TMPLi have been developed.31 Although many organic molecules 
were lithiated successfully with these lithium-amide bases, the high reactivity of these bases 
has precluded the use of many functionalized substrates. The resulting highly reactive 
aryllithium compounds obtained after metalation are usually only stable at low temperature 
and react with important functional groups such as esters or nitriles even under these mild 
conditions.32 Therefore, respective magnesium amide bases have been established that display 
a much higher functional group tolerance.33 However, due to aggregation of the magnesium 
amides low solubility in organic solvents and low kinetic basicity was observed. To overcome 
these problems, Knochel and coworkers broke these aggregates by addition of stoichiometric 
amounts of LiCl. The most prominent example of such a monomeric highly active mixed 
Mg/Li-base is TMPMgCl·LiCl, that can be prepared by reaction of TMPH with 
iPrMgCl·LiCl.34 Besides outstanding advantages like high solubility (up to 1.3 M in THF) and 
excellent kinetic basicity, TMPMgCl·LiCl is stable at room temperature for many months 
under an inert atmosphere. Using this magnesium-amide base, various functionalized 
(hetero)aromatic systems can be magnesiated with excellent regio- and chemoselectivity at 
convenient temperatures (Scheme 8).35 
Recently, Knochel and coworkers further improved the scope of direct magnesiation reactions 
by establishing TMP2Mg·2LiCl as a chemoselective base for less activated substrates.36 
                                                 
29
 Gilman, H.; Bebb, R. L. J. Am. Chem. Soc. 1939, 61, 109. 
30
 Schlenk, W., Bergmann, E. Ann. Chem. 1928, 463, 98. 
31
 (a) Snieckus, V. Chem. Rev. 1990, 90, 879. (b) Schlosser, M. Angew. Chem. Int. Ed. 2005, 44, 376. 
32
 Haag, B.; Mosrin, M.; Ila, H.; Malakhov, V.; Knochel, P. Angew. Chem. Int. Ed. 2011, 50, 9794. 
33
 (a) Hauser, C. R.; Walker, H. W. J. Am. Chem. Soc. 1947, 69, 295. (b) Eaton, P. E.; Lee. C.-H.; Xiong, Y. J. 
Am. Chem. Soc. 1989, 111, 8016. (c) Schlecker, W.; Huth A.; Ottow, E.; Mulzer, J. J. Org. Chem. 1995, 60, 
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Scheme 8. Regio- and chemoselective functionalizations using TMPMgCl·LiCl. 
 
Organic compounds that contain very sensitive functional groups like nitro or aldehyde 
functionalities could not be compatible with magnesiation conditions. Therefore, milder 
bases, like TMPZnCl·LiCl37 (Scheme 9) and TMP2Zn·2MgCl2·2LiCl38 have been developed. 
Zinc-amide bases also offer the advantage, that once the substrates are zincated, they can 
undergo directly palladium-catalyzed cross-coupling reactions with aromatic halides.4 
The concept of mixed Li/metal amide bases was further extended to alternative metals like Al, 
Mn, Fe, Zr and La.32 
 
 
Scheme 9. Regio -and chemoselective functionalizations using TMPZnCl·LiCl. 
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3. Iron-Catalyzed Unsymmetrical Aryl-Aryl Cross-Couplings 
Palladium, nickel and copper constitute the metals of choice, if chemists aim to synthesize 
complex and functionalized organic molecules involving cross-coupling reactions. Numerous 
applications document their advantageous use with respect to generality and functional-group 
tolerance.6i Nevertheless, the high prize of palladium and its complexes,5 as well as 
toxicological issues associated with nickel and copper,39 have prompted the search for 
alternative metals that combine ecological and economical aspects with high catalytic activity 
and chemical selectivity.  
Iron-catalyzed carbon-carbon bond-forming reactions have emerged from exotic phenomenas 
to indispensable tools in organic synthesis over the last decades.6 Whereas alkyl-aryl,40 alkyl-
alkenyl,41 aryl-alkenyl,41b,41c,41k,42 as well as alkynyl coupling reactions are well 
                                                 
39
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documented,43 the corresponding aryl-aryl cross-coupling reactions are much more 
challenging due to unsufficient catalytic activity of the iron-catalyst and due to undesired 
homo-coupling side-reaction of the organometallic species.44  
The first example of an unsymmetrical biaryl-formation mediated by an iron-catalyst was 
reported by Fürstner in 2002.40b Heteroaromatic chlorides were treated with non-
functionalized (hetero)aryl Grignard reagents (2.3 equiv) at low temperatures (-30 °C) in the 
presence of 5 mol% of Fe(acac)3 in THF. Interestingly, this reaction reached full conversion 
in only 10 min reaction time, revealing the high activity of the iron-catalyst. The excess of 
Grignard reagent was found to be necessary, as large amounts of homo-coupling byproducts 
resulting from the Grignard reagent are observed (Scheme 10). 
 
 
Scheme 10. Iron-catalyzed aryl-aryl bond-formation reported by Fürstner et al.40b 
 
Figadère45 and Plé 46 further investigated this iron-catalyzed aryl-aryl cross-coupling reaction 
between N-heterocyclic halides and simple unfunctionalized aromatic Grignard reagents by 
testing various solvents and additives, showing that the conditions reported by Fürstner were 
indeed optimum. Later, Knochel reported an example using catalytic amounts of iron powder 
for efficient cross-coupling between 2-chloroquinoline and phenylmagnesium bromide 
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(Scheme 11).47 This observation supports the involvement of reduced ferrate species in this 
cross-coupling. 
 
 
Scheme 11. Heteroaryl-aryl bond-formation catalyzed by iron powder. 
 
Knochel and coworkers also demonstrated that the undesired homo-coupling side-reaction can 
be suppressed by using organocopper reagents instead of aryl Grignard reagents. 
Transmetalation of functionalized Grignard reagents with CuCN·2LiCl furnishes the 
respective arylcopper reagents that undergo iron-catalyzed coupling reactions with various 
aromatic iodides in the presence of Fe(acac)3 in THF/DME at elevated temperatures (Scheme 
12).48 
 
 
Scheme 12. Organocopper reagents in iron-catalyzed aryl-aryl cross-coupling reactions. 
 
In 2007, Nakamura et al. showed that aromatic Grignard reagents can in fact undergo iron-
catalyzed cross-coupling reactions with aromatic halides by using a novel catalytic system 
                                                 
47
 Korn, T. J.; Cahiez, G.; Knochel, P. Synlett 2003, 1892. 
48
 (a) Sapountzis, I.; Lin, W.; Kofink, C. C.; Despotopoulou, C.; Knochel, P. Angew. Chem. Int. Ed. 2005, 44, 
1654. (b) Kofink, C. C.; Blank, B.; Pagano, S.; Götz, N.; Knochel, P. Chem. Commun. 2007, 1954. 
 23 
based on FeF3·3H2O and N-heterocyclic carbene ligands.49 Under optimized conditions, the 
iron-catalyst FeF3·3H2O (3 mol%) and the carbene ligand precursor SIPr·HCl (1,3-bis-(2,6-
diisopropylphenyl)-4,5-dihydroimidazolium chloride; 9 mol%) have to be pre-treated with 
EtMgBr to produce the active iron species. Subsequently, the electrophile and the desired 
aromatic Grignard reagent have to be added and the reaction mixture has to be stirred at           
60-120 °C for 24 h to produce the respective biaryl coupling product with negligible amounts 
of homo-coupling byproducts (Scheme 13). 
 
FeF3 3H2O (3 mol%)
+
SIPr HCl (9 mol%)
EtMgBr (18 mol%)
THF, 0 °C to r.t., 4 h
Ar1-Cl (1 equiv)
Ar2-MgBr (1.2 equiv)
THF, 60-120 °C, 24 h
Ar1-Ar2
Ar1 = F-, alkyl-, OMe-, NMe2-, acetal- and SMe-substituted (hetero)aromatics
Ar2 = Me-, OMe-, and F-substituted (hetero)aromatics
N N
iPr
iPr
iPr
iPr
Cl
SIPr HCl
Selected examples:
up to 96% yield
F
F
OMe
81% yield 90% yield
OMe
93% yield 94% yield
NMe2
N
S
74% yield
 
Scheme 13. Iron-carbene catalyst for unsymmetrical biaryl formation reactions. 
 
Even if the authors could improve the iron-catalyzed aryl-aryl cross-coupling reaction 
dramatically by suppressing the undesired homo-coupling reaction significantly, this method 
suffers some disadvantages. First, an expensive N-heterocyclic carbene ligand has to be used 
in combination with toxic iron fluoride salts. Second, the reaction requires high temperatures 
of up to 120 °C and long reaction times. And third, the substrate scope is rather limited. 
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4. Cobalt-Catalyzed Unsymmetrical Aryl-Aryl Cross-Couplings 
The first report on a cobalt-catalyzed cross-coupling reaction goes back to 1939, when 
Gilman and Lichtenwalter described the nearly quantitative formation of homo-coupling 
products from aromatic Grignard reagents by treating them with cobalt chloride.50 
Comparable to iron-catalysis, the formation of those homo-coupling products is undesired, if 
on attempts to perform a cobalt-catalyzed cross-coupling reaction between an aromatic halide 
and an aromatic organometallic reagent. Uemura described the first cobalt-catalyzed synthesis 
of unsymmetrical biaryls via reaction of diaryltellurides with aromatic organomagnesium 
reagents (Scheme 14).51 
 
 
Scheme 14. Cobalt-catalyzed cross-coupling reaction between diaryltelurides and aromatic 
Grignard reagents. 
 
Knochel and Cahiez significantly improved this reaction by coupling activated heteroaromatic 
halides with arylmagnesium reagents in the presence of catalytic amounts of cobalt chloride. 
Interestingly, stericially hindered Grignard reagents like mesitylmagnesium bromide react 
smoothly under the described conditions (Scheme 15).47  
 
 
Scheme 15. CoCl2-catalyzed cross-coupling reactions between heteroaryl chlorides and 
aromatic Grignard reagents. 
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The same authors also reported that cobalt powder can be used as catalyst in some cases.47 
Furthermore, Knochel has shown that also ortho-bromo or ortho-chloro aromatic ketones, 
esters and even aldehydes can be coupled using a cobalt catalyst. Regarding this, the aromatic 
Grignard reagent has to be transmetalated to the respective organocopper reagent using 
CuCN·2LiCl. To reach full conversion, a THF/DME/DMPU solvent mixture has to be 
prepared and additives like Bu4NI and 4-fluorostyrene were found to be crucial.52 Numerous 
polyfunctional biaryls could be synthesized following this procedure (Scheme 16). 
 
X
R
O
ArCu(CN)MgCl
(3 equiv)
Co(acac)2 (7.5 mol%)
Bu4NI (1 equiv)
DME/THF/DMPU (3:2:1)
80 °C, 15 min
F
(20 mol%)
X = Cl, Br
R = ester, ketone, aldehyde
Ar = various functionalized (hetero)aromatics
+
Ar
R
O
Selected examples:
Me
O
CN
77% yield
N
O
NC
Cl
82% yield
O
N
74% yield
S
Br
CO2Et
OMe
79% yield
up to 98% yield
 
Scheme 16. Cobalt-catalyzed cross-coupling of polyfunctional aryl copper reagents with aryl 
bromides and chlorides. 
 
This cobalt-catalyzed reaction could also be extended to aromatic tosylates and even 
fluorides.53 Noteworthy, especially aryl fluorides are usually not very reactive using 
traditional metals like palladium or nickel, due to the inherent strength of the C-F bond that 
prevents metal insertion into this bond. Using pentafluorobenzophenones, the two ortho-
fluorides could be functionalized selectively using an excess of arylcopper reagents (Schemes 
17 and 18).54 
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X
R2
O
ArCu(CN)MgCl
(3 equiv)
Co(acac)2 (7.5 mol%)
Bu4NI (1 equiv)
DME/THF/DMPU (3:2:1)
r.t. to 80 °C, 15 min to 16 h
F
(20 mol%)
X = F, OTs
R1 = H, F, OEt
R2 = ester, ketone
Ar = various functionalized (hetero)aromatics
+
Ar
R2
O
Selected examples:
Ph
O
94% yield
X = F
Ph
O
F
78% yield
X = OTs
O
78% yield
X = OTs
Ph
CO2Et
OMe
51% yield
X = F
up to 98% yield
R1
S
CN
EtO
R1
 
Scheme 17. Cobalt-catalyzed cross-couplings of aryl fluorides and tosylates. 
 
 
Scheme 18. Example for cobalt-catalyzed cross-coupling of pentafluorobenzophenone. 
 
Nakamuras method using metal fluorides and N-heterocyclic carbene ligands could also be 
applied to cobalt, resulting in various aryl-aryl coupling products via reaction of an aromatic 
Grignard reagent with aromatic halides (Scheme 19).49b With cobalt fluoride, better results are 
obtained with aromatic iodides and bromides as electrophiles, whereas with iron fluoride 
higher yields are obtained using aryl chlorides.55 
In 2013, Duan presented a novel cobalt-catalyzed cross-coupling reaction between aryl 
halides and aromatic magnesium and lithium reagents. The presence of 40 mol% of Ti(OEt)4 
was  found  to  suppress  undesired  homo-coupling  side-products  from  the  organometallic  
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CoF2 4H2O (3 mol%)
+
SIPr HCl (6 mol%)
EtMgBr (18 mol%)
THF, 0 °C to r.t., 4 h
Ar1-X (1 equiv)
Ar2-MgBr (1.2 equiv)
THF, 60-120°C, 24 h
Ar1-Ar2
X = Cl, Br, I
Ar1 = F-, alkyl-, OMe-, NMe2- and acetal-substituted (hetero)aromatics
Ar2 = Me-, OMe-, and F-substituted (hetero)aromatics
N N
iPr
iPr
iPr
iPr
Cl
SIPr HCl
Selected examples:
up to 99% yield
F
F
OMe
97% yield
X = Cl
84% yield
X = Br
OMe
N
95% yield
X = Br
N
S
99% yield
X = Br
 
Scheme 19. Cobalt-carbene catalyst for unsymmetrical biaryl formation reactions. 
 
reagent. Interestingly, the reaction can also take place in the presence of a free carboxylic 
acid, a hydroxyl or an amide residue (Scheme 20).56 Even if this reaction displays a broad 
functional group tolerance, a large excess of Ti-salts is present in the reaction mixture and 
toxicological anxious PBu3 is used. 
 
Scheme 20. Co/Ti cooperatively catalyzed biaryl couplings. 
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5. Objectives 
The benzylic arylation of pyridines and related N-heterocycles is an important synthetic 
challenge due to their important biological or material properties.57 So far, the arylation of 
methyl-substituted 5- and 6-membered heterocycles is an unsolved problem. Hence, benzylic 
metalation of a range of methyl-substituted heterocycles should be developed, using the direct 
metalation method described in Chapter 2.4. Subsequent cross-coupling reactions of the 
resulting benzylic organometallic reagents should furnish benzylic arylated heterocycles 
(Scheme 21).58 
 
 
Scheme 21. Intended benzylic arylation of heterocycles. 
 
Furthermore, the regioselectivity of benzylic metalation of lutidines should be investigated. 
Examination of Lewis acidic additives should be undertaken and the effect of these additives 
on the regioselectivity of the metalation should be studied (Scheme 22).  
Another project should focus on iron- and cobalt-catalyzed aryl-aryl cross-coupling reactions. 
As described in Chapter 3 and 4, the formation of unsymmetrical biaryls is still dominated by 
palladium and nickel catalysts. Due to ecological and economical reasons, the replacement of 
these metals by more abundant metals like iron or cobalt is highly desired. Previous reports on  
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Scheme 22. Regioselective benzylic arylation of 2,4-lutidine. 
 
these Csp2-Csp2 cross-coupling reactions using iron or cobalt salts have shown that the key to 
success is the suppression of undesired homo-coupling side products arising from the organo- 
metallic reagent. Therefore, conditions for efficient iron- and cobalt-catalyzed cross-coupling 
reactions between N-heterocyclic halides and aromatic Grignard reagents should be 
developed. The Grignard reagents should be prepared according to Chapters 2.2 and 2.3 
(Scheme 23).59 
 
Scheme 23. Attempted iron- and cobalt-catalyzed cross-coupling reactions. 
 
Furthermore, this coupling reaction should be extended to aromatic halides like 2-
chlorobenzophenone or 2-halogenated protected benzaldehydes as well as to alkenyl halides. 
Alternative metal salts like chromium-, vanadium- or molybdenum-chlorides and -bromides 
should also be tested for their efficiency in similiar Csp2-Csp2 cross-coupling reactions.59 
 
 
 
 
 
 
 
 
                                                 
59
 This project was developed in cooperation with Kuzmina, O. M.; Markiewicz, J. T.; Flubacher, D. and 
Fernandez, S. 
 30 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
B. Results and Discussion 
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1.  Benzylic Arylation of Heterocycles 
1.2. Introduction 
The functionalization of pyridines and related heterocycles is very important due to their 
biological or material properties.57 Especially, the benzylic arylation of pyridines is a 
challenging synthetic problem. Pd-catalyzed arylations of 2-picoline involving a direct C-H 
activation60 have no generality and only scarce examples have been reported. Thus, azaarenes 
bearing electron-withdrawing groups may be arylated at 100 °C with a Pd-catalyst.61 Several 
alternative procedures involving the fragmentation of a 2-(2-pyridyl)ethanol,62 the arylation of 
N-oxides63 or N-iminopyridinium ylides64 have been described. These methods, although 
displaying now a good generality, require modified N-heterocyclic precursors. Also, whereas 
2-picoline (1a) can be functionalized in this way, no arylation on 4-picoline (2a) has been 
described. The difficulty for forming a new carbon-carbon bond with metalated 2-picoline (3) 
(or 4-picoline) may be due to the nature of the palladium complexes65 (4a-c) resulting from a 
reaction with ArPdX (Scheme 24). All these possible structures would be reluctant to undergo 
a reductive elimination due to the chelation of the heterocyclic nitrogen with the Pd-center. 
Hartwig has already shown that Pd-catalyzed aminations are accelerated by a Lewis-Acid 
(BEt3).66 Nolan has also reported that reductive eliminations of Pd-complexes are accelerated 
by AlCl3.67 The presence of an appropriate Lewis-Acid (LA) complexing this heterocyclic 
nitrogen should lead to a new Pd-intermediate such as 5 which will now be prone to undergo a 
fast reductive elimination leading to the cross-coupling product 6. A similar behavior may be 
expected for the arylation of 4-picoline (Scheme 24).  The beneficial effect of Lewis-acids for  
performing  additions  of  2-picoline to imines and enones has already been demonstrated. 68,69 
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 (a) Alberico, D.; Scott, M. E.; Lautens, M. Chem. Rev. 2007, 107, 174. (b) For a special issue on Selective 
Functionalization of C-H Bonds: Chem. Rev. 2010, 110, 575. (c) Kalyani, D.; Deprez, N. R.; Desai, L. V.; 
Sanford, M. S. J. Am. Chem. Soc. 2005, 127, 7330. (d) Activation of Unreactive Bonds and Organic Synthesis, 
Murai, S., Ed.; Springer-Verlag, Berlin Heidelberg, 1999. (e) Dick, A. R.; Sanford, M. S. Tetrahedron 2006, 62, 
2439; (f) Schlosser, M.; Mongin, F. Chem. Soc. Rev. 2007, 36, 1161. (g) Niwa, T.; Yorimitsu, H.; Oshima, K. 
Org. Lett. 2007, 9, 2373. 
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 Burton, P. M.; Morris, J. A. Org. Lett. 2010, 12, 5359. 
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 Niwa, T.; Yorimitsu, H.; Oshima, K. Angew. Chem. Int. Ed. 2007, 46, 2643. 
63
 (a) Campeau, L.-C.; Schipper, D. J.; Fagnou, K. J. Am. Chem. Soc. 2008, 130, 3266. (b) Schipper, D. J.; 
Campeau, L.-C.; Fagnou, K. Tetrahedron 2009, 65, 3155. 
64
 Mousseau, J. J.; Larivée, A.; Charette, A. B. Org. Lett. 2008, 10, 1641. 
65
 For structures of palladium picolyl derivatives, see: (a) Onishi, M.; Hiraki, K.; Maeda, K.; Itoh, T. J. 
Organomet. Chem. 1980, 188, 245. (b) Isobe, K.; Nakamura, Y.; Kawaguchi, S. Bull. Chem. Soc. Jpn. 1989, 62, 
1802. (c) Qian, B.; Guo, S.; Shao, J.; Zhu, Q.; Yang, L.; Xia, C.; Huang, H. J. Am. Chem. Soc. 2010, 132, 3650. 
66
 Shen, Q.; Hartwig, J. F. J. Am. Chem. Soc. 2007, 129, 7734. 
67
 Huang, J.; Haar, C. M.; Nolan, S. P. Organometallics 1999, 18, 297. 
68
 For additions to imines, see: (a) Qian, B.; Guo, S.: Xia, Huang, H. Adv. Synth. Catal. 2010, 352, 3195. (b) 
Rueping, M.; Tolstoluzhsky, N. Org. Lett. 2011, 13, 1095. 
69
 For additions to enones, see: Komai, H.; Yoshino, T.; Matsunaga, S.; Kanai, M. Org. Lett. 2011, 13, 1706. 
 32 
 
Scheme 24. Lewis-acid (LA) promoted benzylic cross-coupling. 
 
Thus, the use of bases (Met-base) bearing a Lewis-acid metal centre for performing the 
metalation was attempted to be investigated. TMPZnCl·LiCl (7) displays a high 
chemoselectivity in various directed zincations of aromatics and heterocycles. Besides, 
TMPZnCl·LiCl (7) proved to be an excellent base for the generation of nitrile and ester 
enolates.70,71 Moreover, TMPZnCl·LiCl is compatible with additional strong Lewis-acids 
(MgCl2, BF3·OEt2) forming frustrated Lewis pairs.72 The goal of the following investigation 
was to examine, if Lewis-acids such as ZnCl2, MgCl2, BF3·OEt2 or Sc(OTf)3 can be combined 
with TMPZnCl·LiCl to promote efficiently the Negishi cross-coupling73 of various methyl-
substituted N-heterocycles. 
 
1.2. Benzylic Cross-Coupling of Pyridines with Aryl Bromides 
At first, it was examined, if TMPZnCl·LiCl is able to metalate picolines. Thus, the zincation 
of 2-picoline (1a) with TMPZnCl·LiCl (7: 2.0 equiv)74 gives the zincated picoline 8a (THF, 
                                                 
70
 (a) Hlavinka, M. L.; Hagadorn, J. R. Tetrahedron Lett. 2006, 47, 5049. (b) Hlavinka, M. L.; Hagadorn, J. R. 
Organometallics, 2007, 26, 4105. 
71
 Duez, S.; Bernhardt, S.; Heppekausen, J.; Fleming, F. F.; Knochel, P. Org. Lett. 2011, 13, 1690. 
72
 (a) Jaric, M.; Haag, B. A.; Unsinn, A.; Karaghiosoff, K.; Knochel, P. Angew. Chem. Int. Ed. 2010, 49, 5451. 
(b) For an excellent review see: Stephan, D. W.; Erker, G. Angew. Chem. Int. Ed. 2010, 49, 46. 
73
 (a) Erdik, E. Tetrahedron. 1992, 48, 9577. (b) Negishi, E.-i.; Valente, L. F.; Kobayashi, M. J. Am. Chem. Soc. 
1980, 102, 3298; (c) Negishi, E.-i. Acc. Chem. Res. 1982, 15, 340. 
74
 Usually, 1.5 equiv of base (7) is used. In this case, 2.0 equiv of base are used due to the presence of the indole 
NH-group. 
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25 °C, 1 h). Its cross-coupling with 5-bromoindole (9a: 0.8 equiv) using 2% Pd(OAc)2 and   
2-4% SPhos75 (50 °C, 7 h) affords the desired pyridine 6a in 86% yield (Scheme 25). 
 
 
Scheme 25. Pd-catalyzed direct cross-coupling of picolines 1a and 2a. 
 
Such cross-coupling reactions can be extended to various substituted aryl bromides (9b-d) 
leading to products 6b-d in 66 to 95% yield (Table 1, entries 1-3). Also, 2-substituted 
pyridines such as 1b-c are metalated with TMPZnCl·LiCl (7) under the same conditions and 
provide the desired products (6e-f) with 4-bromoanisole (9b) in very high yields (92-99%, 
entries 4-5). No arylation of 4-picoline (2a) has been reported in the literature so far. 
However, with TMPZnCl·LiCl (7: 1.5 equiv), a smooth zincation of 2a proceeds readily     
(25 °C, 1 h) and the Pd-catalyzed cross-coupling of 8b with various aryl bromides (9b, 9e-i) 
furnishes the 4-substituted pyridines 10a-f in 70 to 98% yield (Scheme 25 and entries 6-10). 
Also, 2-chloro-4-methylpyridine (2b) similarly reacts and produces the arylated products 10g 
and 10h in 69% yield (entries 11-12). Cross-coupling of the 4-substituted pyridine (10b) with 
4-bromoanisole (9b) leads to the desired product (10i) in high yield (entry 13). 
These smooth cross-couplings may be explained by the role that ZnCl2 plays as Lewis-acid. 
Interestingly, the use of TMPZnCl·MgCl2·2LiCl (prepared from TMPMgCl·LiCl and ZnCl2) 
leads to even faster cross-couplings (at least 6 times faster). However, the reaction is 
complicated by increased amounts of bis-arylation76 making a general use of this Lewis-acid  
                                                 
75
 (a) Walker, S. D.; Barder, T. E.; Martinelli, J. R.; Buchwald, S. L. Angew. Chem. Int. Ed. 2004, 43, 1871. (b) 
Barder, T. E.; Walker, S. D.; Martinelli, J. R.; Buchwald, S. L. J. Am. Chem. Soc. 2005, 127, 4685. (c) Altman, 
R. A.; Buchwald, S. L. Nat. Protocols 2007, 2, 3115. (d) Martin, R.; Buchwald, S. L. Acc. Chem. Res. 2008, 41, 
1461. 
76
 Pd-catalyzed arylation of 2-picoline (1a) with 3-chlorobromobenzene (9d) proceeds in 1 h using 
TMPZnCl·MgCl2·LiCl instead of 6 h when using TMPZnCl·LiCl (7) but led to less product 6d (61%) due to the 
formation of 17% of di-arylated product. 
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Table 1: Direct benzylic cross-coupling of 2- and 4-picoline. 
Entry Picolinea Aryl-Br Product Yield (%)b 
 
 
 
 
 
1 1a (3) 9b:R = 4-OMe 6b:R = 4-OMe 95 
2 1a (6) 9c:R = 4-F 6c:R = 4-F 78 
3 1a (6) 9d:R = 3-Cl 6d:R = 3-Cl 66 
 
 
N
Ph
 
 
 
 
 
 
4 1b (20) 9b 6e 99 
 
 
 
 
 
 
 
 
5 1c (11) 9b 6f 92 
 
 
 
 
 
6 1a (1) 9b 10b: R = 4-OMe 98c 
7 2a (1) 9f: R = 3-Me 10c:R = 3-Me 82 
8 2a (1) 9g:R = 4-NMe2 10d:R = 4-NMe2 70 
9 2a (1) 9h:R = 4-OH 10e:R = 4-OH 84c 
10 2a (1) 9i: R = 4-OPiv 10f:R = 4-OPiv 81c 
 
N
Cl
Me
 
 
 
 
 
 
11 2b (1) 9f 10g 69d 
 
  
 
 
12 2b (1) 9a 10h 69 
 
N
p-OMe-C6H4
 
 
 
 
13 10b (3) 9b 10i 93 
(a) Reaction time (h) for the arylation in brackets. (b) Isolated yield of analytically pure 
product. (c) Pd(OCOCF3)2 was used as the Pd-source. (d) 2% Pd(OAc)2, 4% PCy3 was used. 
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undesirable. A further hint showing the importance of Lewis-acids via a tentative Pd-
intermediate of type 5 (Scheme 24) is found in the cross-coupling reaction of picolines (1a or 
2a) with electron-deficient aryl bromides. Such substrates like 4-bromobenzonitrile (9j) or 
ethyl 4-bromobenzoate (9k) gave disappointing results in the presence of ZnCl2 or MgCl2 as 
Lewis-acids. Therefore, we have screened other powerful alternative Lewis-acids77 such as 
ScCl3, Sc(OTf)3,78 Yb(OTf)3,79 Y(OTf)3.77a Thus, the direct cross-coupling of zincated           
2-picoline (8a) with 4-bromobenzonitrile (9j) gave no product (even after an additional Pd-
ligand screening)80 (Scheme 26). However, in the presence of 10% Sc(OTf)3, an efficient Pd-
catalyzed cross-coupling took place and afforded the coupling product 6g in 87% yield 
(Scheme 26). Similarly, 4-picoline (2a) gave the cross-coupling product 10j only in 41% yield 
without Sc(OTf)3, but the addition of 10% Sc(OTf)3 increased the cross-coupling yield to 
78%  (Scheme 26).  The  effect  of  Sc(OTf)3  may  be best explained by an acceleration of the  
 
 
Scheme 26. Sc(OTf)3 catalyzed cross-coupling of 2-picoline (1a) and 4-picoline (2a) with 
electron-withdrawing substituted aryl bromides (9j-k). 
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 (a) Lewis Acid reagents: a practical approach, Yamamoto, H.; Ed.; Oxford University Press, New York, 
1999. (b) Selectivities in Lewis acid promoted reactions, Schinzer, D.; Ed.; Kluwer Academic, Dordrecht, 1989. 
(c) Lanthanides: Chemistry and Use in Organic Synthesis, Kobayashi, S.; Ed.; Springer-Verlag, Berlin 
Heidelberg, 1999. (d) Acid Catalysis in Modern Organic Synthesis, Vol. 2, Shibasaki, M.; Matsunaga, S.; 
Kumagai, N.; Eds.; Wiley: Weinheim, Germany, 2008, p. 635. 
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 (a) Acid Catalysis in Modern Organic Synthesis, Vol 2, Ogawa, C.; Gu, Y.; Boudou, M.; Kobayashi, S.; Eds.; 
Wiley-VCH Weinheim, Germany, 2008, p. 589. (b) Lewis Acids in Organic Synthesis, Vol. 2, Kobayashi; S.; 
Ed.; Wiley: Weinheim, Germany, 2000, p. 883. (c) Kobayashi, S.; Hachiya, I.; Araki, M.; Ishitani, H. 
Tetrahedron Lett. 1993, 34, 3755. 
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 (a) Transition Metals for Organic Synthesis, Vol. 1, Kobayashi, S.; Ed.; Wiley: Weinheim, Germany, 1998, p. 
285. (b) Kobayashi, S.; Sugiura, M.; Kitagawa, H.; Lam, W. L. Chem. Rev. 2002, 102, 2227. 
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 Screenings of various Pd sources such as Pd(OAc)2, Pddba2, Pd(OCOCF3)2 in combination with ligands like 
SPhos, Xantphos, Davephos, BINAP, tfp, PCy3, PtBu3 as well as PEPPSI, Pd(PPh3)4, PdCl2(dppf) have been 
examined without giving satisfactory results. 
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cross-coupling reductive elimination step due to a complexation of Sc(OTf)3 at the 
heterocyclic nitrogen (see 11a-b, Scheme 26). It is anticipated that electron-withdrawing 
substituents lead to Pd-intermediates of type 4 (Scheme 24) which are especially reluctant to 
undergo a reductive elimination. The effect of a Lewis-acid seems to be crucial in these cases. 
Thus, the cross-couplings of picolines 1a and 2a with various electron-deficient aryl bromides 
(9j-l) are dramatically improved by the presence of 10% Sc(OTf)3 affording the cross-
coupling products 6h and 10k-l in 75-85% yield. In the absence of Sc(OTf)3, the yields of 
cross-coupling lay between 0-51% (Table 2, entries 1-3). 
 
Table 2: Effect of Sc(OTf)3 on the benzylic cross-coupling of 2- and 4-picoline with electron-
deficient electrophiles. 
Entry Picolinea Aryl-Br Productb 
 
 
 
 
1 1a  9k 6h: 85% (31%)c 
 
 
 
 
2 2a 9j 10k: 75% (0%)c 
 
 
 
 
3 2a 9l 10l: 78% (51%)c 
(a) Conditions: 50 °C, 1 h. (b) Isolated yield of analytically pure product. (c) 
Isolated yield of reaction performed without Sc(OTf)3. 
 
The mild zincation of picolines and efficient subsequent cross-coupling allows now to tackle 
regioselectivity issues in the arylation of dimethylpyridines. Thus, the arylation of 2,3-, 3,4- 
and 2,4-lutidines (12a-c) was examined. With 2,3-lutidine (12a), an exclusive zincation with 
TMPZnCl·LiCl (7) occurs at position 2 leading after Pd-catalyzed arylation with 4-bromo-
N,N-dimethylaniline (9g) to the disubstituted pyridine (13a) in 85% yield (Scheme 27). 
Further arylations proceed in excellent yields and are described in Table 3, entries 1-3. In the 
case of 3,4-lutidine (12b), a complete regioselective metalation is observed at position 4 
leading after a cross-coupling with 4-bromoanisole (9b) to the disubstituted pyridine 14 in 
92% yield (Scheme 27). The regioselective arylation of 2,4-lutidine (12c) is more challenging 
since a direct zincation with TMPZnCl·LiCl (7) produces a 2:1 mixture of regioisomers. 
However, the addition of BF3·OEt272a prior to TMPZnCl·LiCl (7) directs the zincation only at 
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position 4 since the complexation of 12c with BF3·OEt2 at the heterocyclic nitrogen hampers 
the metalation by TMPZnCl·LiCl (7) at position 2 for steric factors. Therefore the zincation 
occurs at position 4 leading after cross-coupling with ethyl 4-bromobenzoate (9k) to the 
pyridine (15a) in 82% yield. This behavior is general and several typical aryl bromides, 
chlorides and a triflate (9b, i, j, n-q) undergo regioselective arylations at position 4 leading to 
products 15b-g in 77-98% yield (entries 4-10).81 
 
N Me
Me
N
Me
Me
N Me
Me
Br OMe
Br NMe2
Br CO2Et
N
Me
OMe
N Me
CO2Et
N
NMe2Me
2% Pd(OAc)2, 4% SPhos
50 °C, 2 h
TMPZnClLiCl (7: 1.5 equiv)
(9g: 0.8 equiv)
13a: 85%12a
1)
THF:NEP (10:1), 25 °C, 15 min
2)
2% Pd(OAc)2, 4% SPhos
50 °C, 2 h
TMPZnClLiCl (7: 1.5 equiv)
(9b: 0.8 equiv)
14: 92%12b
1)
THF, 25 °C, 15 min
2)
2% Pd(OAc)2, 4%SPhos
50 °C, 2 h
TMPZnClLiCl (7: 1.5 equiv)
(9k: 0.8 equiv)
15a: 82%12c
1) BF3OEt2, 0 °C, THF
-78 °C, 1 h
3)
2)
 
Scheme 27. Selective cross-couplings of lutidines (12a-12c).82 
 
Table 3: Selective benzylic cross-couplings of lutidines with various aryl bromides, chlorides 
and a triflate. 
Entry Lutidinea Aryl-X Product Yield (%)a 
 
 
 
 
 
1 12a 9b 13b: R = 4-OMe 90 
2 12a 9f 13c: R = 3-Me 91 
                                                 
81
 Interestingly, a less hindered base (iPr)2NZnCl·LiCl is not compatible with the Lewis-acid BF3·OEt2, since it 
forms a stable complex (iPr)2NBF3ZnCl which does not dissociate reversibly under the reaction conditions, 
unlike the frustrated Lewis-acid pair TMPBF3ZnCl.72b 
82
 the presence of N-ethylpyrrolidinone (NEP) leads to shorter reaction times (3 times faster). 
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3 12a 9m: R = 4-CF3 13d: R = 4-CF3 88 
 
 
 
 
 
 
 
 
4 12c 9b 15b: R = 4-OMe 92b 
5 12c 9i 15c: R = 4-OPiv 82b 
6 12c 9j 15d: R = 4-CN 77b 
7 12c 9n: X = OTf, R = 4-OMe 15b: R = 4-OMe 98b 
8 12c 9o: X = Br, R = 2-OMe 15e: R = 2-OMe 92b 
9 12c 9p: X = Cl, R = 3-OMe 15f: R = 3-OMe 86b 
10 12c 9q: X = Cl, R = 4-CF3 15g: R= 4-CF3 88b 
(a) Isolated yield of the analytically pure product. (b) BF3·OEt2 was added prior to 
TMPZnCl·LiCl. 
 
 
1.3. Benzylic Arylation of 2-Methyl-5-Membered Heterocycles Using TMP-Bases 
Next, the arylation of methyl-substituted 5-membered heterocycles was envisioned, as this 
remained by far an unsolved problem.83 The arylation of 1,2-dimethylimidazole (16) occurs 
usually at position 5 and no “benzylic” C-H activation followed by cross-couplings has been 
reported.84,85 Only alkylation reactions on the methyl group have been performed successfully 
after deprotonation with nBuLi.86 Also, the benzylic metalation and subsequent arylation of 2-
methylbenzothiophenes87 and 2-methylbenzofurans87b has not yet been described. Therefore, a 
                                                 
83
 (a) Trost, B. M.; Thaisrivongs, D. A.; Hartwig, J. J. Am. Chem. Soc. 2011, 133, 12439. (b) Ackermann, L.; 
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84
 (a) Aoyagi, Y.; Inoue, A.; Koizumi, I.; Hashimoto, R.; Miyafuji, A.; Kunoh, J.; Honma, R.; Akita, Y.; Otha, A. 
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S.; Mannina, L.; Rossi, R.; Viel, S. J. Org. Chem 2005, 70, 3997. (e) Bellina, F.; Cauteruccio, S.; Di Fiore, A.; 
Rossi, R. Eur. J. Org. Chem. 2008, 5436. (f) Bellina, F.; Cauteruccio, S.; Di Fiore, A.; Marchetti, C.; Rossi, R. 
Tetrahedron 2008, 64, 6060. (g) Toure, B. B.; Lane, B. S.; Sames, D. Org. Lett. 2006, 8, 1979. (h) Liégaut, B.; 
Lapointe, D.; Caron, L.; Vlassova, A.; Fagnou, K. J. Org. Chem. 2009, 74, 1826. (i) Roger, J.; Doucet, H. 
Tetrahedron 2009, 65, 9772. (j) Laidaoui, N.; Miloudi, A.; El Abed, D.; Doucet, H. Synthesis 2010, 15, 2553. 
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 Song, G.; Su, Y.; Gong, X.; Han, K.; Li, X. Org. Lett. 2011, 13, 1968. 
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 (a) Field, L. D.; Messerle, B. A.; Vuong, K. Q.; Turner, P. Dalton Trans. 2009, 18, 3599. (b) Oxenford, S. J.; 
Wright, J. M.; O’Brien, P.; Panday, N.; Shipton, M. R. Tetrahedron Lett. 2005, 46, 8315. (c) Sagae, T.; Ogawa, 
S.; Furukawa, N. Bull. Chem. Soc. Jpn. 1991, 64, 3179. 
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 For benzylic functionalization of 2-methylbenzofuran see: (a) Setoh, M.; Kouno, M.; Miyanohana, Y.; Kori 
M. (Takeda Pharmaceutical Company Limited), US 2010/41891, 2010. (b) Ellingboe, J. W.; Alessi, T. R.; 
Dolak, T. M.; Nguyen, T. T.; Tomer, J. D.; Guzzo, F.; Bagli, J. F.; McCaleb, M. L. J. Med. Chem. 1992, 35, 
1176. (c) Alvarez, M.; Bosch, J.; Feliz, M. J. Heterocycl Chem. 1978, 15, 1089. 
 39 
direct benzylic arylation on a variety of different methyl-substituted 5-membered 
heterocycles, including 2-methyl-imidazoles, -benzothiophenes and -benzofurans and related 
5-membered heterocycles using TMP-bases should be investigated. Thus, by using the 
magnesium base TMPMgCl⋅LiCl (17) and subsequent transmetalation with ZnCl2, we were 
able to zincate 1,2-dimethylimidazole (16) selectively at the 2-methyl position. The resulting 
zincated reagent 18 was used successfully to perform cross-coupling reactions with various 
aryl bromides of type 9 affording 2-benzylated imidazoles (19) in 71-91% yield (Table 4). For 
example, the magnesiation of 1,2-dimethylimidazole (16) with TMPMgCl·LiCl (17:            
1.5 equiv) in THF is complete within 3 h at 25 °C.88 After transmetalation with ZnCl2        
(1.5 equiv, 25 °C, 15 min), the zincated imidazole derivative (18) is treated with ethyl 
4-bromobenzoate (9k: 0.8 equiv) in the presence of 2% Pd(dba)2 and 4% SPhos to provide the 
desired arylated 1,2-dimethylimidazole (19a) at 50 °C within 2 h in 85% yield without the 
formation of a 5-arylated imidazole derivative (Table 4, entry 1). Similarly, cyano and 
trifluoromethyl substituted aryl bromides (9j/l) can be successfully converted leading to the 
imidazole derivatives (19b-c, 71-77%, entries 2 and 3). Also, electron-rich aryl bromides 
bearing alkoxy, pivaloxy, methyl or amino substituents undergo the cross-coupling in 
excellent yields (71-91% yields, entries 4-8) showing the broad scope of this arylation. 
Efforts were made to extend this method to even less acidic methyl-substituted 5-membered 
heterocycles. It was found that 2-methyl benzothiophene (20) was readily metalated with 
TMPLi89 (21: 1.15 equiv, -78 °C, 15 min) in THF.90 After transmetalation with ZnCl2, the 
resulting heterocyclic benzylic reagent (22) was smoothly arylated with various aryl bromides 
using 2% Pd(OAc)2 and 4% SPhos (50 °C, 2 h) leading to the benzothiophenes (23a-h) in        
68-98% yield (Table 5, entries 1-8). Interestingly, the 2,3-dimethylbenzothiophene (20b) 
undergoes an exclusive lithiation at position 2 providing after cross-coupling the 2-benzylated 
product (23i) in 87% yield (entry 9). 
 
 
                                                 
88
 The direct zincation with TMPZnCl·LiCl (7) is too sluggish at 25 °C. 
89
 (a) Mulvey, R. E. Acc. Chem. Res. 2009, 42, 743. (b) Whisler, M. C.; MacNeil, S.; Snieckus, V.; Beak, P. 
Angew. Chem. Int. Ed. 2004, 43, 2206. 
90
 Metalation with TMPMgCl·LiCl (17) can only proceed at elevated temperatures and the yield of the 
subsequent cross-coupling proved to be less high, compared to initial metalation with TMPLi (21). 
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Table 4: Pd-catalyzed benzylic arylation of 1,2-dimethylimidazole (16) leading to products 
of type 19. 
 
Entry Aryl-Br a Product Yield (%)a 
  
 
 
 
1 9k 19a R = 4-CO2Et 85 
2 9j 19b R = 4-CN 71 
3 9l 19c R = 3-CF3 77 
4 9b 19d R = 4-OMe 74 
5 9i 19e R = 4-OPiv 91 
6 9f 19f R = 3-Me 83 
7 9g 19g R = 4-NMe2 79 
 
 
 
 
8 9e 19h 71 
(a) Isolated yield of analytically pure product.  
 
A further extension to the 2-methylbenzofuran scaffold was successful using similar 
conditions. The lithiation of 2-methylbenzofuran (24) was complete within 1 h at -78 °C. 
After transmetalation with ZnCl2 and cross-coupling with various aryl bromides, methyl-
substituted benzofurans (26a-d) were obtained in 52-75% yield (Table 6). In the case of 
cyano-substituted aryl bromides (9j and 9r) we have found, that the addition of 10% Sc(OTf)3 
improves the cross-coupling yield. 
The generality of this approach is demonstrated by performing the arylation of other related 5-
membered heterocycles such as the 2-methyl-indole derivative 2791 and the 2-methyl-
benzimidazole 28. In these cases, TMPZnCl·LiCl (7) proved to be the suitable base and a 
complete zincation could be obtained within 1 h at 25 °C. Thus, cross-coupling of 2-methyl- 
 
                                                 
91
 For preparation of 27, see: Macor, J. E.; Ryan, K.; Newman, M. E. J. Org. Chem. 1989, 54, 4785. 
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Table 5: Benzylic cross-coupling of 2-methylbenzo[b]thiophene (20). 
 
Entry Substratea Aryl-Br Product Yield (%)a 
 
 
 
 
 
1 20a 9k 23a R1 = CO2Et 86 
 
  
        R2 = H  
2 20a 9m 23b R1 = CF3  90 
 
  
        R2 = H  
3 20a 9b 23c R1 = OMe  98 
 
  
        R2 = H  
4 20a 9r R1 = OMe;  23d R1 = OMe 78 
 
 
  R2 = CN         R2 = CN  
5 20a 9i 23e R1 = OPiv  97 
 
 
        R2 = H  
6 20a 9g 23f R1 = NMe2 93 
 
  
       R2 = H  
 
 
 
 
 
7 20a 9s 23g 68 
 
 
 
 
 
 
 
 
8 20a 9e 23h 87 
 
 
 
 
 
 
 
 
9 20b 9b 23i 86 
(a) Isolated yield of analytically pure product. 
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Table 6: Benzylic arylation of 2-methylbenzofuran (24). 
 
Entry Aryl-Br a Product Yield (%)a 
 
 
 
 
1 9k 26a R = 4-CO2Et 64 
2 9j 26b R = 4-CN 52b 
3 9r 26c R = 3-CN 74b,c 
 
 
              4-OMe  
4 9b 26d R = 4-OMe 75d 
(a)Isolated yield of analytically pure product. (b) 10% Sc(OTf)3 was added. (c) 
2% Pd(dba)2 and 4% SPhos was used. (d) 2% Pd(dba)2 and 2% Xantphos was 
used. 
 
indole 27 with 4-bromoanisole 9b gave the indole 29 in 57% yield (Scheme 28). This 
example represents the first benzylic cross-coupling on a 2-methyl-indole. Also, 2-methyl-
benzimidazole (28) can be arylated successfully after zincation with TMPZnCl⋅LiCl (7) with 
4-bromoanisole (9b) to yield the benzoimidazole derivative 30 in 68% yield (Scheme 28). 
 
 
Scheme 28. Benzylic cross-coupling of indole 27 and benzo[d]imidazole 28. 
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2.  Aryl-Aryl Cross-Coupling Reactions Using Alternative Metal 
Catalysts 
2.1. Introduction 
Iron-catalyzed cross-coupling reactions have attracted a lot of attention during the last decade, 
especially because of their economic and ecological advantages over other transition metal-
catalyzed couplings. Moreover, iron catalysts reveal characteristic reactivities and 
selectivities, which cannot be easily obtained with more classical Ni- or Pd-catalysts. Whereas 
iron salts have been employed successfully in various kinds of coupling reactions, sp2-sp2 
cross-coupling reactions remain a major challenge due to the formation of symmetrical biaryls 
via undesired homocoupling as by-products. Therefore, conditions for iron- and related 
cobalt-catalyzed coupling reactions between N-heterocyclic halides and aromatic Grignard 
reagents should be examined. 
 
2.2. Iron-Catalyzed Cross-Coupling of N-Heterocyclic Chlorides and Bromides with 
Arylmagnesium Reagents Using tBuOMe as Solvent 
In preliminary experiments, the cross-coupling between 2-chloropyridine (31a) and PhMgCl 
(32a) was examined. Thus, catalytic amounts (5 mol%) of various iron salts like Fe(acac)2, 
Fe(acac)3 or the related Fe(TMHD)3 (entries 1-3 of Table 7) and iron halides such as FeCl2, 
FeCl3, FeBr2 or FeBr3 (entries 4-7) as well as Fe(OTf)3 (entry 8) gave only moderate yields of 
the desired cross-coupling product 33a (46-63%) in THF at room temperature. Also, the use 
of iron fluorides and iodide led to only traces of product at room temperature (entries 9-11). 
Polar co-solvents like NMP hampered the cross-coupling (entry 12). Unpolar solvents like    
n-hexane or toluene did not display any considerable improvement (entries 13-14).92 
However, ethereal solvents such as diethyl ether or tBuOMe dramatically increased the GC-
yield up to 87% affording after isolation the arylated pyridine 33a in 84% yield (entries      
15-16). Since comparable yields are obtained using tBuOMe or Et2O, we have pursued our 
investigations using the industry-friendly solvent tBuOMe. 
The use of such ethereal solvents proved to be a key determinant and allowed us to extend this 
cross-coupling to various other N-heterocycles. In order to study the reaction scope, we have 
first varied the N-heterocyclic chlorides or bromides and determined their reactions with 
PhMgCl (32a) in tBuOMe at room temperature.93 Thus, we observed that 2-bromopyridine 
                                                 
92
 The low yields in entries 1-14 of Table 7 are due to the fact that the reaction conversion never reaches 100% 
for these substrates. 
93
 Since PhMgCl is prepared in THF, the cross-coupling reaction is in fact performed in a mixture of THF and 
tBuOMe (ca. 2:5). 
 44 
(1b) reacted with PhMgCl at a faster rate for completion than 2-chloropyridine (70 min 
instead of 90 min) and produced 33a in the same yield (83%, entry 2 of Table 8). Substituted 
bromo- or chloro-pyridines such as 2-chloro-4-picoline (31c) and 2-bromo-5-chloropyridine 
(31d) reacted smoothly with similar reaction times leading to the pyridines 33b and 33c in  
78-84% yield (entries 3 and 4). Interestingly, the presence of a tert-butoxycarbonyl group in 
position  3  (31e)  dramatically  increased  the  reaction  rate  leading to full conversion within  
 
Table 7: Optimization of the conditions for reaction of pyridyl chloride (31a) with PhMgCl 
(32a) in the presence of various Fe-salts. 
 
Entry Fe-salta Solvent Reaction timeb Yield (%)c 
1 Fe(acac)2 THF 2 h 46 
2 Fe(acac)3 THF 2 h 55 
3 Fe(TMHD)3 THF 2 h 53 
4 FeCl2 THF 5 h 56 
5 FeCl3 THF 2 h 55 
6 FeBr2 THF 2 h 62 
7 FeBr3 THF 1.5 h 63 
8 Fe(OTf)3 THF 5 h 60 
9 FeF2 THF 20 h tracesd 
10 FeF3 THF 20 h tracesd 
11 FeI2 THF 20 h tracesd 
12 FeBr3 THF/NMPe 2 h traces 
13 FeBr3 n-hexane 2 h 53 
14 FeBr3 toluene 1.5 h 14 
15 FeBr3 Et2O 1.5 h 73, 87,f (84)f 
16 FeBr3 t-BuOMe 1.5 h 75, 85,f (82)f 
(a) 5 mol% of Fe-salt was used. (b) Reaction time until reaction completion according to GC 
analysis. (c) Calibrated GC-yield using undecane (C11H24) as internal standard. Numbers in 
brackets indicate isolated yields. (d) Starting material was not consumed even after 20 h. (e) A 
mixture of THF/NMP (5:1) was used. The reaction of PhMgCl with NMP was dominant. (f)  
3 mol% of FeBr3 was used. 
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5 min (entry 5). The cross-coupling product 33d was isolated in 60% yield. No starting 
chloride was detected and the relatively moderate yield may be due to a polymerization of 
31e. The annulation of the pyridine ring with a benzene moiety also accelerated the reaction 
rate and the cross-couplings of PhMgCl with 2-chloroquinoline (31f) or 1-chloroisoquinoline 
(31g) were completed in 5 min and gave the expected phenylated N-heterocycles 33e and 33f 
in 88-90% yield (entries 6 and 7). The cross-coupling was also extended to diazines. Whereas 
the 2-chloropyrimidine derivative 31h reacted with PhMgCl within 2 h providing the arylated 
pyrimidine 33g in 76% yield (entry 8), the more sensitive chloro-pyridazine 31i and pyrazine 
31j required 3-5 h for the reaction to go to completion, but led to the phenylated products in 
only 22-24% yield (entries 9 and 10).94 
 
Table 8: Scope of iron-catalyzed cross-coupling of N-heteroarylchlorides and -bromides 31a-
31j with PhMgCl (32a). 
Entrya Substrate Reaction time Product Yield (%)b 
 
 
 
 
 
1 31a: X = Cl 1.5 h 33a 82 
2 31b: X = Br 70 min 33a 83 
 
N Cl
Me
 
 
N Ph
Me
 
 
3 31c 2 h 33b 84 
 
 
 
 
 
4 31d 70 min 33c 78 
 
 
 
 
 
5 31e 5 min 33d 60 
 
 
 
 
 
6 31f 5 min 33e 88 
 
N
Cl
 
 
 
 
                                                 
94
 The use of other heterocyclic halides, like 3- and 4-chloropyridine, 2-chlorothiophene or 2-bromofuran as well 
as standard haloarenes resulted in only low yields. 
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7 31g 5 min 33f 90 
 
 
 
 
 
8 31h 2 h 33g 76 
 
 
 
 
 
9 31i 5 h 33h 22c 
 
 
 
 
 
10 31j 3 h 33i 24c 
(a) The reaction was performed on a 1 mmol scale with 3 mol% of FeBr3 in THF:tBuOMe (ca. 
2:5) at room temperature. (b) Isolated yield. (c) GC-yield. 
 
Next, the nature of the Grignard reagent95 was varied using typical N-heterocyclic chlorides 
and bromides (31b, 31f, 31g) as electrophiles (Table 9). In all cases, the Fe-catalyzed cross-
couplings were fast (2 min to 5 h) and led to complete conversion. Both electron-rich and 
electron-poor substituents can be present in the Grignard reagent. First, the substitution 
pattern of the arylmagnesium reagent was examined and it was found that ortho-, meta- and 
para-substituted Grignard reagents can be used. Whereas m-TolMgBr·LiCl (32b) and           
p-TolMgBr·LiCl (32c) react in similar rates as the unsubstituted magnesium reagent, the 
presence of an ortho-methyl substituent in o-TolMgBr·LiCl (32d) reduced the reaction rate 
(compare entry 3 of Table 9 with entry 6 of Table 8). However, in all cases excellent yields 
(80-93%; entries 1-3 of Table 9) were obtained. Various electron-poor substitutents like a 
trifluoromethyl group (like in 3-trifluoromethylmagnesium bromide 32e; and in 3,5-
ditrifluoromethylphenylmagnesium bromide 32f; entries 4-6), a fluorine-group (as in 4-
fluorophenylmagnesium bromide 32g; entries 7 and 8) or a chlorine-goupe (like in 32h; entry 
9) were well tolerated in the cross-couplings providing the expected products in 66-92% yield 
(entries 4-9). Interestingly, also electron-rich substituents such as methoxy- (see reagents 32i 
and 32j; entries 10-12), methylenedioxy- (see reagent 32k; entry 13) and pivalate-groups 
(OPiv; see reagent 32l; entry 14) were compatible with rapid iron-catalyzed cross-couplings. 
The more sensitive Boc-protected Grignard reagent 32m also smoothly underwent the cross-
                                                 
95
 The Grignard reagents were prepared by LiCl-mediated Mg insertion. 
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coupling with 2-chloroquinoline leading to the 2-arylated quinoline 33x in 84% yield (entry 
15). An amino-substituent did not disturb the cross-coupling and the Grignard reagent 32n 
reacted with 31f within 5 min providing the product 33y in 82% yield (entry 16). 
 
Table 9: Iron-catalyzed cross-couplings of N-heteroarylchlorides and -bromides with various 
Grignard reagents. 
Entrya Grignard reagent Substrate; 
Reaction time 
Product; Yieldb 
  
m-TolMgBr·LiCl  
 
1 32b 31b; 1.5 h 33j; 80% 
 
 
 
 
p-TolMgBr·LiCl 
N
Cl
 
N
Me
 
2 32c 31g; 2 min 33k; 93% 
 
 
o-TolMgBr·LiCl 
 
 
3 32d 31f; 45 min 33l; 84% 
 
 
 
 
 
4 32e 31f; 15 min 33m; 92% 
 
 
  
 
 
5 32e 31b; 2 h 33n; 66% 
  
 
 
N
Cl
 
N
CF3F3C
 
6 32f 31g; 5 h 33o; 75% 
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7 32g 31b; 5 min 33p; 68% 
 
 
N
Cl
 
N
F
 
8 32g 31g; 5 min 33q; 90% 
 
 
 
 
9 32h 31f; 5 min 33r; 84% 
 
 
 
 
10 32i 31b; 10 min 33s; 82% 
  
 
 
11 32i 31f; 5 min 33t; 87% 
 
 
N
Cl
 
 
12 32j 31g; 5 min 33u; 71% 
 
 
 
 
13 32k 31f; 5min 33v; 81% 
 
 
N
Cl
 
N
OPiv
 
14 32l 31g; 15 min 3w; 80% 
 
   
15 32m 31f; 15 min 33x; 84% 
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16 32n 31f; 5 min 33y; 82% 
(a) The reaction was performed on a 1 mmol scale with 3 mol% of FeBr3 in THF:tBuOMe (ca. 
2:5) at room temperature. (b) Isolated yield. 
 
Even though the mechanism of this cross-coupling could not yet be elucidated, we noticed 
that the use of Fe(II) or Fe(III) salt led to similar results. Reducing the Fe(III)-catalyst in situ 
with iPrMgCl prior to cross-coupling, desactivated the catalytic system and hampered the 
coupling reaction. The use of an apolar co-solvent like tBuOMe was found to be vital to 
achieve high yields mainly by avoiding homo-coupling products. 
 
2.3.  Ligand-Accelerated Fe- and Co-Catalyzed Cross-Coupling Reactions between 
 N-Heterocyclic Halides and Arylmagnesium Reagents 
In Chapter 2.2 one can see that the iron-catalyzed cross-coupling reaction between 2-
chloroquinoline (31f) and PhMgCl (32a) proceeds much faster than the related coupling 
reaction using 2-chloropyridine (31a) as electrophile. Therefore, we were wondering, if the 
quinoline moiety that is certainly responsible for these fast couplings, could be used as a 
separate ligand, and if this ligand could accelerate iron-catalyzed cross-coupling reactions of 
related substrates with arylmagnesium reagents.  
The cross-coupling of 2-chloroquinoline (31f) with PhMgCl (32a) in the presence of 3% 
FeBr3 in tBuOMe:THF is completed at 25 °C in 5 min (producing the phenylated product 33e 
in 88% yield; Scheme 29), the cross-coupling of the 2-chloropyrimidine 31h under the same 
reaction conditions requires 2 h for completion and provides the arylated pyrimidine 33g in 
76% yield. However, carrying out the same reaction in the presence of 7 mol% quinoline 
leads to a reaction completion within 5 min (ca. 50 times faster reaction!) and an increased 
yield of 33g (89% isolated yield, Scheme 29). 
Prompted by these results, a ligand-screening was undertaken. NMP and TMEDA that have 
been traditionally used for Fe-catalysis had a detrimental effect under our conditions 
(compare entries 1-4 of Table 10). We systematically examined substituted quinolines. 
Erosion of the rate enhancement occurs when a methyl group is attached to either the 2- or 8-
position (entries 5 and 6), and only a slight improvement can be seen when a methyl group is 
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Scheme 29. Rate acceleration and improved yield of Fe-catalyzed cross-couplings in the 
presence of quinoline. 
 
placed at position 6 (entry 7). Benzo[h]quinoline and acridine led even to a decrease in yield 
(entries 8 and 9). Electron-donating groups have a positive effect while electron-withdrawing 
groups decrease the catalytic activity of the quinoline core (compare entries 10-14). Finally, it 
was discovered that isoquinoline gave the best results with a 92% yield after 15 min (entry 
15). 1-Methyl isoquinoline had a similar catalytic activity as isoquinoline, but surprisingly, 
electron-rich 1-benzyl-6,7-dimethoxyisoquinoline performed very poorly (compare entries 16 
and 17). Two nitrogen-containing heterocycles hindered the reaction (entries 18 and 19).  
 
Table 10: Screening of different additives for Fe-catalyzed cross-coupling reaction of 2-
chloropyridine (31a) with PhMgCl (32a). 
 
Entry Additive Yield of 33a (%)a 
1 without additive 40 
2 quinoline 75 
3 NMP 0 
4 TMEDA 32 
5 2-methylquinoline 67 
6 8-methylquinoline 48 
7 6-methylquinoline 82 
8 benzo[h]quinoline 30 
9 acridine 32 
10 4-methoxyquinoline 73 
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11 6-methoxyquinoline 82 
12 4-((tert-butyldimethylsilyl)oxy)quinoline 75 
13 6-((tert-butyldimethylsilyl)oxy)quinoline 83 
14 quinoline-3-carbonitrile 43 
15 isoquinoline 92 (89)b 
16 1-methylisoquinoline 91 
17 1-benzyl-6,7-dimethoxyisoquinoline 28 
18 2,9-diphenyl-1,10-phenanthroline 27 
19 4-(dimethylamino)pyridine 25 
20 styrene 40 
21 1-methoxy-3-vinylbenzene 67 
22 1-methoxy-4-vinylbenzene 68 
23 2-vinylpyridine 37 
(a) Yield determined after 15 min by integration of a GC-chromatogram and 
comparison against undecane as a calibrated internal standard. (b) Isolated yield 
after purification by flash column chromatography. 
 
Knochel and coworkers have shown that 4-fluorostyrene promotes Co-catalyzed coupling 
reactions.96 However, styrene had no effect (entry 20), and various substituted styrene 
derivatives caused only a moderate rate enhancement (entries 21-23). Lastly, the amount of 
isoquinoline was varied from 1-100% and it was found that 10% of the ligand was optimum. 
It was also noted that isoquinoline (or quinoline) was not consumed during the cross-
coupling. With isoquinoline, the ability of other metallic salts to undergo rate-enhanced cross-
coupling reactions was tested. In response to the current debate as to whether trace impurities 
of Cu in commercial samples of Fe salts can be the cause of catalytic activity,97 CuBr2 was 
tested and none to minimal activity was found (compare entries 1-2 with 3-4 of Table 11). A 
mixture of FeBr3 and CuBr2 displayed no synergistic benefit, as the yield was essentially the 
same as when no Cu is added (entry 5). Vanadium salts also had very little catalytic activity 
(entries 6-9). But, isoquinoline can also be used as a ligand to enhance the yield of Co-
                                                 
96
 (a) Jensen, A. E.; Knochel, P. J. Org. Chem. 2002, 67, 79. (b) Rohbogner, C. J.; Diène, C. R.; Korn, T. J.; 
Knochel, P. Angew. Chem. Int. Ed. 2010, 49, 1874. 
97
 For the role of metal contaminants in iron catalysis, see: a) Buchwald, S. L.; Bolm, C. Angew. Chem. Int. Ed. 
2009, 48, 5586. (b) Larsson, P.-F.; Correa, A.; Carril, M.; Norrby, P.-O.; Bolm, C. Angew. Chem., Int. Ed. 2009, 
48, 5691. (c) Thomé, I.; Nijs, A.; Bolm, C. Chem. Soc. Rev. 2012, 41, 979. 
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catalyzed reactions (entries 12 and 13).98 Since both Fe and Co had similar activity, both of 
these transition metals were utilized, while exploring the scope of this new catalytic system. 
Using isoquinoline as a ligand (10 mol%), it is possible to obtain the expected cross-coupling 
products with a variety of chloro- or bromo-substituted pyridines as well as with a fair range 
of Grignard reagents. Good yields of the substituted pyridines 34a-34h (65-91%) were 
obtained especially with electron-rich Grignard reagents (entries 1-6 of Table 12) as well as 
with electron-poor 4-fluorophenylmagnesium bromide 32g to give pyridine 34g (77-79% 
yield, entry 7). It is possible to couple the polyfunctional pyridine 35h with the sensitive ester- 
substituted Grignard compound 32l to produce pyridine 34h in 65% yield (entry 8). Often 
both Co- and Fe-catalyzed couplings proceed with comparable yield, and it is difficult to 
favour one metallic salt as a superior catalyst for all substrates. Pyrimidines, which are 
common motifs in pharmaceuticals, can be produced from the same set of Grignard reagents 
to yield functionalized N-heterocycles 34h-34n in 60-95% yield (entries 11-14). Triazines are 
of great importance as material building blocks and as agrochemicals. This new method 
allows various chlorotriazines to be cross-coupled with magnesium reagents, leading to the 
desired products (34o-34r) in 61-84% yield (entries 15-18). 
 
Table 11: Performance of different transition metals with isoquinoline-promoted cross-
coupling reactions. 
 
Entry Metal salt Isoquinoline (mol%) Yield of 33a (%)a 
1 FeBr3 0 40 
2 FeBr3 10 92 (89)b 
3 CuBr2c 0 0 
4 CuBr2 10 2 
5 FeBr3 + CuBr2 10 89 
6 VCl3 0 0 
                                                 
98
 (a) Ohmiya, H.; Yorimitsu, H.; Oshima, K. Chem. Lett. 2004, 33, 1240. (b) Amatore, A.; Gosmini, C. Angew. 
Chem. Int. Ed. 2008, 47, 2089. (c) Gosmini, C.; Bégouin, J.-M.; Moncomble, A. Chem. Commun. 2008, 3221. 
(d) Moncomble, A.; Le Floch, P.; Gosmini, C. Chem.–Eur. J. 2009, 15, 4770. (e) Cahiez, G.; Chaboche, C.; 
Duplais, C.; Moyeux, A. Org. Lett. 2009, 11, 277. (f) Murakami, K.; Yorimitsu, H.; Oshima, K. Org. Lett., 2009, 
11, 2373. (g) Gosmini, C.; Moncomble, A. Isr. J. Chem. 2010, 50, 568. (h) Bégouin, J.-M.; Rivard, M.; Gosmini, 
C. Chem. Commun 2010, 46, 5972. (i) Qian, X.; Auffrant, A.; Felouat, A.; Gosmini, C. Angew. Chem. Int. Ed. 
2011, 50, 10402. (j) Moncomble, A.; Le Floch, P.; Lledos, A.; Gosmini, C. J. Org. Chem. 2012, 77, 5056. (k) 
Nicolas, L.; Angibaud, P.; Stansfield, I.; Bonnet, P.; Meerpoel, L.;Reymond, S.; Cossy, J. Angew. Chem. Int. Ed. 
2012, 51, 11101. 
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7 VCl3 10 2 
8 VCl4 0 5 
9 VCl4 10 9 
10 MnCl2 0 28 
11 MnCl2 10 14 
12 CoCl2 0 46 
13 CoCl2 10 90 
(a) Yield determined after 15 min by integration of a GC-chromatogram and comparison 
against undecane as a calibrated internal standard. (b) Isolated yield after purification by flash 
column chromatography. (c) Cu2O was also used and gave the same results. 
 
Table 12: Scope of Co- and Fe-catalyzed cross-coupling reactions utilizing isoquinoline as a 
ligand. 
 
Entry Starting material Grignard reagent Producta 
  
 
 
 
 
1 35a 32i 34a; Fe: 91% 
 
  
        Co: 85% 
  
 
 
 
N
Cl
NMe2
 
2 35b 32n 34b; Fe: 82% 
 
  
         Co: 77% 
 
N Br
S
 
 
 
 
N
S
TMS
 
3 35c 32o 34c; Fe: 65% 
 
  
         Co: 70% 
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N
F
OTBS
 
4 35d 32p 34d; Fe: 71% 
 
  
         Co: 79% 
 
 
 
N Br
Cl
Br
 
 
 
 
N
Cl
Br
Me
MeMe
 
5b 35e 32q 34e; Co: 82% 
  
 
 
 
 
6c 35f 32r 34f; Co: 65% 
 
 
 
N
MeO
F
 
7 35g 32g 34g; Fe: 77% 
 
  
         Co: 79% 
 
 
N Br
F
Cl
 
 
 
 
 
N
F
Cl
OPiv
 
8 35h 32l 34h; Fe: 65% 
 
 
 
 
9 35i 32i 34i; Co: 78% 
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10 35j 32g 34j; Fe: 82% 
 
  
        Co: 67% 
 
 
 
 
11d 31h 32s 34k; Fe: 78% 
 
  
        Co: 63% 
 
 
N
N Cl
Cl
 
 
 
 
N
N
OTBS
OTBS
 
12e 35k 32p 34l; Fe: 95% 
 
 
 
 
 
 
 
N
N
Cl
F
OMe
OMe
 
13 35l 32t 34m; Co: 68% 
 
 
 
N
N
CF3
F
Cl
 
14 35m 32u 34n; Fe: 61% 
 
  
         Co: 60% 
 
 
  
15 35n 32i 34o; Fe: 81% 
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         Co: 79% 
 
N
N
N
Cl
N
N
 
 
N
N
N
Ph
N
N
 
16f 35o 32a 34p; Fe: 76% 
 
 
  
17g 35p 32v 34q; Fe: 84% 
 
  
         Co: 79% 
 
   
18 35q 32t 34r; Fe: 61% 
(a) Isolated yield after purification by flash column chromatography. (b) Reaction run at       
25 °C for 5 h. (c) Reaction run at 25 °C for 1 h. (d) Reaction run at 25 °C for 30 min. (e)        
4 equivalents of 32p were used. (f) Reaction run at 50 °C for 12 h. (g) Reaction run at 25 °C 
for 12 h. 
 
The synthesis of heteroaryl-heteroaryl coupling products is often challenging. In the case of 
Pd- or Ni-catalysis, deactivation of the catalyst is observed due to chelation of the product 
with the catalyst.99 However, it was noted that both Fe- and Co-catalysts promoted by 10% 
isoquinoline allow smooth cross-couplings with either the 3-magnesiated benzothiophene 32w 
or the 2-magnesiated heterocycle 32x to afford heterobyaryls 34s and 34t in 61-66% isolated 
yield (Scheme 30). 
 
                                                 
99
 (a) Hanan, G. S.; Schubert, U. S.; Volkmer, D.; Rivière, E.; Lehn, J.-M.; Kyritsakas, N.; Fischer, J. Can. J. 
Chem. 1997, 75, 169. (b) Kaes, C.; Katz, A.; Hosseini, M. W. Chem. Rev. 2000, 100, 3553. (c) Bedel, S.; Ulrich, 
G.; Picard, C.; Tisnès, P. Synthesis 2002, 1564. (d) Comprehensive Coordination Chemistry II, Vol 1; 
McCleverty, J. A.; Meyer, T. J.; Eds.; Elsevier, Oxford, 2004, 1. 
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N Br
TMS
35a
N
TMS
34s
N Br
TMS
35a
N
TMS
34t
S
S
Fe: 64%
Co: 66%
32w (2 equiv)
3% FeBr3 or CoCl2
10% isoquinoline
tBuOMe:THF
25 ºC, 24 h
32x (2 equiv)
3% FeBr3 or CoCl2
10% isoquinoline
tBuOMe:THF
25 ºC, 12 h
Fe: 61%*
Co: 66%
*reaction
run at 50 ºC
S
MgBrLiCl
S
MgClLiCl
 
Scheme 30. Heteroaryl-heteroaryl cross-coupling reactions between bromopyridine 35a and 
benzothiophene. 
 
Sensitive functional groups such as alkynes, which are prone to undergo carbometallation 
with Fe-catalysis,100 gave poor yields of cross-coupling products. However, it was found that 
the use of 3% CoCl2 and 10% isoquinoline improved the yield and allows the isolation of 
pyridine 34u in 62% yield (Scheme 31). 
 
 
Scheme 31. Cross-coupling reactions of acetylene-containing pyridine 35r. 
 
In order to probe the mechanism of Fe- and Co-catalyzed cross-coupling reactions, we have 
prepared radical clock 35s.101 Treatment of this unsaturated pyridine 35s with PhMgCl (32a), 
using either FeBr3 or CoCl2, produces a 4:1 mixture of the expected cross-coupling product 
34v and the cyclized pyridine 36 indicative of radical intermediates. The addition of 
                                                 
100
 (a) Hojo, M.; Murakami, Y.; Aihara, H.; Sakuragi, R.; Baba, Y.; Hosomi, A. Angew. Chem. Int. Ed. 2001, 40, 
621. (b) Zhang, D.; Ready, J. M. J. Am. Chem. Soc. 2006, 128, 15050. (c) Shirakawa, E.; Ikeda, D.; Masui, S.; 
Yoshida, M.; Hayashi, T. J. Am. Chem. Soc. 2012, 134, 272. (d) Ilies, L.; Yoshida, T.; Nakamura, E. J. Am. 
Chem. Soc. 2012, 134, 16951. 
101
 (a) Wakabayashi, K.; Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2001, 123, 5374. (b) Ohmiya, H.; 
Yorimitsu, H.; Oshima, K. J. Am. Chem. Soc. 2006, 128, 1886. (c) Manolikakes, G.; Knochel, P. Angew. Chem. 
Int. Ed. 2009, 48, 205. (d) Guisán-Ceinos, M.; Tato, F.; Bunuel, E.; Calle, P.; Cárdenas, D. J. Chem. Sci. 2013, 4, 
1098. 
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isoquinoline did not change the product ratio, but as expected, it improved the yields 
(compare entries 1-4 of Table 13). These results indicate that both Fe- and Co-catalyzed 
cross-couplings undergo the radical pathway, at least partially. Interestingly, the 
corresponding Pd- and Ni-catalyzed cross-couplings, using 3% Pd(Ph3P)4 or 3% NiCl2(dppe) 
provided much less, if any, of cyclized products. 
 
Table 13: Cyclization reactions of 35s indicative for radicals. 
 
Entry Catalyst 34v:36 Yield (%)a 
1 FeBr3 80:20 47 
2 FeBr3 /isoquinoline 80:20 62 
3 CoCl2 80:20 72 
4 CoCl2 /isoquinoline 80:20 78 
5b Pd(Ph3P)4 100:0 64 
6 NiCl2(dppe) 95:5 67 
(a) Isolated yield after purification by flash column chromatography. (b) Reaction was 
performed at 50 °C. 
 
 
2.4. Chromium(II)-Catalyzed Cross-Coupling Reactions between Csp2-Centers 
In the search for alternative metal catalysts having an acceptable low toxicity, we have 
examined the potential use of chromium salts.102 Although CrVI is highly toxic (ORL-RAT 
LD50 = 50-150 mg/kg), CrII has a much lower toxicity (ORL-RAT LD50 = 1870 mg/kg), also 
                                                 
102
 For key coupling reactions using chromium(II)-salts see: (a) Okude, Y.; Hirano, S.; Hiyama, T.; Nozaki, H. 
J. Am. Chem. Soc. 1977, 99, 3179. (b) Okude, Y.; Hiyama, T.; Nozaki, H. Tetrahedron Lett. 1977, 3829. (c) 
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compared to other metals: ORL-RAT LD50(NiCl2) = 105 mg/kg, (PdCl2) = 2700 mg/kg, 
(CoCl2) = 766 mg/kg, (MnCl2) =1480 mg/kg, (FeCl2) = 450 mg/kg.103 
Preliminary experiments showed that chromium-catalyzed cross-couplings between Csp2-
centers proceed quite smoothly and lead to significantly lower amounts of homo-coupling 
side-products compared to iron or cobalt. Thus, the reaction of 2-chloropyridine (31a,         
1.0 equiv) with PhMgCl (32a, 2.3 equiv) in THF in the presence of 3% CrCl2 (purity 99.99%) 
is complete within 15 min at 25 °C, affording the desired cross-coupling product 33a in 90% 
yield. GC-analysis of the crude reaction mixture indicated that less than 1% of the homo-
coupling product (biphenyl) is obtained (Scheme 32). Performing the same reaction with 3% 
FeBr3 or 3% CoCl2 under optimized conditions leads to about 15% of the homo-coupling 
product. A solvent screening (THF, n-hexane, toluene and tBuOMe) showed that THF was 
the optimal solvent. The optimization of the reagent stoichiometry indicated that only a small 
excess of Grignard reagent (1.2 equiv) was required. For all subsequent reactions standard 
grade CrCl2 (purity 97%) was used, since no difference with CrCl2 (purity 99.99%) was 
observed. Also, performing the cross-coupling with 5% MnCl2 leads, under optimum 
conditions, to only 58% yield of 33a104 compared to 90% yield obtained with 3% CrCl2. 
 
 
Scheme 32. Chromium-catalyzed cross-coupling between 2-chloropyridine (31a) and 
PhMgCl. 
 
The reaction scope of this new cross-coupling proved to be quite broad. Thus, a range of      
N-heterocyclic chlorides and bromides can be readily used (Table 14). PhMgCl (32a) also 
undergoes a smooth cross-coupling with 2-bromo-3-(but-3-en-1-yl)pyridine (35s; 25 °C,      
15 min), leading to the 2,3-disubstituted pyridine 34v in 95% yield (entry 1 of Table 14). 
Interestingly, no radical cyclization product is observed in this cross-coupling (similar iron 
and cobalt cross-couplings produce 20% of radical cyclization product). Both electron-rich 
and electron-poor Grignard reagents can be used for such cross-couplings. Thus, the sterically 
hindered bromo-pyridine 35b reacts with 4-N,N-dimethyl-aminophenylmagnesium bromide 
(32n) within 1.5 h at 25 °C, producing the 2,3-diarylated pyridine 34b (80% yield; entry 2). 
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Also, the electron-poor Grignard reagent 32y reacts with 2-bromo-3-chloropyridine (35t) in 
15 min at 25 °C, leading to the pyridine 37a in 76% yield (entry 3). The similar cross-
coupling performed with 3% of FeBr3 gives only traces of product and significant amounts of 
homo-coupling. 2-Chloro-5-fluoropyridine (35u) also undergoes the cross-coupling reaction 
with the sensitive ester-substituted Grignard reagent 32l to give the pyridine 37b in 66% yield 
(entry 4). Further N-heterocyclic halides such as the 2-chloroquinoline 35j and the 4-
chloroquinoline 35v, react well with Grignard reagents 32k and 32n, affording the expected 
products 37c and 37d (74-78%; entries 5 and 6). In contrast, the corresponding iron-catalyzed 
cross-coupling with the 4-chloroquinoline 35v fails, indicating that this Cr(II)-catalyzed cross-
coupling may have a broader reaction scope than the corresponding Fe- and Co-catalyzed 
cross-couplings. Halogenated diazenes, such as the 2-chloropyrimidines 31h and 35m as well 
as the 2-chloropyrazine 31j, rapidly react with the magnesium organometallics 32z, 32p and 
32i to provide the substituted diazenes 37e-g (71-85%; entries 7-9). 
 
Table 14: Room-temperature Cr-catalyzed cross-coupling reactions between N-heterocyclic 
halides and arylmagnesium reagents. 
 
Entry Starting material Grignard reagent Producta 
  
 
 
 
 
1 35s 32a 34v; 95%; 15 min 
  
 
 
 
N
Cl
NMe2
 
2 35b 32n 34b; 80%; 90 min 
 
 
 
 
 
 
 
3 35t 32y 37a; 76%; 15 min 
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4 35u 32l 37b; 66%; 15 min 
 
 
 
 
 
 
 
5 35j 32k 37c; 74%; 1 h 
  
 
 
 
 N Ph
NMe2
 
6 35v 32n 37d; 78%; 15 min 
 
 
 
 
 
7 31h 32z 37e; 71%; 2 h 
 
 
 
 
 
 
 
N
N
CF3
OTBS
 
8 35m 32p 37f; 85%; 15 min 
 
 
 
 
9 31j 32i 37g; 72%; 30 min 
(a) Isolated yield after purification by flash column chromatography. 
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Table 15: Cr-catalyzed cross-coupling reactions between 2-chlorobenzophenone (38) and 
phenylmagnesium reagents. 
 
Entry Grignard reagent Product Yielda 
  
 
 
 
1 39 41a 79%; 15 min 
 
 
 
 
 
2b 40 41b 71%; 2 h 
 
 
 
 
 
 
 
3 32y 41c 93%; 15 min 
 
 
 
 
 
 
4 32n 41d 94%; 15 min 
 
 
 
 
Ph
O
S
 
 
5c 32w 41e 89%; 2 h 
(a) Isolated yields after purification by flash column chromatography. (b) 0.7 equiv of 40 
were used. (c) Reaction run at 50 °C for 2 h. 
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Remarkably, 2-halogenated aromatic ketones also undergo the chromium-catalyzed cross-
coupling at room temperature within 15 min to 2 h (Table 15).105 Thus, 2-
chlorobenzophenone (38) reacts with a range of aryl- and heteroaryl-magnesium reagents 
(32n, 32w, 32y, 39, 40) yielding the corresponding polyfunctional ketones 41a-e (71-94%; 
entries 1-5 of Table 15). 
Interestingly, the (2-bromophenyl)(6-chloropyridin-3-yl)-methanone (42) reacts with the 
Grignard reagent 32a with complete regioselectivity (no chloride-substitution occurs) and 
gives the pyridyl ketone 43 in 72% yield (Scheme 33). Heterocyclic ketones, such as 44, also 
couple well with 3-thienylmagnesium chloride 45 affording the new ketone 46 in 90% yield 
(Scheme 33). These reactions show a remarkable functional group tolerance, since ester, 
nitriles and ketones are compatible with this Cr-catalyzed cross-coupling. 
 
 
Scheme 33. Cr-catalyzed cross-coupling reactions between heteroaryl-substituted ketones and 
Grignard reagents. 
 
Interestingly, the imine-protected 2-chlorobenzaldehyde 47 reacts readily with various 
Grignard reagents (32a, 32i, 45) at 25 °C. Acidic work-up provides the aldehydes 48a-c in  
69-84% yield (Scheme 34). The presence of the sulfur-containing Grignard reagent 45 
extends considerably the reaction-rate and 16 h reaction time is required to complete the 
cross-coupling leading to 48c. Thus, this cross-coupling constitutes a simple way for 
functionalizing aromatic aldehydes in the ortho-position. 
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Scheme 34. Cr-catalyzed cross-coupling reactions between imine-protected aldehyde 47 and 
Grignard reagents. 
 
Finally, alkenyl iodides, such as 49, also undergo a fast stereoselective chromium-catalyzed 
arylation with a range of Grignard reagents (32i, 32n, 32p, 32t), affording in all cases the 
functionalized styrenes 50a-d in 69-80% yield with an E:Z ratio better than 99:1. Remarkably, 
all reactions were performed at 25 °C and were completed within 15 min (Scheme 35). 
Hex
I 3% CrCl2
THF, 15 min
25 °C
Hex
Ar
49
50a: 70% yield
32n: Ar=p-C6H4N(Me)2
32i: =p-C6H4OMe
32p: =m-C6H4OTBS
32t: =p-C6H4CH(OMe)2
ArMgBr (1.5 equiv)+
N(Me)2
Hex
50b: 75% yield
OMe
Hex
50c: 80% yield
Hex
OTBS
50d: 69% yield
Hex
MeO OMe
50: 69-80% yield
E:Z > 99:1
 
Scheme 35. Cr-catalyzed cross-coupling reactions between alkenyl iodide 49 and Grignard 
reagents. 
 
 
2.5. Regio- and Chemoselective Chromium(II)-Catalyzed Cross-Coupling Reactions 
of Dihalogenated Heteroaromatics with Aromatic Grignard Reagents 
After having found that unexpectedly CrCl2 catalyzes very efficiently the coupling-reaction 
between N-heterocyclic chlorides and (hetero)aromatic Grignard reagents with only traces of 
homo-coupling by-products, we aimed to expand the scope of this cross-coupling reaction. 
Malhotra reported in 2013 an iron-catalyzed chemoselective sp2-sp3 cross-coupling involving 
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alkylmagnesium reagents.106 As the pharmaceutical industry is searching for cheap, efficient 
and nonhazardous ways to form aryl-aryl bonds chemoselectively, the potential to perform 
regio- and chemoselective Cr(II)-catalyzed cross-couplings of dihalogenated N-heterocycles 
with aromatic Grignard reagents should be investigated. 
Preliminary results showed that the coupling reaction of 2,4-dichloropyridine (51a) with 
PhMgCl (32a), using our optimized isoquinoline-accelerated Fe-protocol, led to an exclusive 
formation of the 2-arylated product 52a in 58% isolated yield (see Scheme 36). In 
comparison, the related chromium(II) chloride catalyzed reaction using less equivalents of 
32a (1.2 instead of 2 equiv) furnished regioselectively the same coupling product 52a in much 
higher yield (80% instead of 58% isolated yield). Also, only trace amounts of homo-coupling 
resulting from the Grignard reagent were detected using CrCl2 as catalyst.  
 
 
Scheme 36. Comparison of FeBr3 and CrCl2 in catalyzed regioselective cross-coupling 
reactions of 2,4-dichloropyridine (51a) with PhMgCl (32a). 
 
The scope of this regioselective chromium-catalyzed cross-coupling was examined next. It 
was found, that a range of dichloro-N-heterocycles can be phenylated at 25 °C within 0.5 h. 
Thus, 2,3-dichloropyridine (51b) as well as 2,5-dichloropyridine (51c) react within minutes 
with 32a to produce regioselectively the 2-arylated products 52b (76% yield, entry 1 of Table 
16) and 52c (87% yield, entry 2). The sterically more demanding acetal-protected 2,4-
dichloropyridines 51d-e react within 30 min with 32a to furnish the products 52d-e in isolated 
yields of 67% and 76% respectively (entries 3-4). 
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Table 16: Regioselective Csp2-Csp2 cross-coupling reactions between dichlorinated pyridines 
51b-e and PhMgCl (32a). 
Entry Substrate Product Reaction time Yielda 
 
 
 
  
1 51b 52b 15 min 76% 
 
 
 
  
2 51c 52c 15 min 87% 
 
 
 
  
3 51d 52d 30 min 67% 
 
 
 
  
4 51e 52e 30 min 76% 
(a) Isolated yields after purification by flash column chromatography. 
 
Next, CrCl2-catalyzed biaryl formations on 1,3-dichloroisoquinoline 51f and 2,6-
dichloroquinoline 51g (see Scheme 37) were investigated. Using the standard protocol in THF 
resulted in low conversions of starting material to desired coupling product. Thus, 51f reacts 
with 32a at position 1, but no complete conversion could be reached. A careful solvent 
screening revealed that CPME (cyclopentyl methyl ether) leads to much higher conversions in 
this CrCl2-catalyzed cross-coupling reaction. The desired coupling product 52f was obtained 
in 71% yield after only 1 h reaction time at room temperature, using 3 mol% of CrCl2 in 
CPME as solvent. An analog behavior is observed in the regioselective coupling reaction 
between 51g and Grignard reagent 32k. Whereas in THF, only low conversion is observed, in 
CPME full-conversion is reached after 1 h at room temperature, furnishing the 2-arylated 
compound 52g in 82% yield (Scheme 37). 
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Scheme 37. Rate-acceleration in Cr(II)-catalyzed cross-couplings of isoquinoline 51f and 
quinoline 51g with aromatic Grignard reagents using CPME as solvent. 
 
Subsequently, various aromatic Grignard reagents were prepared and used in chromium(II) 
chloride catalyzed chemoselective cross-coupling reactions with various dichlorinated          
N-heterocycles (see Table 17). Electron-rich Grignard reagents, like (3-
methoxyphenyl)magnesium bromide (53), the methylenedioxy-arylmagnesium bromide 32k 
or 4-(dimethylamino)phenyl magnesium bromide (32n) reacted smoothly with dihalogenated 
pyridines 51a and 51c, as well as with quinolines 51g and 51h. The coupling products 52h-k 
were all obtained in good yields (71-77%, entries 1-4) in a complete regioselective manner. 5-
Magnesiated indole 32r reacts with 2,3-dichloro-5-(trifluoromethyl)pyridine (51i) within 1 h 
to furnish the 2-arylated coupling product 52l in 56% yield (entry 5). TBS-protected 3-
hydroxyphenylmagnesium bromide (32p) and the acetal-substituted arylmagnesium derivative 
54 undergo the CrCl2-catalyzed cross-coupling reaction with dichlorinated pyridines 51b, 51e 
and 51i regioselectively in position 2 in yields from 66-82% (entries 6-8). Also electron-poor 
Grignard reagents reacted smootly in this cross-coupling reaction. E.g. 4-
fluorophenylmagnesium bromide (32g) or 4-(trifluoromethyl)phenylmagnesium bromide 
(32y) undergo fast couplings with pyridines 51a or 51d to produce the substituted 
heterocycles 52p (79% yield, entry 9) and 52q (92% yield, entry 10). Even the electron-poor 
chloro-substituted Grignard reagent 55 can be coupled with quinoline 51g and 
trifluoromethylated 2,3-dichloropyridine 51i to furnish 52r and 52s (entries 11-12). For the 
first time, the sensitive ester-substituted aromatic Grignard reagent 39 can perform well in 
CrCl2-catalyzed cross-couplings with N-heterocyclic halides (entry 13). 
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Table 17: Chemoselective Csp2-Csp2 cross-coupling reactions between dichlorinated 
heterocycles and various Grignard reagents. 
Entry Starting material Grignard reagent Producta 
  
 
 
 
 
1 51c 53 52h; 71%; 30 min 
 
 
 
 
 
 
2 51h 53 52i; 72%; 2 h 
  
N Cl
Cl
 
 
 
 
3 51a 32k 52j; 77%; 15 min 
 
 
 
 
 
 
 
4 51g 32n 52k; 71%; 3 h 
 
 
 
 
 
 
 
5 51i 32r 52l; 56%; 1 h 
  
 
 
 
 
6 51b 32p 52m; 82%; 15 min 
 
 
 
 
 
 
7 51i 54 52n; 71%; 15 min 
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8 51e 54 52o; 66%; 30 min 
 
 
 
 
 
9 51d 32g 52p; 79%; 30 min 
 
N Cl
Cl
   
10 51a 32y 52q; 92%; 30 min 
 
   
11 51g 55 52r; 87%; 1 h 
 
   
12 51i 55 52s; 66%; 30 min 
 
   
13 51i 39 52t; 70%; 15 min 
(a) Isolated yield after purification by flash column chromatography. 
 
 
3.  Summary and Outlook 
3.1. Lewis-Acid Promoted Benzylic Cross-Couplings of Pyridines with Aryl Bromides 
In this work, the direct benzylic metalation of various methylpyridines was developed using 
various TMP-bases. Subsequent cross-coupling reactions with the resulting benzylic 
metalated heterocycles were performed. In general, Pd-catalyzed cross-couplings with these 
laterally metalated methylpyridines are difficult due to the high stability of the Pd-
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intermediates of type A which are reluctant to undergo reductive elimination due to chelate 
stabilization. A general solution to this problem was found by the addition of a Lewis-acid 
(LA) which competitively complexes the heterocyclic nitrogen leading to the tentative 
intermediate B. This facilitates the reductive elimination leading to the arylated product C in 
good yields (Scheme 38). 
 
 
Scheme 38. Positive effect of Lewis-acids in benzylic cross-coupling reactions of 
methylpyridines. 
 
Although ZnCl2 is in most cases an effective Lewis-acid, for electron-deficient aryl bromides, 
the use of catalytic amounts of Sc(OTf)3 (10 mol%) leads by far to the best results. Under 
these Lewis-acid assisted conditions, a general method for the arylation of various methyl-
substituted pyridines and related heterocycles was established (Scheme 39). 
 
 
Scheme 39. Efficient arylation of 2-picoline promoted by Sc(OTf)3. 
 
Furthermore, it was shown for the first time, that 4-picoline can be metalated efficiently with 
TMPZnCl·LiCl in benzylic position. Subsequent Negishi cross-coupling reactions furnish 
several benzylic arylated 4-picoline derivatives (Scheme 40). 
 
 
Scheme 40. First arylation of 4-picoline. 
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It was also found that a Lewis-acid such as BF3·OEt2 promotes highly regioselective 
metalations in the case of 2,4-lutidine (Scheme 41). 
 
 
Scheme 41. BF3·OEt2 promoted regioselective zincation of 2,4-lutidine. 
 
3.2. Benzylic Arylation of 2-Methyl-5-Membered Heterocycles using TMP-Bases 
So far, the arylation of methyl-substituted 5-membered heterocycles has been an unsolved 
problem. For example, no benzylic C-H activation followed by cross-coupling has been 
reported for 1,2-dimethylimidazole and only alkylation reactions have been performed 
successfully after initial deprotonation with n-butyllithium. Furthermore, no benzylic 
metalation and subsequent arylation of 2-methylbenzothiophenes and 2-methylbenzofurans 
has been described. In this work, it was shown that such a direct benzylic arylation can be 
performed on various methyl-substituted 5-membered heterocycles using TMP-bases and 
subsequent Negishi cross-coupling reactions. 
Thus, 1,2-dimethylimidazole can be metalated selectively at the 2-methyl position using the 
mild magnesium base TMPMgCl·LiCl. Subsequent transmetalation with ZnCl2 and palladium 
catalyzed cross-coupling reaction with various aryl bromides yields 2-benzylated imidazoles 
in high yields (Scheme 42). 
 
 
Scheme 42. Efficient arylation of 1,2-dimethylimidazole. 
 
Efforts were made to extend this method to even less acidic methyl-substituted 5-membered 
heterocycles. It was found that 2-methylbenzothiophene and 2-methylbenzofuran is readily 
metalated with TMPLi. After treatment with ZnCl2, the resulting heterocyclic benzylic 
reagent was smoothly arylated with aryl bromides under palladium catalysis (Scheme 43). 
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Scheme 43. Benzylic arylation of 2-methylbenzothiophene and 2-methylbenzofuran. 
 
The generality of this approach is demonstrated by performing the arylation of other related 5-
membered heterocycles such as 2-methyl-indole and 2-methylbenzimidazole. In these cases, 
the mild and selective zinc base TMPZnCl·LiCl was sufficient for benzylic zincation (Scheme 
44). 
 
 
Scheme 44. Benzylic cross-coupling of protected 2-methylbenzimidazole and a 2-
methylindole. 
 
3.3. Iron-Catalyzed Cross-Coupling of N-Heterocyclic Chlorides and Bromides with 
Arylmagnesium Reagents Using tBuOMe as Solvent 
An extension to previously described iron-catalyzed cross-coupling reactions between 
aromatic halides and aromatic Grignard reagents has been achieved. It was found that apolar 
ethereal solvents like tBuOMe suppress significantly the undesired formation of homo-
coupling by-products that result from the Grignard reagent. A wide range of functionalized 
Grignard reagents was prepared using direct magnesium insertion into the aromatic C-Br 
bond, and was cross-coupled with various N-heterocyclic halides in the presence of 3% FeBr3 
in a THF/tBuOMe solvent mixture (Scheme 45). 
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HetAr X
HetAr= substituted pyridines and pyrimidines,
quinolines, isoquinolines
Ar= various substituted aromatics
X= Cl, Br
3% FeBr3
THF:tBuOMe (2:5)
20 °C, 2 min to 5 h
Ar-MgBr LiCl+ HetAr Ar
up to 93% yield
Selected examples:
N
OMe
82% yield
N
92% yield
CF3
N
OPiv
80% yield
N
Cl
78% yield
N
84% yield
OBocN
82% yield
NMe2
N
N
Me
Me
76% yield
N
75% yield
F3C CF3
 
Scheme 45. Fe-catalyzed Csp2-Csp2 coupling reactions in tBuOMe as solvent. 
 
 
3.4. Ligand-Accelerated Fe- and Co-Catalyzed Cross-Coupling Reactions between N-
Heterocyclic Halides and Arylmagnesium Reagents 
Iron- as well as cobalt-catalyzed cross-coupling reactions between N-heterocyclic halides and 
aromatic Grignard reagents were optimized by the addition of isoquinoline as practical ligand. 
It was found that isoquinoline can accelerate significantly these cross-coupling reactions and 
is able to suppress the formation of homo-coupling side-products. Furthermore, the scope of 
such coupling reactions was extended to heterocyclic Grignard reagents that reacted 
previously in lower efficiency (Scheme 46). 
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FG= various functional groups
Ar= various substituted (hetero)aromatics
X= Cl, Br
Selected examples:
N X N R
RMgXLiCl (2 equiv)
3% FeBr3 or CoCl2
10% isoquinoline
tBuOMe:THF
FG FG
N
Br
Me
Me Me
82% yield using CoCl2
Cl
N
Me
MeO
F
MeO
82% yield using FeBr3
N
N
N
Ph
Ph
OMe
81% yield using FeBr3
N
TMS
S
66% yield using CoCl2
N
Cl
F
O O
tBu
65% yield using FeBr3
N
S
TMS
70% yield using CoCl2
 
Scheme 46. Ligand-accelerated Fe- and Co-catalyzed cross-coupling reactions. 
 
Future work could focus on optimizing this ligand system. Preliminary results indicate that 
more electron-rich quinolines and isoquinolines lead to even faster reactions between N-
heterocyclic halides and (hetero)aromatic Grignard reagents. Future extensions could involve 
coupling reactions with non-activated aromatic halides instead of N-heterocyclic halides. 
 
3.5. Chromium(II)-Catalyzed Cross-Coupling Reactions between Csp2-Centers 
Against common wisdom, toxicological data indicate that CrCl2 is a chromium-salt of low 
toxicity, compared to other commonly used salts like PdCl2, NiCl2 or even CoCl2. Therefore 
CrCl2 is sold as a low-toxic chemical by major international suppliers. In this work it was 
shown, that unexpectedly CrCl2 can undergo very efficiently aryl-aryl cross-coupling 
reactions between a range of aromatic halides and aromatic Grignard reagents, using a very 
simple procedure. No ligand or additive is required for coupling reactions to proceed at room 
temperature in the presence of CrCl2 with THF as solvent. Using this novel methodology, 
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various unsymmetrical biaryls are formed from N-heterocyclic halides and aromatic Grignard 
reagents (Scheme 47). 
 
 
 
Scheme 47. CrCl2-catalyzed cross-coupling reactions between N-heterocyclic halides and 
aromatic Grignard reagents. 
 
It was found that also aromatic chloro-and bromo-ketones as well as chloro-imines react 
smoothly under these CrCl2-catalyzed conditions (Scheme 48). 
 
 Scheme 48. CrCl2-catalyzed coupling reactions of aromatic chloro-ketones and chloro-
imines. 
 
Furthermore, also alkenyliodides are able to undergo CrCl2-catalyzed coupling reactions with 
aromatic Grignard reagents in a stereoselective manner (Scheme 49). 
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Scheme 49. E-Alkenyl iodides undergo stereoselective Cr(II)-catalyzed cross-couplings. 
 
This chromium-catalysis protocol was also applied to regio- and chemoselective cross-
coupling reactions of dihalogenated heteroaromatics with aromatic Grignard reagents. Similar 
coupling reactions of more electron-rich dihalogenated quinolines or isoquinolines proceed 
much faster in CPME than in THF (Scheme 50). 
 
N
Cl
Ar
ArMgXLiCl (1.2 equiv)
3% CrCl2
THF or CPME, 25 °C
15 min-2 h
up to 92% yield
N
Cl
Cl
N
ClF3C
CO2Et
70% yield; 15 min
N
Cl
Cl
CF3
87% yield; 1 h in CPME
N
Cl
O O
O
O
66% yield; 30 min
N
Cl
CF3
92% yield; 30 min
N
Cl
OMe
71% yield; 30 min
N
Ph
Cl
71% yield; 1h in CPME
Ar= various substituted aromatics
Selected examples:
 
Scheme 50. Regio- and chemoselective CrCl2-catalyzed Csp2-Csp2 coupling reactions. 
 
After having made the unexpected discovery that CrCl2 can serve as a catalyst in cross-
coupling reactions, future work could focus on extending the scope of chromium-catalysis to 
other potential reactions like aminations, C-H activations and carbometalation reactions. 
 
 77 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
C. Experimental Section 
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1.  General Considerations 
All reactions were carried out with magnetic stirring and, if the reagents were air or moisture 
sensitive, in flame-dried glassware under argon. Syringes which were used to transfer 
reagents and solvents were purged with argon prior to use.  
 
1.1. Solvents 
Solvents were dried according to standard procedures by distillation over drying agents and 
stored under argon. 
tBuOMe was predried over CaCl2 and distilled from CaH2. 
CPME was predried over CaCl2 and distilled from CaH2. 
Et2O was predried over calcium hydride and dried with the solvent purification system SPS-
400-2 from INNOVATIVE TECHNOLOGIES INC. 
Hexane was predried over CaCl2 and distilled from CaH2. 
NEP was heated to reflux for 14 h over CaH2 and distilled from CaH2. 
NMP was heated to reflux for 14 h over CaH2 and distilled from CaH2. 
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under 
nitrogen. 
Toluene was predried over CaCl2 and distilled from CaH2. 
Solvents for column chromatography were distilled prior to use. 
 
1.2. Reagents 
All reagents were obtained from commercial sources and used without further purification 
unless otherwise stated. Following compounds were prepared according to literature 
procedures: compound 27,91 compound 44,107 compound 47108 and compound 49.109  
 
BF3·OEt2 was distilled under Ar prior to use. 
nBuLi solution in hexane was purchased from Rockwood Lithium GmbH. 
iPrMgCl·LiCl solution in THF was purchased from Rockwood Lithium GmbH. 
PhMgCl solution in THF was purchased from Rockwood Lithium GmbH. 
TMPH was distilled under Ar prior to use. 
TMPLi was prepared in the following way: 
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A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic stirrer and a 
septum, was charged with freshly distilled TMPH (10.2 mL, 60 mmol) dissolved in THF    
(60 mL). This solution was cooled to -40 °C and nBuLi (2.4 M in hexane, 25 mL, 60 mmol) 
was added dropwise. After the addition was complete, the reaction mixture was allowed to 
warm up slowly to -10 °C for 1 h. The solvents were then removed under vacuum affording a 
yellowish solid. Freshly distilled THF was then slowly added under vigorous stirring until the 
salts were completely dissolved. The freshly prepared TMPLi solution was titrated prior to 
use at -10 °C with benzoic acid using 4-(phenylazo)diphenylamine as indicator. A 
concentration of ca. 1.0 M in THF was obtained. TMPLi is stored at -78 °C under an argon 
atmosphere. 
TMPMgCl·LiCl was prepared in the following way:  
A dry and argon flushed 250 mL flask, equipped with a magnetic stirrer and a septum, was 
charged with freshly titrated iPrMgCl·LiCl (100 mL, 1.2 M in THF, 120 mmol). TMPH (19.8 
g, 126 mmol, 1.05 equiv) was added dropwise at room temperature. The reaction mixture was 
stirred at r.t. until gas evolution was completed (ca. 48 h). The freshly prepared 
TMPMgCl·LiCl solution was titrated prior to use at 25 °C with benzoic acid using 4-
(phenylazo)diphenylamine as indicator. A concentration of ca. 1.1 M in THF was obtained. 
TMPZnCl·LiCl was prepared in the following way: 
A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic stirrer and a 
septum, was charged with freshly distilled TMPH (10.2 mL, 60 mmol) dissolved in THF    
(60 mL). This solution was cooled to -40 °C and nBuLi (2.4 M in hexane, 25 mL, 60 mmol) 
was added dropwise. After the addition was complete, the reaction mixture was allowed to 
warm up slowly to -10 °C for 1 h. ZnCl2 (1.0 M in THF, 66 mL, 66 mmol) was added 
dropwise and the resulting solution was stirred for 30 min at -10 °C and then for 30 min at   
25 °C. The solvents were then removed under vacuum affording a yellowish solid. Freshly 
distilled THF was then slowly added under vigorous stirring until the salts were completely 
dissolved. The freshly prepared TMPZnCl·LiCl solution was titrated prior to use at 25 °C 
with benzoic acid using 4-(phenylazo)diphenylamine as indicator. A concentration of about     
1.3 M in THF was obtained. 
ZnCl2 solution (1.0 M) was prepared by drying ZnCl2 (100 mmol, 13,6 g) in a Schlenk-flask 
under vacuum at 140 °C for 5 h. After cooling, 100 mL dry THF were added and stirring was 
continued until the salt was dissolved. 
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1.3. Content Determination of Organometallic Reagents 
Organzinc and organomagnesium reagents were titrated against I2 in THF. 
Organolithium reagents were titrated against menthol using 1,10-phenanthroline as indicator 
in THF. 
TMPLi, TMPMgCl·LiCl and TMPZnCl·LiCl were titrated against benzoic acid using 4-
(phenylazo)diphenylamine as indicator in THF.  
 
1.4. Chromatography 
Flash column chromatography was performed using silica gel 60 (0.040-0.063 mm) from 
Merck.  
Thin layer chromatography was performed using SiO2 pre-coated aluminium plates (Merck 
60, F-254). The chromatograms were examined under UV light at 254 nm and/or by staining 
of the TLC plate with one of the solutions given below followed by heating with a heat gun: 
- KMnO4 (3.0 g), 5 drops of conc. H2SO4 in water (300 mL). 
- Phosphomolybdic acid (5.0 g), Ce(SO4)2 (2.0 g) and conc. H2SO4 (12 mL) in water 
(230 mL). 
 
1.5. Analytical Data 
NMR spectra were recorded on VARIAN Mercury 200, BRUKER AXR 300, VARIAN VXR 
400 S and BRUKER AMX 600 instruments. Chemical shifts are reported as δ-values in ppm 
relative to the residual solvent peak of CHCl3 (δH : 7.25, δC : 77.0). For the characterization of 
the observed signal multiplicities the following appreviations were used: s (singlet), d 
(doublet), t (triplet), q (quartet), quint (quintet), sept (septet), m (multiplet) as well as br 
(broad). 
Mass spectroscopy: High resolution (HRMS) and low resolution (MS) spectra were recorded 
on a FINNIGAN MAT 95Q instrument. Electron impact ionization (EI) was conducted with 
an electron energy of 70 eV.  
For the combination of gas chromatography with mass spectroscopic detection, a GC/MS 
from Hewlett-Packard HP 6890 / MSD 5973 was used.  
Infrared spectra (IR) were recorded from 4500 cm-1 to 650 cm-1 on a PERKIN ELMER 
Spectrum BX-59343 instrument. For detection a SMITHS DETECTION DuraSamplIR II 
Diamond ATR sensor was used. The absorption bands are reported in wavenumbers (cm-1) 
Melting points (M.p.) were determined on a BÜCHI B-540 apparatus and are uncorrected. 
 
 81 
2. Typical Procedures (TP) 
2.1. Typical Procedure for the Metalation of Methylpyridines and Related  
 N-Heterocycles with TMPZnCl·LiCl (7) (TP1). 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, the respective methylpyridine (1.00 equiv) was dissolved in dry THF (2 mL). Then, 
TMPZnCl·LiCl (7; 1.5 equiv) was added dropwise and the reaction mixture was stirred at the 
desired temperature for 10 min. The completion of the zincation was checked by GC-analysis 
of reaction aliquots quenched with a solution of I2 in dry THF. 
 
2.2. Typical Procedure for Fe-Catalyzed Cross-Coupling Reactions of N-Heterocyclic 
Chlorides and Bromides with Arylmagnesium Reagents Using tBuOMe as 
Solvent (TP2). 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, the appropriate halogenated N-heterocycle (1.0 mmol, 1.0 equiv.) and iron (III) 
bromide (3 mol%) were dissolved in dry t-BuOMe (5 mL). Then, the appropriate Grignard 
reagent (2.3 mmol, 2.3 equiv) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture. When the conversion was complete it was quenched with 
brine or with a mixture of aqueous saturated solution of NH4Cl and ammonia (10:1) and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained after purification by flash chromatography. 
 
2.3.  Typical Procedure for Fe- or Co-Catalyzed Cross-Coupling Reactions with 
Isoquinoline (TP3). 
A solution of the appropriate Grignard reagent (concentration in THF varying depending on 
the identity of the Grignard reagent, 1.0 mmol, 2.0 equiv) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and the aryl halide (0.5 mmol, 1.0 equiv) in 
tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 25 °C for the indicated time before 
being quenched with NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA 
(1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 15 min, before being 
filtered through a pad of Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. 
aq. was added, and the mixture was extracted with CH2Cl2. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield the final compound as an analytically pure substance. 
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2.4. Typical Procedure for Cr-Catalyzed Cross-Coupling Reactions between Aryl 
Halides and Aromatic Grignard Reagents (TP4). 
A solution of the appropriate Grignard reagent (concentration in THF varying depending on 
the nature of the Grignard reagent, 1.2 mmol, 1.2 equiv) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv.; 97% purity) and the aryl halide (1 mmol,      
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for the indicated time 
before being quenched with brine and extracted with EtOAc. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield the final compound as an analytically pure substance. 
 
2.5. Typical Procedure for Cr-Catalyzed Cross-Coupling Reactions with Imine 47 
(TP5). 
A solution of the appropriate Grignard reagent (concentration in THF varying depending on 
the nature of the Grignard reagent, 1.2 mmol, 1.2 equiv) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and imine 47 (1 mmol,     
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for the indicated time 
before being quenched with an aq. solution of HCl (2M) and extracted with EtOAc. The 
organic layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude 
compound, which was purified by column chromatography to yield the final compound as an 
analytically pure substance. 
 
2.6. Typical Procedure for Cr-Catalyzed Cross-Coupling Reactions with Alkenyl 
Iodide 49 (TP6). 
A solution of the appropriate Grignard reagent (concentration in THF varying depending on 
the nature of the Grignard reagent, 1.5 mmol, 1.5 equiv) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and alkenyl iodide 49         
(1 mmol, 1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for the 
indicated time before being quenched with brine and extracted with EtOAc. The organic layer 
was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield the final compound as an analytically 
pure substance. 
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2.7. Typical Procedure for Cr-Catalyzed Regio- and Chemoselective Cross-Coupling 
Reactions in THF as Solvent (TP7). 
A solution of the appropriate Grignard reagent (concentration in THF varying depending on 
the nature of the Grignard reagent, 1.2 mmol, 1.2 equiv) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and the dihalogenated halide        
(1 mmol, 1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for the 
indicated time before being quenched with brine and extracted with EtOAc. The organic layer 
was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield the final compound as an analytically 
pure substance. 
 
2.8.  Typical Procedure for Cr-Catalyzed Regio- and Chemoselective Cross-Coupling 
Reactions in CPME as Solvent (TP8). 
A solution of the appropriate Grignard reagent (concentration in THF varying depending on 
the nature of the Grignard reagent, 1.2 mmol, 1.2 equiv) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and the dihalogenated halide        
(1 mmol, 1.0 equiv) in CPME (5 mL) at 25 °C. The suspension was stirred at 25 °C for the 
indicated time before being quenched with brine and extracted with EtOAc. The organic layer 
was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield the final compound as an analytically 
pure substance. 
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3. Benzylic Cross-Coupling of Pyridines with Aryl Bromides 
 
Synthesis of 5-(pyridine-2-ylmethyl)-1H-indole (6a):  
 
N
H
N
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 2.00 mL, 2.60 mmol) was added to a solution of 2-
methylpyridine (1a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 5-bromoindole (9a: 196 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 7 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane/ether, 3:2) furnished 5-(pyridine-2-ylmethyl)-1H-indole (6a: 
180 mg, 86%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.58 (d, J = 4.89 Hz, 1H), 8.22 (s, 1H), 7.57 (dt, J = 
7.62, 1.88 Hz, 1H), 7.57-7.56 (m, 1H), 7.35 (d, J = 8.69 Hz, 1H), 7.21 (t, J = 2.96 Hz, 1H), 
7.16-7.09 (m, 3H), 6.53-6.51 (m, 1H), 4.29 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 162.1, 149.1, 136.5, 134.7, 130.8, 128.2, 124.4, 123.5, 
123.1, 121.0, 120.9, 111.1, 102.5, 44.8. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3114, 3097, 3028, 2852, 2361, 1739, 1592, 1474, 
1344, 1218, 1138, 1093, 998, 889, 793, 755, 736, 655. 
MS (EI, 70 eV): m/z (%) = 208 (M+, 70), 207 (100), 130 (48), 127 (18), 44 (62). 
HRMS for C14H12N2: calc.: 208.1000; found: 208.0933 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)pyridine (6b):  
 
N
OMe
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TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-
methylpyridine (1a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane/ether, 7:3) furnished 2-(4-methoxybenzyl)pyridine (6b: 190 mg, 
95%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.52 (dd, J = 5.80, 1.92 Hz, 1H), 7.54 (dt, J = 7.49, 
2.02 Hz, 1H), 7.16 (d, J  = 8.76 Hz, 2H), 7.07 (d, J = 7.49 Hz, 2H), 6.83 (d, J = 8.76 Hz, 2H), 
4.08 (s, 2H), 3.76 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 161.4, 158.2, 149.3, 136.5, 131.6, 130.1, 123.0, 121.1, 
114.0, 55.2, 43.8. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3004, 2951, 2931, 2833, 1737, 1609, 1587, 1508, 
1470, 1433, 1300, 1243, 1175, 1032, 993, 850, 841, 805, 781, 748, 725.  
MS (EI, 70 eV): m/z (%) = 199 (M+, 57), 198 (100), 184 (52), 167 (12), 156 (15), 121 (15). 
HRMS for C13H13NO: calc.: 199.0997; found: 199.0975 (M+). 
 
Synthesis of 2-(4-fluorobenzyl)pyridine (6c):  
 
N
F
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-
methylpyridine (1a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-4-fluorobenzene (9c: 175 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 6 h at  
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
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flash-chromatography (i-hexane/ether, 4:1) furnished 2-(4-fluorobenzyl)pyridine (6c: 147 mg, 
78%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.55 (dd, J = 4.63, 1.92 Hz, 1H), 7.58 (dt, J = 7.82, 
2.02 Hz, 1H), 7.22 (dd, J = 8.68, 5.57 Hz, 2H), 7.13-7.09 (m, 2H), 6.98 (d, J = 8.68, 5.57 Hz, 
2H), 4.12 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 161.5 (1JC-F = 253.4 Hz), 160.8, 149.4, 136.6, 135.2, 130.4 
(3JC-F = 7.9 Hz), 123.0, 121.3, 115.3 (2JC-F = 21.4 Hz), 43.8. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3068, 3008, 2924, 2362, 1892, 1738, 1600, 1588, 
1570, 1506, 1472, 1434, 1298, 1098, 994, 846, 790, 748, 628. 
MS (EI, 70 eV): m/z (%) = 187 (M+, 22), 186 (100), 109 (8), 93 (10), 83 (8). 
HRMS for C12H10FN: calc.: 187.0797; found: 187.0742 (M+). 
 
Synthesis of 2-(3-chlorobenzyl)pyridine (6d):  
 
N Cl
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-
methylpyridine (1a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-3-chlorobenzene (9d: 191 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 6 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1,  2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 7:3) furnished 2-(3-chlorobenzyl)pyridine (6d:        
134 mg, 66%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.58 (ddd, J = 4.88, 1.86, 0.91 Hz, 1H), 7.61 (dt, J = 
7.39, 2.02 Hz, 1H), 7.28-7.12 (m, 6H), 4.14 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 160.1, 149.5, 141.5, 136.6, 134.3, 129.8, 129.2, 127.3, 
126.6, 123.1, 121.5, 44.3. 
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IR (Diamond-ATR, neat): ν~  / cm-1 = 3061, 2924, 1737, 1668, 1588, 1568, 1471, 1428, 
1303, 1077, 994, 865, 775, 769, 694, 681. 
MS (EI, 70 eV): m/z (%) = 203 (M+, 22), 202 (100), 167 (71), 139 (4), 84 (11). 
HRMS for C12H10ClN: calc.: 203.0502; found: 203.0471 (M+). 
 
Synthesis of 2-((4-methoxyphenyl)(phenyl)methyl)pyridine (6e): 
 
N
OMe
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-
(benzyl)pyridine (1b: 220 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 
(5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 20 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 7:3) furnished 2-((4-methoxyphenyl)(phenyl)methyl)-
pyridine (6e: 272 mg, 99%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.62 (ddd, J = 4.88, 1.86, 0.95 Hz, 1H), 7.62 (dt, J = 
7.76, 1.97 Hz, 1H), 7.34-7.05 (m, 9H), 6.86 (dt, J = 8.78, 2.98 Hz, 2H), 5.67 (s, 1H), 3.80 (s, 
3H). 
13C-NMR (CDCl3, 75 MHz): δ = 163.6, 158.2, 149.5, 143.1, 136.4, 135.0, 130.3, 129.3, 
128.6, 126.4, 123.7, 121.3, 113.8, 58.6, 55.2. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3004, 2951, 2931, 2876 1737, 1609, 1587, 1504, 
1465, 1427, 1300, 1241, 1177, 1032, 993, 850, 841, 805, 781, 748, 725.  
MS (EI, 70 eV): m/z (%) = 275 (M+, 100), 260 (31), 243 (8), 230 (12), 197 (32), 167 (23), 
153 (23). 
HRMS for C19H17NO: calc.: 275.1310; found: 275.1305 (M+). 
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Synthesis of 2-((tert-butyldimethylsilyl)(4-methoxyphenyl)methyl)pyridine (6f): 
 
N
Si
OMe
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-(tert-
butyldimethylsilyl)pyridine (1c: 269 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and 
the reaction mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 
(5 mg,  2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 11 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 95:5) furnished 2-((tert-butyldimethylsilyl)(4-
methoxyphenyl)methyl)pyridine (6f: 288 mg, 92%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.55 (ddd, J = 4.89, 1.92, 0.91 Hz, 1H), 7.47 (dt, J = 
7.58, 2.03 Hz, 1H), 7.42 (dt, J = 8.66, 2.15 Hz, 2H), 7.16 (dt, J = 7.76, 2.07 Hz, 1H), 6.98 
(ddd, J = 7.52, 4.85, 1.18 Hz, 1H), 6.80 (dt, J = 8.66, 2.15 Hz, 2H), 3.78 (s, 4H), 0.72 (s, 9H), 
0.05 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 163.6, 157.4, 148.9, 135.9, 134.2, 129.9, 123.2, 120.0, 
113.5, 55.2, 45.0, 27.0, 17.8, -6.0. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2948, 2927, 2852, 1583, 1504, 1465, 1427, 1240, 
1181, 1031, 869, 857, 824, 807, 778, 692. 
MS (EI, 70 eV): m/z (%) = 313 (M+, 14), 298 (9), 256 (100), 242 (10), 225 (23), 212 (11), 
198 (10), 182 (11), 167 (13), 154 (8), 120 (3), 73 (42). 
HRMS for C19H27NOSi: calc.: 313.1862; found: 313.1855 (M+). 
 
Synthesis of 4-(pyridin-2-ylmethyl)benzonitrile (6g):  
 
N
CN
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TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-
methylpyridine (1a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 
0.13 mmol, 0.10 equiv) was added at 25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromobenzonitrile (9j: 183 mg, 1.00 mmol,          
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at  
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 1:1) furnished 4-(pyridin-2-ylmethyl)benzonitrile (6g: 
170 mg, 87%) as a colorless oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.58 (ddd, J = 4.84, 1.86, 0.81 Hz, 1H), 7.65 (dt, J = 
7.77, 1.77 Hz, 1H), 7.60 (dt, J = 8.55, 2.06 Hz, 2H), 7.39 (dt, J = 8.55, 2.06 Hz, 2H), 7.21-
7.14 (m, 2H), 4.22 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 159.2, 149.6, 145.0, 136.9, 132.3, 129.8, 123.3, 121.8, 
118.9, 110.4, 44.5. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3061, 3044, 3005, 2932, 2226, 1737, 1670, 1585, 
1504, 1470, 1433, 1310, 1153, 1048, 994, 865, 809, 774, 749, 691.  
MS (EI, 70 eV): m/z (%) = 194 (M+, 23), 193 (100), 166 (4), 140 (2), 89 (3). 
HRMS (ESI) for C13H10N2: calc.: 195.0922; found: 195.0916 ([M+H]+). 
 
Synthesis of ethyl 4-(pyridin-2-ylmethyl)benzoate (6h):  
 
N
COOEt
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-
methylpyridine (1a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 
0.13 mmol, 0.10 equiv) was added at 25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and ethyl 4-bromobenzoate (9k: 227 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The
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50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 1:1) furnished ethyl 4-(pyridin-2-ylmethyl)benzoate 
(6h: 206 mg, 85%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.57 (d, J = 5.13 Hz, 1H), 8.00 (d, J = 8.62 Hz, 2H), 
7.61 (dt, J = 7.71, 1.94 Hz, 1H), 7.35 (d, J = 8.62 Hz, 2H), 7.18-7.11 (m, 2H), 4.38 (q, J = 
7.10 Hz, 2H), 4.23 (s, 2H), 1.39 (t, J = 7.10 Hz, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 166.5, 160.0, 149.5, 144.7, 136.7, 129.9, 129.1, 128.7, 
123.2, 121.5, 60.8, 44.6, 14.3. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3059, 2904, 1710, 1709, 1585, 1472, 1434, 1415, 
1366, 1270, 1176, 1100, 1020, 752, 702. 
MS (EI, 70 eV): m/z (%) = 241 (M+, 32), 240 (100), 212 (26), 196 (15), 167 (41). 
HRMS (ESI) for C15H15NO2: calc.: 242.1181; found: 242.1175 ([M+H]+). 
 
Synthesis of 4-(benzo[d][1,3]dioxol-5-ylmethyl)pyridine (10a):  
 
N
O
O
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 5-bromobenzo[1,3]dioxol (9e: 199 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (CH2Cl2/MeOH, 99:1) furnished 4-(benzo[d][1,3]dioxol-5-
ylmethyl)pyridine (10a: 203 mg, 95%) as a slightly yellow oil. 
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1H-NMR (300 MHz, CDCl3): δ / ppm = 8.51 (d, J = 6.06 Hz, 2H), 7.11 (d, J = 6.06 Hz, 2H), 
6.78 (d, J = 8.45 Hz, 1H), 6.68-6.65 (m, 2H), 5.95 (s, 2H), 3.89 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.1, 149.9, 147.9, 146.3, 132.6, 124.0, 122.0, 109.4, 
108.4, 101.0, 40.9. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3066, 3024, 2982, 2854, 1596, 1485, 1440, 1413, 
1244, 1186, 1109, 1033, 925, 868, 814, 799, 767, 728, 713. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 100), 183 (17), 154 (22), 135 (36), 127 (10), 77 (11). 
HRMS for C13H11NO2: calc.: 213.0790; found: 213.0784 (M+). 
 
Synthesis of 4-(4-methoxybenzyl)pyridine (10b):  
 
N
MeO
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OCOCF3)2 (12 mg,       
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 1 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane/ether, 1:1) furnished 4-(4-methoxybenzyl)pyridine (10b: 195 mg, 
98%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.50 (d, J = 5.53 Hz, 2H), 7.13-7.08 (m, 4H), 6.88 
(dt, J = 8.71, 3.05 Hz, 2H), 3.98 (s, 2H), 3.81 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.4, 150.5, 149.8, 130.9, 130.0, 124.1, 114.1, 55.3, 40.4. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3065, 3027, 2954, 2907, 2834, 1737, 1598, 1509, 
1413, 1245, 1176, 1152, 1107, 1030, 993, 796, 759. 
 MS (EI, 70 eV): m/z (%) = 199 (M+, 100), 184 (23), 168 (17), 154 (11), 121 (54). 
HRMS for C13H13NO: calc.: 199.0997; found: 199.0977 (M+). 
 
 92 
Synthesis of 4-(3-methylbenzyl)pyridine (10c):  
 
N
Me
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-3-methylbenzene (9f: 169 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 1:1 then 2:3) furnished 4-(3-methylbenzyl)pyridine 
(10c: 150 mg, 82%) as a colorless oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.52 (d, J = 5.53 Hz, 2H), 7.25-6.97 (m, 6H), 3.95 
(s, 2H), 2.35 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.1, 149.8, 138.8, 138.4, 129.8, 128.6, 127.4, 126.0, 
124.2, 41.2, 21.4. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3023, 2920, 2854, 1737, 1720, 1597, 1558, 1490, 
1413, 1284, 1247, 1217, 1110, 993, 800, 778, 750, 698.  
MS (EI, 70 eV): m/z (%) = 183 (M+, 100), 168 (58), 152 (4), 141 (5), 128 (4), 115 (5), 105 
(6), 91 (7). 
HRMS for C13H13N: calc.: 183.1048; found: 183.1047 (M+). 
 
Synthesis of N,N-dimethyl-4-(pyridine-4-ylmethyl)aniline (10d):  
 
N
N
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TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromo-N,N-dimethylaniline (9g: 199 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 1:1 then 2:3) furnished N,N-dimethyl-4-(pyridine-4-
ylmethyl)aniline (10d: 149 mg, 70%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.49 (dd, J = 4.63, 1.54 Hz, 2H), 7.12 (d, J = 6.03 
Hz, 2H), 7.06 (dt, J = 9.25, 2.41 Hz, 2H), 6.71 (dt, J = 9.25, 2.41 Hz, 2H), 3.89 (s, 2H), 2.95 
(s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 151.1, 149.7, 149.4, 129.7, 126.7, 124.1, 112.9, 40.7, 40.3. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3020, 2894, 2808, 2338, 2360, 1739, 1611, 1597, 
1518, 1484, 1445, 1420, 1410, 1346, 1230, 1170, 111, 1065, 945, 914, 827, 787, 720.  
MS (EI, 70 eV): m/z (%) = 212 (M+, 100), 195 (4), 167 (14), 134 (60), 118 (14). 
HRMS for C14H16N2: calc.: 212.1313; found: 212.1323 (M+). 
 
Synthesis of 4-(pyridin-4-ylmethyl)phenol (10e):  
 
N
HO
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 2.00 mL, 2.60 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OCOCF3)2 (12 mg,       
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromo-phenol (9h: 172 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 1 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1,  2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
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chromatography (CH2Cl2/MeOH, 97:3) furnished 4-(pyridin-4-ylmethyl)phenol (10e: 155 mg, 
84%) as a colorless oil. 
 
1H-NMR (300 MHz, DMSO): δ / ppm = 9.24 (s, 1H), 8.43 (dd, J = 4.49, 1.56 Hz, 2H), 7.19 
(dd, J = 4.33, 1.66 Hz, 2H), 7.03 (d, J = 8.46 Hz, 2H), 6.69 (d, J = 8.46 Hz, 2H), 3.83 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 156.2, 151.1, 149.9, 130.2, 130.0, 124.3, 115.7, 39.7. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2997, 2925, 2883, 2794, 2673, 2594, 2360, 2339, 
1602, 1513, 1455, 1420, 1430, 1380, 1245, 1217, 1205, 1007, 919, 845, 804. 
MS (EI, 70 eV): m/z (%) = 185 (M+, 100), 167 (8), 156 (9), 128 (7), 107 (43), 77 (14). 
HRMS for C12H11NO: calc.: 185.0841; found: 185.0840 (M+). 
 
Synthesis of 4-(pyridin-4-ylmethyl)phenyl pivalate (10f):  
 
N
O
O
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OCOCF3)2 (12 mg,       
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromophenyl pivalate (9i: 256 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 2:3) furnished 4-(pyridin-4-ylmethyl)phenyl pivalate 
(10f: 218 mg, 81%) as a colorless oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.52 (dd, J = 5.75, 1.61 Hz, 2H), 7.18 (d, J = 8.63 
Hz, 2H), 7.11 (d, J = 5.75 Hz, 2H), 7.03 (d, J = 8.63 Hz, 2H), 3.98 (s, 2H), 1.36 (s, 9H). 
13C-NMR (CDCl3, 75 MHz): δ = 177.1, 149.9, 149.8, 149.7, 135.1, 129.9, 124.1, 121.7, 
40.6, 39.1, 27.1. 
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IR (Diamond-ATR, neat): ν~  / cm-1 = 3069, 3033, 3017, 2933, 2973, 2872, 1741, 1595, 
1505, 1477, 1411, 1277, 1294, 1112, 1030, 899, 806, 760. 
MS (EI, 70 eV): m/z (%) = 269 (M+, 26), 226 (4), 185 (100), 156 (12), 128 (10), 107 (11), 85 
(8), 57 (50). 
HRMS for C17H19NO2: calc.: 269.1416; found: 269.1425 (M+). 
 
Synthesis of 2-chloro-4-(3-methylbenzyl)pyridine (10g):  
 
N
Me
Cl
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-chloro-
4-methylpyridine (2b: 165 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 
(5 mg, 2 mol%), PCy3 (12 mg, 4 mol%) and 1-bromo-3-methylbenzene (9f: 169 mg, 
1.00 mmol, 0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred 
for 1 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous 
NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/ether, 4:1) furnished 2-chloro-4-(3-
methylbenzyl)pyridine (10g: 150 mg, 69%) as a colorless oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.26 (d, J = 5.05 Hz, 1H), 7.22 (t, J = 7.22, 1H), 
7.14 (dd, J = 1.47, 0.72 Hz, 1H), 7.08 (d, J = 7.61 Hz, 1H), 7.03 (d, J = 5.05 Hz, 1H), 6.98-
6.95 (m, 2H), 3.91 (s, 2H), 2.33 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 153.6, 151.7, 149.5, 138.6, 137.9, 129.8, 128.8, 127.7, 
126.0, 124.4, 123.0, 40.9, 21.4. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3052, 2920, 2863, 1740, 1720, 1589, 1558, 1490, 
1413, 1381, 1284, 1247, 1217, 1110, 1084, 993, 800, 745, 750, 715, 698.  
MS (EI, 70 eV): m/z (%) = 217 (M+, 100), 202 (42), 182 (32), 166 (35), 152 (9), 139 (10). 
HRMS (ESI) for C13H13ClN: calc.: 218.0737; found: 218.0732 ([M+H]+). 
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Synthesis of 5-((2-chloropyridine-4-yl)methyl)-1H-indole (10h):  
 
N Cl
H
N
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-chloro-
4-methylpyridine (2b: 165 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 
(5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 5-bromoindole (9a: 195 mg, 1.00 mmol, 0.80 
equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at 50 °C. 
The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane/ether, 3:2) furnished 5-((2-chloropyridine-4-yl)methyl)-1H-indole 
(10h: 167 mg, 69%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.23 (d, J = 5.26 Hz, 1H), 8.16 (s, 1H), 7.42 (s, 1H), 
7.34 (dd, J = 8.36 Hz, 1H), 7.23-7.14 (m, 2H), 7.06 (d, J = 5.12 Hz, 1H), 6.96 (d, J = 8.36 Hz, 
1H), 6.51-6.49 (m, 1H), 4.04 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 155.2, 151.4, 149.1, 134.8, 129.2, 128.3, 124.8, 125.6, 
123.2, 123.1, 121.0, 111.5, 102.5, 41.1. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3052, 3022, 2920, 2863, 1740, 1589, 1545, 1464, 
1381, 1216, 1119, 1084, 989, 835, 785, 745, 715, 697. 
MS (EI, 70 eV): m/z (%) = 242 (M+, 100), 205 (21), 178 (10), 151 (8), 130 (79). 
HRMS (ESI) for C14H12ClN2: calc.: 243.0689; found: 243.0683 ([M+H]+). 
 
Synthesis of 4-(bis(4-methoxyphenyl)methyl)pyridine (10i): 
 
N
OMe
OMe
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TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-(4-
methoxybenzyl)pyridine (10b: 259 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and 
the reaction mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 
(5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 3 h at 
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 7:3) furnished 4-(bis(4-methoxyphenyl)methyl)-
pyridine (10i: 283 mg, 93%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.52 (dd, J = 4.44, 1.60 Hz, 2H), 7.06-6.99 (m, 6H), 
6.89-6.83 (m, 4H), 5.42 (s, 1H), 3.81 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.4, 153.4, 149.8, 134.6, 130.2, 124.3, 113.9, 55.3, 54.6. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3066, 3032, 2995, 2833, 1608, 1594, 1581, 1506, 
1491, 1457, 1441, 1412, 1303, 1240, 1177, 1111, 1030, 819. 
MS (EI, 70 eV): m/z (%) = 305 (M+, 61), 274 (23), 227 (100), 212 (6), 198 (7), 169 (7), 154 
(14). 
HRMS for C20H19NO2: calc.: 305.1416; found: 305.1411 (M+). 
 
Synthesis of ethyl 4-(pyridin-4-ylmethyl)benzoate of (10j):  
 
N
EtOOC
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 
0.13 mmol, 0.10 equiv) was added at 25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 
2 mol%), SPhos (16 mg, 4 mol%) and ethyl 4-bromobenzoate (9k: 227 mg, 1.00 mmol, 
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at        
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
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and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 1:1) furnished ethyl 4-(pyridin-4-ylmethyl)benzoate 
(10j: 188 mg, 78%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.49 (dd, J = 4.45, 1.68 Hz, 2H), 7.97 (dt, J = 8.37, 
1.93 Hz, 2H), 7.26-7.05 (m, 4H), 4.35 (q, J = 7.08 Hz, 2H), 4.01 (s, 2H), 1.36 (t, J = 7.08 Hz, 
3H). 
13C-NMR (CDCl3, 75 MHz): δ = 166.3, 149.7, 149.5, 143.8, 130.0, 130.0, 129.0, 124.2, 
60.9, 41.2, 14.3. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3028, 2981, 2931, 1710, 1597, 1413, 1365, 1270, 
1177, 1100, 1020, 994, 870, 786, 754, 704.  
MS (EI, 70 eV): m/z (%) = 241 (M+, 31), 213 (32), 196 (100), 167 (43), 139 (10), 115 (8). 
HRMS (ESI) for C15H16NO2: calc.: 242.1181; found: 242.1173 ([M+H]+). 
 
Synthesis of 4-(pyridin-4-ylmethyl)benzonitrile of (10k):  
 
N
NC
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg,          
0.13 mmol, 0.10 equiv) was added at 25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg,       
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromobenzonitrile (9j: 183 mg, 1.00 mmol,          
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 1 h at  
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1,  2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane/ether, 1:1) furnished 4-(pyridin-4-ylmethyl)benzonitrile 
(10k: 146 mg, 75%) as a colorless oil. 
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1H-NMR (300 MHz, CDCl3): δ / ppm = 8.53 (dd, J = 4.55, 2.00 Hz, 2H), 7.60 (dt, J = 8.30, 
1.93 Hz, 2H), 7.30-7.23 (m, 2H), 7.12 (d, J = 6.05 Hz, 2H), 4.05 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 149.8, 148.5, 144.2, 132.5, 129.8, 124.2, 119.6, 110.9, 
41.2. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3064, 3016, 226, 1739, 1597, 1554, 1506, 1496, 1414, 
1426, 1223, 993, 927, 865, 840, 783, 722. 
MS (EI, 70 eV): m/z (%) = 194 (M+, 100), 166 (9), 140 (9), 116 (10), 89 (7), 63 (5). 
HRMS (ESI) for C13H10N2: calc.: 195.0922; found: 195.0916 ([M+H]+). 
 
Synthesis of 4-(3-(trifluoromethyl)benzyl)pyridine (10l):  
 
N
F3C
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-
methylpyridine (2a: 121 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg,          
0.13 mmol, 0.10 equiv) was added at 25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg,       
2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-3-(trifluoromethyl)benzene (9l: 224 mg,         
1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting mixture was stirred 
for 1 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous 
NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/ether, 2:3) furnished 4-(3-
(trifluoromethyl)benzyl)pyridine (10l: 185 mg, 78%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.55 (dd, J = 6.23, 1.72 Hz, 2H), 7.55-7.36 (m, 4H), 
7.11 (d, J = 6.23, 2H), 4.05 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.1, 148.8, 139.8, 132.4, 131.1 (2JC-F = 32.2 Hz), 129.2, 
125.7 (3JC-F = 3.8 Hz), 124.1, 124.0 (1JC-F = 272.2 Hz), 123.6 (3JC-F = 3.8 Hz), 40.9. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3070, 3028, 2992, 1737, 1673, 1598, 1449, 1414, 
1327, 1160, 117, 1071, 919, 880, 791, 701, 663.  
MS (EI, 70 eV): m/z (%) = 237 (M+, 100), 218 (6), 167 (18), 159 (7), 139 (3). 
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HRMS for C13H10F3N: calc.: 237.0765; found: 237.0760 (M+). 
 
Synthesis of N,N-dimethyl-4-((3-methylpyridin-2-yl)methyl)aniline (13a) 
 
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2,3-
lutidine (12a: 139 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 15 min according to TP1. NEP (0.2 mL), 
Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-bromo-N,N-dimethylaniline (9g: 
199 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting mixture 
was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of 
saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane/EtOAc, 1:1) furnished N,N-
dimethyl-4-((3-methylpyridin-2-yl)methyl)aniline (13a: 192 mg, 85%) as a slightly yellow 
oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.43 (d, J = 4.13 Hz, 1H), 7.40 (d, J = 7.27 Hz, 1H), 
7.01-7.15 (m, 3H), 6.67 (d, J = 8.75 Hz, 2H), 4.11 (s, 2H), 2.90 (s, 6H), 2.26 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 159.5, 149.0, 146.5, 137.9, 131.6, 129.2, 126.9, 
121.4, 112.8, 41.2, 40.7, 18.9. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2917, 2874, 2797, 1613, 1517, 1442, 1342, 1212, 
1161, 946, 804, 781. 
MS (EI, 70 eV): m/z (%) = 226 (M+, 100), 225 (39), 211 (18), 209 (11), 181 (22), 134 (77), 
120 (20), 112 (17), 104 (13). 
HRMS for C15H18N2: calc. 226.1470; found: 226.1452 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)-3-methylpyridine (13b) 
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TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2,3-
lutidine (12a: 139 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 15 min according to TP1. NEP (0.2 mL), 
Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 
mmol, 0.80 equiv.) were added to the reaction mixture. The resulting mixture was stirred for  
2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous 
NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/ether, 1:1) furnished 2-(4-methoxybenzyl)-3-
methylpyridine (13b: 192 mg, 90%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.42 (d, J = 3.81 Hz, 1H), 7.41 (d, J = 7.34 Hz, 1H), 
7.03-7.17 (m, 3H), 6.81 (d, J = 8.66 Hz, 2H), 4.14 (s, 2H), 3.76 (s, 3H), 2.25 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 159.0, 157.9, 146.6, 138.0, 131.6, 131.0, 129.5, 
121.6, 113.8, 55.1, 41.2, 18.9. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2952, 2931, 2833, 1610, 1573, 1508, 1440, 1301, 
1244, 1175, 1110, 1033, 816, 785. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 57), 212 (100), 198 (78), 196 (11), 170 (16), 168 (15), 
121 (14), 78 (12), 44 (10). 
HRMS for C14H15NO: calc. 213.1154; found: 213.1129 (M+). 
 
Synthesis of 3-methyl-2-(3-methylbenzyl)pyridine (13c) 
 
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2,3-
lutidine (12a: 139 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 15 min according to TP1. NEP (0.2 mL), 
Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-3-methylbenzene (9f:      
171 mg, 1.00 mmol, 0.80 equiv) were added to the reaction mixture. The resulting mixture 
was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of 
saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
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pressure. Purification by flash-chromatography (i-hexane/ether, 1:1) furnished 3-methyl-2-(3-
methylbenzyl)pyridine (13c: 179 mg, 91%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.45 (d, J = 3.96 Hz, 1H), 7.43 (d, J = 7.43Hz, 1H), 
6.98-7.19 (m, 5H), 4.18 (s, 2H), 2.30 (s, 3H), 2.27 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.8, 146.6, 138.8, 138.0, 137.9, 131.7, 129.4, 
128.2, 126.8, 125.7, 121.6, 42.1, 21.4, 18.9. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2971, 2921, 2862, 1606, 1584, 1573, 1447, 1438, 
1422, 1104, 786, 765, 715, 694. 
MS (EI, 70 eV): m/z (%) = 197 (M+, 30), 196 (100), 194 (10), 182 (15), 181 (25), 180 (12), 
167 (6), 98 (6), 84(6), 77 (7). 
HRMS for C14H15N: calc. 197.1204; found: 197.1187 (M+). 
 
Synthesis of 3-methyl-2-(4-(trifluoromethyl)benzyl)pyridine (13d) 
 
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2,3-
lutidine (12a: 139 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 15 min according to TP1. NEP (0.2 mL), 
Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-4-(trifluoromethyl)benzene 
(9m: 225 mg, 1.00 mmol, 0.80 equiv) were added to the reaction mixture. The resulting 
mixture was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) 
and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane/ether, 1:1) furnished 3-methyl-2-(4-
(trifluoromethyl)benzyl)pyridine (13d: 221 mg, 88%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.44 (d, J = 3.96 Hz, 1H), 7.52 (m, J = 8.09 Hz, 2H), 
7.45 (d, J = 7.27 Hz, 1H), 7.31 (m, J = 7.93 Hz, 2H), 7.11 (dd, J = 7.60, 4.95 Hz, 1H), 4.25 (s, 
2H), 2.25 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 157.8, 146.9, 143.1, 138.2, 131.7, 129.0, 128.5 (2JC-F 
= 32.3 Hz), 125.3 (3JC-F = 3.9 Hz), 124.3 (1JC-F = 271.8 Hz), 122.0, 41.8, 18.9. 
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IR (Diamond-ATR, neat): ν~  (cm-1) = 1618, 1574, 1444, 1415, 1321, 1160, 1109, 1065, 
1018, 818, 788, 715. 
MS (EI, 70 eV): m/z (%) = 251 (M+, 100), 250 (39), 248 (21), 236 (22), 235 (15), 181 (39), 
167 (12), 65 (8). 
HRMS for C14H12F3N: calc. 251.0922; found: 251.0911 (M+). 
 
Synthesis of 4-(4-methoxybenzyl)-3-methylpyridine (14) 
 
N
Me
OMe
 
 
TMPZnCl·LiCl (7: 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 3,4-
lutidine (12b: 139 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 15 min according to TP1. Pd(OAc)2 (5 mg,    
2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 2 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane/ether, 1:1) furnished 4-(4-methoxybenzyl)-3-methylpyridine (14: 
196 mg, 92%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.31-8.38 (m, 2H), 7.02 (m, J = 8.66 Hz, 2H), 6.95 
(d, J = 4.99 Hz, 1H), 6.83 (m, J = 8.66 Hz, 2H), 3.88 (s, 2H), 3.77 (s, 3H), 2.23 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.1, 150.5, 148.3, 147.5, 131.9, 130.0, 129.7, 
124.1, 114.0, 55.1, 37.7, 16.2. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2953, 2931, 2834, 1610, 1593, 1510, 1453, 1441, 
1301, 1245, 1176, 1032, 814, 775, 758. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 100), 198 (15), 182 (13), 167 (8), 121 (73), 115 (9), 108 
(43), 105 (79), 78 (25), 77 (13). 
HRMS for C14H15NO: calc. 213.1154; found: 213.1158 (M+). 
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Synthesis of ethyl 4-((2-methylpyridin-4-yl)methyl)benzoate (15a) 
 
N
CO2Et
Me
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv.) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and ethyl 4-
bromobenzoate (9k: 227 mg, 1.00 mmol, 0.80 equiv) were added and the reaction mixture 
was warmed slowly to 50 °C and was stirred at that temperature for 2 h. The reaction mixture 
was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography          
(i-hexane/EtOAc, 1:1) furnished ethyl 4-((2-methylpyridin-4-yl)methyl)benzoate (15a:       
209 mg, 82%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.38 (d, J = 5.14 Hz, 1H), 7.98 (m, J = 8.25 Hz, 2H), 
7.23 (m, J = 8.07 Hz, 2H), 6.94 (s, 1H), 6.89 (d, J = 5.14 Hz, 1H), 4.36 (q, J = 7.15 Hz, 2H), 
3.96 (s, 2H), 2.50 (s, 3H), 1.37 (t, J = 7.15 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 166.3, 158.5, 149.3, 149.1, 144.1, 129.9, 129.2, 
128.9, 123.6, 121.2, 60.9, 41.1, 24.2, 14.3. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2979, 1711, 1600, 1415, 1366, 1271, 1177, 1099, 
1020, 749, 705. 
MS (EI, 70 eV): m/z (%) = 255 (M+, 40), 227 (36), 211 (18), 210 (100), 182 (30), 181 (22), 
167 (15), 115 (7), 90 (6). 
HRMS for C16H17NO2: calc. 255.1259; found: 255.1247 (M+). 
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Synthesis of 4-(4-methoxybenzyl)-2-methylpyridine (15b) 
 
N
OMe
Me
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.25 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-bromoanisole 
(9b: 187 mg, 1.00 mmol, 0.80 equiv) were added and the reaction mixture was warmed 
slowly to 50 °C and was stirred at that temperature for 2 h. The reaction mixture was then 
quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with 
ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was 
evaporated under reduced pressure. Purification by flash-chromatography (i-hexane/ether, 
1:1) furnished 4-(4-methoxybenzyl)-2-methylpyridine (15b: 196 mg, 92%) as a slightly 
yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.36 (d, J = 5.01 Hz, 1H), 7.08 (d, J = 8.61 Hz, 2H), 
6.80-6.99 (m, 4H), 3.86 (s, 2H), 3.78 (s, 3H), 2.50 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.2, 150.7, 148.9, 131.0, 129.9, 123.5, 121.2, 
114.0, 55.2, 40.2, 24.2. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2931, 2834, 1601, 1510, 1463, 1440, 1300, 1245, 
1176, 1033, 928, 815, 769. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 100), 212 (20), 198 (29), 182 (9), 170 (6), 128 (6), 121 
(62), 77 (7). 
HRMS for C14H15NO: calc. 213.1154; found: 213.1157 (M+). 
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Synthesis of 4-((2-methylpyridin-4-yl)methyl)phenyl pivalate (15c) 
 
N
OPiv
Me
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol, 
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-bromophenyl 
pivalate (9i: 257 mg, 1.00 mmol, 0.80 equiv) were added and the reaction mixture was 
warmed slowly to 50 °C and was stirred at that temperature for 2 h. The reaction mixture was 
then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted 
with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent 
was evaporated under reduced pressure. Purification by flash-chromatography                       
(i-hexane/ether, 1:1) furnished 4-((2-methylpyridin-4-yl)methyl)phenyl pivalate (15c: 232 mg, 
82%) as a slightly yellow solid. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.37 (d, J = 4.95 Hz, 1H), 7.15 (d, J = 8.44 Hz, 2H), 
6.86 - 7.04 (m, 4H), 3.90 (s, 2H), 2.50 (s, 3H), 1.34 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 177.0, 158.3, 150.0, 149.7, 149.0, 136.2, 129.8, 
123.6, 121.6, 121.2, 40.4, 38.9, 27.0, 24.2. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2976, 2963, 1743, 1602, 1505, 1276, 1196, 1162, 
1115, 1016, 894, 818, 759, 731. 
MS (EI, 70 eV): m/z (%) = 283 (M+, 4), 199 (34), 198 (8), 107 (12), 85 (31), 77 (6), 57 (100), 
41 (13). 
HRMS for C18H21NO2: calc. 283.1572; found: 283.1570 (M+). 
M.p. (°C): 72.0-73.4 °C. 
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Synthesis of 4-((2-methylpyridin-4-yl)methyl)benzonitrile (15d) 
 
N
CN
Me
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-
bromobenzonitrile (9j: 182 mg, 1.00 mmol, 0.80 equiv) were added and the reaction mixture 
was warmed slowly to 50 °C and was stirred at that temperature for 2 h. The reaction mixture 
was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography           
(i-hexane/EtOAc, 1:1) furnished 4-((2-methylpyridin-4-yl)methyl)benzonitrile (15d: 160 mg, 
77%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.42 (d, J = 4.95 Hz, 1H), 7.61 (d, J = 8.25 Hz, 2H), 
7.24 - 7.32 (m, 2H), 6.95 (s, 1H), 6.90 (d, J = 5.14 Hz, 1H), 3.99 (s, 2H), 2.53 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.8, 149.3, 148.4, 144.5, 132.4, 129.7, 123.6, 
121.2, 118.6, 110.7, 41.1, 24.3. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2227, 1677, 1599, 1560, 1504, 1407, 1287, 1177, 
1021, 858, 816, 770. 
MS (EI, 70 eV): m/z (%) = 208 (M+, 100), 207 (26), 193 (9), 192 (9), 166 (7), 140 (7), 116 
(4), 89 (3). 
HRMS for C14H12N2: calc. 208.1000; found: 208.0994 (M+). 
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Synthesis of 4-(4-methoxybenzyl)-2-methylpyridine (15b) 
 
N
OMe
Me
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-methoxyphenyl 
trifluoromethanesulfonate (9n: 256 mg, 1.00 mmol, 0.80 equiv) were added and the reaction 
mixture was warmed slowly to 50 °C and was stirred at that temperature for 2 h. The reaction 
mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography                
(i-hexane/ether, 1:1) furnished 4-(4-methoxybenzyl)-2-methylpyridine (15b: 209 mg, 98%) as 
a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.35 (d, J = 4.95 Hz, 1H), 7.02 - 7.14 (m, 2H), 6.79 - 
7.00 (m, 4H), 3.85 (s, 2H), 3.77 (s, 3H), 2.50 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.3, 158.2, 150.9, 148.8, 131.0, 129.9, 123.6, 
121.2, 114.0, 55.2, 40.3, 24.1. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2931, 2834, 1601, 1510, 1440, 1300, 1245, 1176, 
1106, 1033, 815, 769, 760. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 100), 212 (20), 198 (34), 182 (13), 168 (9), 128 (9), 121 
(76), 77 (16). 
HRMS for C14H15NO: calc. 213.1154; found: 213.1150 (M+). 
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Synthesis of 4-(2-methoxybenzyl)-2-methylpyridine (15e) 
 
N Me
MeO
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 2-bromoanisole 
(9o: 187 mg, 1.00 mmol, 0.80 equiv) were added and the reaction mixture was warmed 
slowly to 50 °C and was stirred at that temperature for 2 h. The reaction mixture was then 
quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with 
ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was 
evaporated under reduced pressure. Purification by flash-chromatography (i-hexane/ether, 
1:1) furnished 4-(2-methoxybenzyl)-2-methylpyridine (15e: 196 mg, 92%) as a slightly 
yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.36 (d, J = 5.14 Hz, 1H), 7.25 (td, J = 7.89, 1.83 
Hz, 1H), 7.10 (dd, J = 7.34, 1.28 Hz, 1H), 6.99 (s, 1H), 6.85-6.96 (m, 3H), 3.92 (s, 2H), 3.80 
(s, 3H), 2.51 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 157.9, 157.2, 150.4, 148.7, 130.4, 127.9, 127.5, 
123.5, 121.2, 120.5, 110.4, 55.2, 35.3, 24.1. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2956, 2923, 2835, 1601, 1492, 1462, 1438, 1291, 
1242, 1178, 1106, 1027, 816, 751. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 100), 198 (26), 182 (17), 180 (9), 121 (15), 107 (16), 91 
(12). 
HRMS for C14H15NO: calc. 213.1154; found: 213.1157 (M+). 
 
 
 
 
 110 
Synthesis of 4-(3-methoxybenzyl)-2-methylpyridine (15f) 
 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 3-chloroanisole 
(9p: 143 mg, 1.00 mmol, 0.80 equiv) were added and the reaction mixture was warmed 
slowly to 50 °C and was stirred at that temperature for 2 h. The reaction mixture was then 
quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with 
ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was 
evaporated under reduced pressure. Purification by flash-chromatography (i-hexane/ether, 
1:1) furnished 4-(3-methoxybenzyl)-2-methylpyridine (15f: 183 mg, 86%) as a slightly yellow 
oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.37 (d, J = 5.14 Hz, 1H), 7.23 (t, J = 7.89 Hz, 1H), 
6.97 (s, 1H), 6.92 (d, J = 5.14 Hz, 1H), 6.73-6.81 (m, 2H), 6.71 (s, 1H), 3.88 (s, 2H), 3.77 (s, 
3H), 2.51 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 159.8, 158.2, 150.2, 148.8, 140.4, 129.6, 123.7, 
121.3, 121.3, 114.9, 111.6, 55.1, 41.1, 24.1. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 2921, 2834, 1596, 1584, 1488, 1453, 1435, 1258, 
1147, 1048, 1041, 763, 746, 695. 
MS (EI, 70 eV): m/z (%) = 213 (M+, 100), 212 (17), 182 (11), 170 (8), 128 (6), 121 (17), 91 
(5), 77 (5). 
HRMS for C14H15NO: calc. 213.1154; found: 213.1144 (M+). 
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Synthesis of 2-methyl-4-(4-(trifluoromethyl)benzyl)pyridine (15g) 
 
N Me
CF3
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2,4-lutidine (12c: 139 mg, 1.30 mmol, 1.00 equiv) was dissolved in dry THF (5 mL). 
BF3⋅OEt2 (163 mg, 1.43 mmol, 1.10 equiv) was added dropwise at 0 °C and the mixture was 
stirred at 0 °C for 15 min. Then, TMPZnCl⋅LiCl (7: 1.50 mL, 1.30 M in THF, 1.95 mmol,      
1.50 equiv) was added dropwise at -78 °C and the reaction mixture was stirred at that 
temperature for 1 h. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-chloro-4-
(trifluoromethyl)benzene (9q: 181 mg, 1.00 mmol, 0.80 equiv) were added and the reaction 
mixture was warmed slowly to 50 °C and was stirred at that temperature for 2 h. The reaction 
mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography                
(i-hexane/ether, 1:1) furnished 2-methyl-4-(4-(trifluoromethyl)benzyl)pyridine (15g: 221 mg, 
88%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.41 (d, J = 5.14 Hz, 1H), 7.57 (m, J = 8.07 Hz, 2H), 
7.29 (m, J = 7.89 Hz, 2H), 6.97 (s, 1H), 6.91 (d, J = 5.14 Hz, 1H), 3.98 (s, 2H), 2.53 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.6, 149.1, 143.1, 143.0, 129.3, 129.0 (2JC-F = 32.5 
Hz), 125.6 (3JC-F = 3.9 Hz), 124.1 (1JC-F = 272.1 Hz), 123.7, 121.2, 40.9, 24.2. 
IR (Diamond-ATR, neat): ν~  (cm-1) = 1602, 1561, 1418, 1321, 1161, 1119, 1105, 1065, 
1018, 857, 815, 773. 
MS (EI, 70 eV): m/z (%) = 251 (M+, 100), 250 (15), 236 (4), 182 (15), 181 (9), 167 (7), 159 
(3), 141 (3). 
HRMS for C14H12F3N: calc. 251.0922; found: 251.0911 (M+). 
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4. Benzylic Arylation of 2-Methyl-5-Membered Heterocycles Using 
TMP-Bases 
 
Synthesis of ethyl 4-((1-methyl-1H-imidazol-2-yl)methyl)benzoate (19a):  
N
Me
N
COOEt
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 1,2-
dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg, 4 mol%) and ethyl 4-bromobenzoate (9k: 229 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (DCM/MeOH, 99:1) furnished ethyl 4((1methyl-1H-imidazol-2-
yl)methyl)benzoate (19a: 208 mg, 85%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.98 (dt, J = 8.36, 1.91 Hz, 2H), 7.25 (d, J = 8.36 
Hz, 2H), 7.00 (d, J = 1.36 Hz, 1H), 6.84 (d, J = 1.36 Hz, 1H), 4.37 (q, J = 7.08 Hz, 2H), 4.18 
(s, 2H), 3.45 (s, 3H), 1.38 (t, J = 7.08 Hz, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 166.4, 145.9, 142.3, 130.0, 129.1, 128.3, 127.3, 121.2, 
60.9, 33.5, 32.9, 14.3. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3060 (vw), 3030 (vw), 3028 (vw), 2978 (s), 2930 
(vw), 2853 (vw), 1710 (s), 1609 (m), 1587 (m), 1471 (vw), 1449 (w), 1417 (w), 1392 (w), 
1366 (m), 1273 (s), 1179 (m), 1104 (s), 1021 (m), 1010 (m), 937 (vw), 851 (w), 746 (s), 697 
(S).  
MS (EI, 70 eV): m/z (%) = 244 (M+, 100), 229 (11), 215 (53), 199 (27), 171 (26), 156 (17), 
81 (40). 
HRMS (C14H16N2O2): calc.: 244.1212; found: 244.1220 (M+). 
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Synthesis of 4-((1-methyl-1H-imidazol-2-yl)methyl)benzonitrile (19b):  
N
Me
N
CN
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 1,2-
dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg,    4 mol%) and 4-bromobenzonitrile (9j: 182 mg, 1.00 mmol, 0.80 equiv) were 
added to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The reaction 
mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography 
(DCM/MeOH, 99:1) furnished 4-((1-methyl-1H-imidazol-2-yl)methyl)benzonitrile (19b:    
141 mg, 71%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.61 (d, J = 8.02 Hz, 2H), 7.31 (d, J = 8.02 Hz, 2H), 
7.00 (d, J = 1.25 Hz, 1H), 6.86 (d, J = 1.25 Hz, 1H), 4.18 (s, 2H), 3.49 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 145.2, 142.6, 132.5, 129.2, 127.6, 121.3, 118.7, 110.8, 
33.4, 32.9. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3359 (w), 3143 (w), 3112 (w), 2947 (w), 2852 (vw), 
2226 (s), 1607 (s), 1496 (s), 1470 (m), 1416 (s), 1281 (s), 1170 (m), 1126 (s), 1084 (w), 1021 
(w), 934 (w), 854 (m), 823 (m), 781 (s), 735 (s), 704 (m).  
MS (EI, 70 eV): m/z (%) = 208 (M+, 70), 207 (100), 130 (48), 127 (18), 44 (62). 
HRMS (C12H11N3): calc.: 197.0953; found: 197.0928 (M+). 
 
Synthesis of 1-methyl-2-(3-(trifluoromethyl)benzyl)-1H-imidazole (19c): 
N
Me
N CF3
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 1,2-
dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
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SPhos (21 mg, 4 mol%) and 1-bromo-3-trifluoromethylbenzene (9l: 225 mg, 1.00 mmol,   
0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred for 3 h at  
50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl 
and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (DCM/MeOH, 99:1) furnished 1-methyl-2-(3-(trifluoromethyl)benzyl)-
1H-imidazole (19c: 186 mg, 77%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.53-7.32 (m, 4H), 6.98 (d, J = 1.33 Hz, 1H), 6.83 
(d, J = 1.33 Hz, 1H), 4.16  (s, 2H), 3.47 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 145.7, 138.1, 134 (2JC-F = 32.2 Hz), 131.8, 129.2, 127.4, 
125.0 (3JC-F = 3.8 Hz), 124.0 (1JC-F = 274.5 Hz), 123.6 (3JC-F = 3.8 Hz), 121.2, 32.2, 32.9. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3357 (vw), 3110 (vw), 2931 (vw), 1711 (vw), 1677 
(vw), 1615 (vw), 1496 (m), 1448 (w), 1330 (s), 1282 (m), 1160 (s), 1116 (s), 1074 (s), 917 
(w), 972 (w), 775 (m), 734 (m), 700 (s), 663 (w).  
MS (EI, 70 eV): m/z (%) = 239 (M+, 100), 225 (27), 205 (16), 171 (16), 81 (49). 
HRMS (C12H11F3N2): calc.: 240.0874; found: 240.0901 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)-1-methyl-1H-imidazole (19d):  
N
Me
N
OMe
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 1,2-
dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg, 4 mol%) and 4-bromoanisole (9b: 187 mg, 1.00 mmol, 0.80 equiv) were added 
to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The reaction 
mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography 
(DCM/MeOH, 98:2) furnished 2-(4-methoxybenzyl)-1-methyl-1H-imidazole  (19d: 150 mg, 
74%) as a pale yellow oil. 
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1H-NMR (300 MHz, CDCl3): δ / ppm = 7.09 (d, J = 8.84 Hz, 2H), 6.97 (s, 1H), 6.85-6.79 
(m, 3H), 4.07 (s, 2H), 3.77 (s, 3H), 3.45 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.3, 147.0, 129.3, 128.8, 126.6, 121.0, 114.1, 55.2, 33.0, 
32.6. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3362 (vw), 3110 (vw), 3001 (vw), 2934 (w), 2836 
(vw), 1609 (m), 1584 (m), 1510 (s), 1498 (m), 1463 (m), 1442 (m), 1410 (w), 1302 (w), 1281 
(m), 1244 (s), 1176 (m), 1123 (m), 1108 (m), 1084 (w), 1029 (s), 932 (w), 835 (m), 821 (m), 
782 (s), 736 (s), 705 (w), 661 (vw).  
MS (EI, 70 eV): m/z (%) = 202 (M+, 65), 187 (58), 170 (5), 159 (9), 121 (100). 
HRMS (C12H14N2O): calc.: 202.1106; found: 202.1093 (M+). 
 
Synthesis of 4-((1-methyl-1H-imidazol-2-yl)methyl)phenyl pivalate (19e):  
N
Me
N
OPiv
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 
1,2-dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg, 4 mol%) and 4-bromophenylpivalate (9i: 258 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (DCM/MeOH, 9:1) furnished 4-((1-methyl-1H-imidazol-2-yl)methyl)phenyl 
pivalate (19e: 249 mg, 91%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.16-7.01 (m, 3H), 6.95 (d, J = 8.17 Hz, 2H), 6.82 
(d, J = 1.36 Hz, 1H), 4.18 (s, 2H), 3.43 (s, 3H), 1.35 (s, 9H). 
13C-NMR (CDCl3, 75 MHz): δ = 177.1, 149.9, 146.8, 133.7, 129.1, 126.7, 121.7, 121.3, 
57.1, 39.0, 35.2, 33.2, 27.6, 27.1. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3117 (vw), 3037 (vw), 2973 (w), 2935 (w), 2873 
(vw), 1744 (s), 1605 (w), 1594 (w), 1546 (vw), 1505 (m), 1478 (m), 1461 (m), 1420 (w), 
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1396 (w), 1366 (vw), 1278 (m), 1250 (vw), 1199 (m), 1166 (m), 1113 (s), 1029 (w), 1017 
(w), 894 (w), 773 (m), 758 (m), 737 (m), 703 (w).  
MS (EI, 70 eV): m/z (%) = 272 (M+, 100), 187 (73), 173 (17), 159 (14), 107 (29), 82 (65), 57 
(71). 
HRMS (C16H20N2O2): calc.: 272.1525; found: 272.1516 (M+). 
 
Synthesis of 1-methyl-2-(3-methylbenzyl)-1H-imidazole (19f):  
N
Me
N
Me
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 
1,2-dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg, 4 mol%) and 3-bromotoluene (9f: 172 mg, 1.00 mmol, 0.80 equiv) were added 
to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The reaction 
mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), 
extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the 
solvent was evaporated under reduced pressure. Purification by flash-chromatography 
(DCM/MeOH, 99:1 (500 mL) then 98:2) furnished 1-methyl-2-(3-methylbenzyl)-1H-
imidazole (19f: 155 mg, 83%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.16 (t, J = 7.53, 1H), 7.04-6.93 (m, 4H), 6.79 (d, J 
= 1.55 Hz, 1H), 4.06 (s, 2H), 3.44 (s, 3H), 2.29 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 146.8, 138.3, 137.0, 129.0, 128.5, 127.4, 127.1, 125.3, 
121.0, 33.4, 32.9, 21.4. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3363 (vw), 3137 (vw), 3108 (vw), 2947 (w), 2921 
(w), 1644 (w), 1606 (m), 1590 (w), 1494 (s), 1461 (m), 1431 (m), 1410 (m), 1379 (vw), 1281 
(s), 1219 (vw), 1168 (vw), 1122 (s), 1089 (w), 1039 (w), 998 (w), 936 (w), 886 (vw), 760 (s), 
693 (s), 656 (w).  
MS (EI, 70 eV): m/z (%) = 185 (M+, 100), 171 (30), 156 (10), 105 (21), 81 (18). 
HRMS (C12H14N2): calc.: 186.1157; found: 186.1142 (M+). 
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Synthesis of N,N-dimethyl-4-((1-methyl-1H-imidazol-2-yl)methyl)aniline (19g):  
N
Me
N
NMe2
 
 
TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 
1,2-dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg, 4 mol%) and 4-bromo-N,N-dimethylaniline (9g: 200 mg, 1.00 mmol, 0.80 
equiv) were added to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. 
The reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (DCM/MeOH, 98:2) furnished N,N-dimethyl-4-((1-methyl-1H-imidazol-2-
yl)methyl)aniline (19g: 171 mg, 79%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.13-6.96 (m, 3H), 6.80 (d, J = 1.55 Hz, 1H), 6.68 
(m, 2H), 4.06 (s, 2H), 3.44 (s, 3H), 2.92 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 149.4, 147.8, 129.0, 126.8, 124.8, 120.9, 112.9, 40.7, 33.0, 
32.5. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3279 (w), 3135 (w), 3009 (w), 2889 (w), 2811 (w), 
1696 (w), 1619 (s), 1527 (s), 1491 (s), 1447 (s), 1411 (m), 1363 (m), 1281 (m), 1236 (w), 
1187 (w), 1174 (w), 1123 (m), 1006 (m), 1087 (w), 1070 (w), 951 (m), 933 (m), 848 (w), 827 
(w), 808 (m), 775 (s), 749 (s), 705 (m), 656 (w).  
MS (EI, 70 eV): m/z (%) = 215 (M+, 100), 200 (47), 184 (6), 170 (17), 156 (16), 134 (65), 
118 (16). 
HRMS (C13H17N3): calc.: 215.1422; found: 215.1416 (M+). 
 
Synthesis of 2-benzo[d][1,3]dioxol-5-ylmethyl)-1-methyl-1H-imidazole (19h):  
N
Me
N
OO
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TMPMgCl·LiCl (17: 1.15 M in THF, 1.70 mL, 1.95 mmol) was added to a solution of 
1,2-dimethylimidazole (16: 125 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 3 h. Pd(dba)2 (15 mg, 2 mol%), 
SPhos (21 mg, 4 mol%) and 5-bromo-benzo[1,3]dioxole (9e: 201 mg, 1.00 mmol, 0.80 equiv) 
were added to the reaction mixture. The resulting mixture was stirred for 3 h at 50 °C. The 
reaction mixture was then quenched with a mixture of saturated aqueous NH4Cl and NH3 
(10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (DCM/MeOH, 99:1) furnished 2-benzo[d][1,3]dioxol-5-ylmethyl)-1-methyl-
1H-imidazole (19h: 154 mg, 71%) as a pale yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 6.98 (d, J = 1.36 Hz, 1H), 6.84-6.59 (m, 4H), 5.93 (s, 
2H), 4.04 (s, 2H), 3.48 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 147.9, 146.7, 146.3, 130.8, 127.1, 121.2, 121.0, 108.8, 
108.3, 101.0, 33.2, 32.9. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3269 (w), 3142 (vw), 3069 (vw), 2905 (w), 2788 
(vw), 1697 (w), 1605 (w), 1500 (s), 1490 (s), 1447 (m), 1413 (w), 1349 (w), 1282 (m), 1255 
(s), 1214 (m), 1188 (w), 1113 (s), 1038 (s), 946 (m), 923 (s), 856 (m), 863 (m), 781 (s), 753 
(m), 700 (m), 661 (m).  
MS (EI, 70 eV): m/z (%) = 216 (M+, 100), 201 (16), 187 (11), 157 (30), 135 (76). 
HRMS (C12H12N2O2): calc.: 216.0899; found: 216.0887 (M+). 
 
Synthesis of ethyl 4-(benzo[b]thiophen-2-ylmethyl)benzoate (23a): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and ethyl 4-bromobenzoate (9k: 229 mg, 
1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was stirred 
for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous 
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NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 20:1) furnished 4-(benzo[b]thiophen-2-
ylmethyl)benzoate (23a: 255 mg, 86%) as a white powder. 
 
Melting point (°C): 91.3 – 92.8. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 8.02 (m, J = 8.22 Hz, 2H), 7.74 (d, J = 7.92 Hz, 1H), 
7.67 (d, J = 7.78 Hz, 1H), 7.37 (m, J = 8.22 Hz, 2H), 7.30 - 7.33 (m, 1H), 7.25 - 7.28 (m, 1H), 
7.01 (s, 1H), 4.38 (q, J = 7.04 Hz, 2H), 4.28 (s, 2H), 1.40 (t, J = 7.12 Hz, 3H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 166.4, 144.6, 143.8, 139.9, 139.8, 129.9, 129.1, 
128.7, 124.2, 123.8, 123.0, 122.1, 122.0, 60.9, 36.9, 14.3. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2971, 2360, 2340, 1737, 1714, 1366, 1277, 1252, 
1230, 1217, 1205, 1108, 1102, 834, 744, 726, 712.  
MS (EI, 70 eV): m/z (%) = 296 (M+, 100), 295 (17), 251 (24), 223 (44), 147 (52), 126 (12). 
HRMS (C18H16O2S): calc.: 296.0871; found: 296.0866 (M+). 
 
Synthesis of 2-(4-(trifluoromethyl)benzyl)benzo[b]thiophene (23b): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 1-bromo-4-(trifluoromethyl)benzene 
(9m: 225 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting 
mixture was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) 
and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane) furnished 2-(4-
(trifluoromethyl)benzyl)benzo[b]thiophene (23b: 263 mg, 90%) as a white powder. 
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Melting point (°C): 83.7 – 85.3. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.78 (d, J = 7.99 Hz, 1H), 7.71 (d, J = 7.87 Hz, 1H), 
7.61 (m, J = 8.11 Hz, 2H), 7.42 (m, J = 8.11 Hz, 2H), 7.33 - 7.37 (m, 1H), 7.28 - 7.32 (m, 
1H), 7.05 (s, 1H), 4.29 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 143.5, 143.5 (d, J = 1.4 Hz), 139.9, 139.8, 129.1 (q, J 
= 32.5 Hz), 129.0, 125.5 (q, J = 3.9 Hz), 124.3, 124.2 (q, J = 272.1 Hz), 123.9, 123.1, 122.2, 
122.2, 36.7. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2359, 2340, 1739, 1719, 1700, 1418, 1372, 1366, 
1320, 1229, 1217, 1207, 1123, 1114, 1102, 1067, 1018, 854, 836, 749, 727. 
MS (EI, 70 eV): m/z (%) = 292 (M+, 100), 291 (51), 223 (17), 221 (21), 147 (57). 
HRMS (C16H11F3S): calc.: 292.0534; found: 292.0525 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)benzo[b]thiophene (23c): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 1-bromo-4-methoxybenzene (9b:        
187 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 20:1) furnished 2-(4-
methoxybenzyl)benzo[b]thiophene (23c: 249 mg, 98%) as a white powder. 
 
Melting point (°C): 117.6 – 118.6. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.75 (d, J = 7.70 Hz, 1H), 7.67 (d, J = 7.52 Hz, 1H), 
7.23 - 7.35 (m, 4H), 7.01 (s, 1H), 6.90 (d, J = 8.62 Hz, 2H), 4.19 (s, 2H), 3.83 (s, 3H). 
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13C-NMR (CDCl3, 75 MHz): δ / ppm = 158.4, 145.8, 140.1, 139.8, 131.7, 129.8, 124.1, 
123.6, 122.9, 122.1, 121.3, 114.0, 55.3, 36.1. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2359, 2341, 1739, 1719, 1700, 1610, 1508, 1490, 
1472, 1463, 1456, 1436, 1420, 1374, 1366, 1300, 1237, 1231, 1218, 1206, 1181, 1174, 1162, 
1150, 1103, 1034, 1010, 838, 823, 813, 757, 743, 726. 
MS (EI, 70 eV): m/z (%) = 254 (M+, 39), 253 (26), 223 (11), 147 (15), 74 (76), 59 (100). 
HRMS (C16H14OS): calc.: 254.0765; found: 254.0762 (M+). 
 
 
Synthesis of 5-(benzo[b]thiophen-2-ylmethyl)-2-methoxybenzonitrile (23d): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 5-bromo-2-methoxybenzonitrile (9r:  
212 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 5:1) furnished 5-(benzo[b]thiophen-2-
ylmethyl)-2-methoxybenzonitrile (23d: 218 mg, 78%) as a slightly yellow powder. 
 
Melting point (°C): 93.9 – 95.2. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.74 (d, J = 7.80 Hz, 1H), 7.68 (d, J = 7.60 Hz, 1H), 
7.42 - 7.48 (m, 2H), 7.25 - 7.36 (m, 2H), 7.00 (s, 1H), 6.91 (d, J = 8.38 Hz, 1H), 4.15 (s, 2H), 
3.90 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 160.0, 143.7, 139.8, 139.7, 134.6, 133.5, 132.1, 
124.3, 123.9, 123.0, 122.1, 121.9, 116.3, 111.4, 101.7, 56.0, 35.4. 
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IR (Diamond-ATR, neat): ν~  / cm-1 = 2361, 2341, 2224, 1739, 1701, 1608, 1580, 1496, 
1471, 1457, 1435, 1417, 1366, 1292, 1280, 1265, 1230, 1217, 1182, 1152, 1134, 1123, 1108, 
1092, 1064, 1017, 941, 899, 870, 832, 819, 760, 751, 737, 728, 720. 
MS (EI, 70 eV): m/z (%) = 279 (M+, 100), 278 (45), 264 (8), 248 (10), 147 (27). 
HRMS (C17H13NOS): calc.: 279.0718; found: 279.0712 (M+). 
 
Synthesis of 4-(benzo[b]thiophen-2-ylmethyl)phenyl pivalate (23e): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 4-bromophenyl pivalate (9i: 257 mg, 
1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was stirred 
for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous 
NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 20:1) furnished 4-(benzo[b]thiophen-2-
ylmethyl)phenyl pivalate (23e: 315 mg, 97%) as a white powder. 
 
Melting point (°C): 100.0 – 101.1. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.75 (d, J = 7.96 Hz, 1H), 7.67 (d, J = 7.96 Hz, 1H), 
7.29 - 7.33 (m, 3H), 7.25 - 7.28 (m, 1H), 7.04 (d, J = 8.51 Hz, 2H), 7.00 (s, 1H), 4.23 (s, 2H), 
1.37 (s, 9H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 177.1, 149.8, 144.8, 140.0, 139.8, 136.7, 129.7, 
124.1, 123.7, 122.9, 122.1, 121.8, 121.6, 39.0, 36.3, 27.1. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2971, 2360, 2340, 1739, 1507, 1489, 1475, 1457, 
1444, 1433, 1420, 1394, 1366, 1279, 1229, 1217, 1203, 1164, 1128, 1105, 1062, 1034, 1016, 
938, 901, 868, 854, 820, 796, 764, 745, 727, 676. 
MS (EI, 70 eV): m/z (%) = 324 (M+, 100), 241 (22), 240 (30), 239 (61), 221 (9), 147 (20). 
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HRMS (C20H20O2S): calc.: 324.1184; found: 324.1179 (M+). 
 
Synthesis of 4-(benzo[b]thiophen-2-ylmethyl)-N,N-dimethylaniline (23f): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 4-bromo-N,N-dimethylaniline (9g:      
200 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 20:1) furnished 4-(benzo[b]thiophen-2-
ylmethyl)-N,N-dimethylaniline (23f: 249 mg, 93%) as a white powder. 
 
Melting point (°C): 91.1 – 92.8. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.77 (d, J = 7.96 Hz, 1H), 7.69 (d, J = 7.96 Hz, 1H), 
7.30 - 7.36 (m, 1H), 7.25 - 7.30 (m, 1H), 7.22 (m, J = 8.78 Hz, 2H), 7.03 (s, 1H), 6.78 (m, J = 
8.51 Hz, 2H), 4.18 (s, 2H), 2.97 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 149.3, 146.6, 140.1, 139.8, 129.4, 127.7, 124.0, 
123.4, 122.8, 122.1, 121.0, 112.9, 40.7, 36.0. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2359, 2340, 1739, 1719, 1700, 1615, 1519, 1508, 
1498, 1489, 1474, 1464, 1456, 1447, 1436, 1419, 1366, 1352, 1338, 1311, 1228, 1217, 1206, 
1192, 1160, 1149, 1127, 1062, 820, 805, 746, 726. 
MS (EI, 70 eV): m/z (%) = 267 (M+, 100), 266 (51), 223 (15), 221 (11), 147 (6), 133 (6). 
HRMS (C17H17NS): calc.: 267.1082; found: 267.1078 (M+). 
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Synthesis of 3-(benzo[b]thiophen-2-ylmethyl)pyridine (23g): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 3-bromopyridine (9s: 158 mg, 
1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was stirred 
for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated aqueous 
NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 1:1) furnished 3-(benzo[b]thiophen-2-
ylmethyl)pyridine (23g: 153 mg, 68%) as a slightly yellow powder. 
 
Melting point (°C): 71.9 – 73.8. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 8.62 (d, J = 1.66 Hz, 1H), 8.54 (d, J = 3.59 Hz, 1H), 
7.59 - 7.85 (m, 3H), 7.24 - 7.38 (m, 3H), 7.04 (s, 1H), 4.26 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 149.5, 147.8, 143.2, 139.9, 139.8, 136.6, 135.2, 
124.3, 124.0, 123.6, 123.1, 122.2, 122.2, 34.1. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2360, 2340, 1572, 1478, 1454, 1428, 1420, 1299, 
1235, 1182, 1147, 1130, 1122, 1104, 1092, 1064, 1024, 1012, 940, 909, 860, 841, 813, 787, 
748, 728, 714, 699, 676, 668. 
MS (EI, 70 eV): m/z (%) = 225 (M+, 100), 224 (54), 223 (11), 148 (6), 147 (49), 112 (6). 
HRMS (C14H11NS): calc.: 225.0612; found: 225.0603 (M+). 
 
Synthesis of 5-(benzo[b]thiophen-2-ylmethyl)benzo[d][1,3]dioxole (23h): 
S
O
O
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TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2-
methylbenzo[b]thiophene (20a: 193 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and 
the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 (1 M 
in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 5-bromobenzo[d][1,3]dioxole (9e:      
201 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane) furnished 5-(benzo[b]thiophen-2-
ylmethyl)benzo[d][1,3]dioxole (23h: 233 mg, 87%) as a slightly orange powder. 
 
Melting point (°C): 93.8 – 95.6. 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.74 (d, J = 7.96 Hz, 1H), 7.67 (d, J = 7.96 Hz, 1H), 
7.31 (t, J = 7.14 Hz, 1H), 7.24 - 7.27 (m, 1H), 7.01 (s, 1H), 6.78 (s, 3H), 5.94 (s, 2H), 4.14 (s, 
2H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 147.8, 146.3, 145.4, 140.0, 139.8, 133.3, 124.1, 
123.6, 122.9, 122.1, 121.7, 121.5, 109.2, 108.3, 100.9, 36.7. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2360, 2340, 1737, 1719, 1498, 1485, 1456, 1436, 
1419, 1398, 1373, 1362, 1235, 1218, 1205, 1188, 1154, 1112, 1096, 1036, 1014, 943, 924, 
865, 828, 814, 806, 773, 746, 726, 720, 662. 
MS (EI, 70 eV): m/z (%) = 268 (M+, 100), 267 (54), 238 (17), 210 (11), 208 (24), 165 (10), 
147 (40), 104 (13). 
HRMS (C16H12O2S): calc.: 268.0558; found: 268.0549 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)-3-methylbenzo[b]thiophene (23i): 
 
 
TMPLi (21: 1.25 M in THF, 1.20 mL, 1.15 equiv) was added to a solution of 2,3-
dimethylbenzo[b]thiophene (20b: 211 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C 
and the reaction mixture was then stirred at this temperature for 15 min. A solution of ZnCl2 
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(1 M in THF, 1.56 mL, 1.20 equiv) was added and the mixture was allowed to warm up to   
25 °C. Pd(OAc)2 (6 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 1-bromo-4-methoxybenzene 
(9b: 187 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture 
was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture of 
saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane/Et2O, 20:1) furnished 2-(4-
methoxybenzyl)-3-methylbenzo[b]thiophene (23i: 231 mg, 86%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.80 (d, J = 7.70 Hz, 1H), 7.71 (d, J = 7.89 Hz, 1H), 
7.40 - 7.46 (m, 1H), 7.31 - 7.37 (m, 1H), 7.24 (m, J = 8.62 Hz, 2H), 6.92 (m, J = 8.62 Hz, 
2H), 4.22 (s, 2H), 3.84 (s, 3H), 2.45 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 158.2, 140.9, 138.6, 138.4, 131.8, 129.4, 127.2, 
123.8, 123.6, 122.1, 121.4, 113.9, 55.2, 33.5, 11.6. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3058, 2997, 2970, 2912, 2833, 1739, 1719, 1610, 
1584, 1509, 1460, 1436, 1379, 1366, 1317, 1301, 1273, 1243, 1175, 1152, 1127, 1108, 1073, 
1033, 1016, 933, 820, 784, 752, 728, 708, 674, 668. 
MS (EI, 70 eV): m/z (%) = 268 (M+, 85), 253 (100), 237 (8), 221 (9), 161 (26), 160 (11). 
HRMS (C17H16OS): calc.: 268.0922; found: 268.0915 (M+). 
 
Synthesis of ethyl 4-(benzofuran-2-ylmethyl)benzoate (26a):  
O
COOEt
 
 
TMPLi (21: 1.30 M in THF, 1.50 mL, 1.5 equiv) was added to a solution of 2-
methylbenzofuran (24: 172 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and the 
reaction mixture was then stirred at this temperature for 1 h. A solution of ZnCl2 (1 M in 
THF, 1.95 mL, 1.5 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(OAc)2 (6 mg, 2 mol%), Xantphos (15 mg, 2 mol%) and ethyl 4-bromobenzoate (9k:      
229 mg, 1.00 mmol, 0.80 equiv) were added to the reaction mixture. The resulting mixture 
was stirred for 12 h at 50 °C. The reaction mixture was then quenched with a mixture of 
saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
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pressure. Purification by flash-chromatography (i-hexane/Et2O, 10:1) furnished ethyl 4-
(benzofuran-2-ylmethyl)benzoate (26a: 179 mg, 64%) as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 8.03 (dt, J = 8.46 Hz, 2H), 7.50 (dd, J = 6.42, 1.72 
Hz, 1H), 7.46-7.34 (m, 3H), 7.27-7.16 (m, 2H), 6.42 (s, 1H), 4.39 (q, J = 7.10 Hz, 2H), 4.18 
(s, 2H), 1.41 (t, J = 7.10 Hz, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 166.4, 156.6, 155.0, 142.4, 129.9, 129.1, 128.9, 128.6, 
123.6, 122.6, 120.4, 110.9, 103.7, 60.9, 35.0, 14.3. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3063 (vw), 3037 (vw), 2981 (w), 2934 (w), 1711 (s), 
1611 (m), 1586 (m), 1474 (m), 1453 (s), 1416 (m), 1366 (m), 1271 (s), 1250 (s), 1176 (m), 
1101 (s), 1021 (m), 1010 (m), 951 (m), 924 (w), 854 (m), 826 (m), 794 (m), 749 (s), 720 (s), 
686 (w).  
MS (EI, 70 eV): m/z (%) = 280 (M+, 100), 251 (26), 235 (35), 207 (89), 178 (45), 131 (53). 
HRMS (C18H16O3): calc.: 280.1099; found: 280.1081 (M+). 
 
Synthesis of 4-(benzofuran-2-ylmethyl)benzonitrile (26b):  
O
CN
 
 
Sc(OTf)3 (49 mg, 0.10 mmol) was added to a solution of 2-methylbenzofuran (24: 172 mg,     
1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C. The reaction mixture was stirred at 25 °C for 
15 min then cooled to -78 °C. TMPLi (21: 1.30 M in THF, 1.50 mL, 1.5 equiv) was added to 
the solution. After 1 h at -78 °C, a solution of ZnCl2 (1 M in THF, 1.95 mL, 1.5 equiv) was 
added and the mixture was allowed to warm up to 25 °C. After 30 min at 25 °C, Pd(OAc)2    
(6 mg, 2 mol%), Xantphos (15 mg, 2 mol%) and 4-bromobenzonitrile (9j: 183 mg,            
1.00 mmol, 0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred 
for 12 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 10:1) furnished 4-(benzofuran-2-
ylmethyl)benzonitrile (26b:  121 mg, 52%) as a yellow oil. 
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1H-NMR (300 MHz, CDCl3): δ / ppm: 7.64 (dt, J = 8.39, 1.87 Hz, 2H), 7.52 (dd, J = 6.42, 
2.14 Hz, 1H), 7.46-7.40 (m, 3H), 7.27-7.19 (m, 2H), 6.47 (s, 1H), 4.19 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 155.6, 155.0, 142?8, 132.4, 129.6, 128.5, 123.9, 122.8, 
120.6, 118.8, 111.0, 110.8, 104.1, 35.0. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3062 (w), 3037 (w), 2918 (vw), 2229 (s), 1600 (m), 
1583 (m), 1482 (m), 1453 (s), 1432 (m), 1315 (vw), 1289 (vw), 1251 (s), 1191 (m), 1164 (m), 
1145 (m), 1104 (w), 1007 (w), 955 (s), 932 (m), 891 (w), 864 (vw), 797 (s), 738 (s), 707 (w), 
682 (s).  
MS (EI, 70 eV): m/z (%) = 233 (M+, 100), 214 (7), 204 (15), 190 (4), 176 (8), 131 (53). 
HRMS (C16H11NO): calc.: 233.0841; found: 233.0815 (M+). 
 
Synthesis of 5-(benzofuran-2-ylmethyl)-2-methoxybenzonitrile (26c):  
O
OMe
CN
 
 
Sc(OTf)3 (49 mg, 0.10 mmol) was added to a solution of 2-methylbenzofuran (24: 172 mg,     
1.30 mmol, 1.00 equiv) in THF (2 mL) at 25 °C. The reaction mixture was stirred at 25 °C for   
15 min then cooled to -78 °C. TMPLi (21: 1.30 M in THF, 1.50 mL, 1.5 equiv) was added to 
the solution. After 1 h at -78 °C, a solution of ZnCl2 (1 M in THF, 1.95 mL, 1.5 equiv) was 
added and the mixture was allowed to warm up to 25 °C. After 30 min at 25 °C, Pd(dba)2   
(15 mg, 2 mol%), SPhos (21 mg, 4 mol%) and 2-methoxy-5-bromobenzonitrile (9r: 212 mg, 
1.00 mmol, 0.80 equiv) were added to the reaction mixture. The resulting mixture was stirred 
for 12 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 10:1) furnished 5-(benzofuran-2-
ylmethyl)-2-methoxybenzonitrile (26c: 197 mg, 75%) as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.53-7.37 (m, 4H), 7.24-7.15 (m, 2H), 6.92 (d, J = 
8.46 Hz, 1H), 6.40 (d, J = 1.02 Hz, 1H), 4.05 (s, 2H), 3.92 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 160.2, 156.4, 155.0, 134.8, 133.8, 129.9, 128.5, 123.7, 
122.7, 116.3, 111.5, 110.9, 103.7, 101.9, 56.1, 33.6. 
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IR (Diamond-ATR, neat): ν~  / cm-1 = 3057 (vw), 3036 (vw), 2947 (w), 2929 (w), 2225 (m), 
1711 (w), 1609 (m), 1584 (m), 1501 (s), 1453 (s), 1287 (s), 1266 (s), 1251 (s), 1181 (m), 1158 
(m), 1121 (m), 1019 (m), 952 (m), 894 (w), 813 (s), 742 (s).  
MS (EI, 70 eV): m/z (%) = 263 (M+, 100), 248 (21), 232 (16), 220 (11), 190 (16), 165 (14), 
131 (29). 
HRMS (C17H13NO2): calc.: 263.0946; found: 263.0947 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)benzofuran (26d):  
O
OMe
 
 
TMPLi (21: 1.30 M in THF, 1.50 mL, 1.5 equiv) was added to a solution of 2-
methylbenzofuran (24: 172 mg, 1.30 mmol, 1.00 equiv) in THF (2 mL) at -78 °C and the 
reaction mixture was then stirred at this temperature for 1 h. A solution of ZnCl2 (1 M in 
THF, 1.95 mL, 1.5 equiv) was added and the mixture was allowed to warm up to 25 °C. 
Pd(dba)2 (15 mg, 2 mol%), Xantphos (15 mg, 2 mol%) and 1-bromo-4-methoxybenzene (9b: 
187 mg, 1.00 mmol, 0.8 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 12 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/Et2O, 50:1) furnished 2-(4-
methoxybenzyl)benzofuran (26d: 178 mg, 75 %) as a yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.52-7.38 (m, 2H), 7.29-7.15 (m, 4H), 6.90 (dt, J = 
8.79, 2.39 Hz, 2H), 6.39-6.37 (m, 1H), 4.08 (s, 2H), 3.82 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.5, 158.3, 155.0, 129.9, 129.3, 128.9, 123.3, 122.5, 
120.4, 114.0, 110.9, 103.1, 55.4, 55.3, 34.1. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 3063 (vw), 3037 (vw), 2981 (w), 1711 (s), 1611 (m), 
1586 (w), 1453 (m), 1416 (w), 1271 (s), 1250 (m), 1176 (m), 1101 (s), 1021 (m), 951 (m), 
854 (w), 826 (w), 794 (m), 749 (s), 720 (s), 686 (w).  
MS (EI, 70 eV): m/z (%) = 238 (M+, 100), 223 (17), 207 (29), 194 (8), 178 (7), 165 (16), 131 
(13). 
HRMS (C16H11NO): calc.: 238.0994; found: 238.0967 (M+). 
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Synthesis of N,N-diethyl-2-(4-methoxybenzyl)-1-methyl-1H-indole-3-carboxamide (29):  
N
Me
CONEt2
OMe
 
 
TMPZnCl·LiCl (7: 1.37 M in THF, 0.55 mL, 1.50 equiv) was added to a solution of N,N-
diethyl-1,2-dimethyl-1H-indole-3-carboxamide (27: 122 mg, 0.5 mmol, 1.00 equiv) in THF  
(2 mL) at   25 °C and the reaction mixture was then stirred at this temperature for 1 h. 
Pd(OAc)2 (5 mg, 4 mol%), SPhos (16 mg, 8 mol%) and 1-bromo-4-methoxybenzene (9b:    
94 mg, 0.5 mmol, 1.0 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 12 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/EtOAc, 3:2) furnished N,N-diethyl-2-(4-
methoxybenzyl)-1-methyl-1H-indole-3-carboxamide (29: 100 mg, 57%) as an orange oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.49 (d, J = 7.25 Hz, 1H), 7.11 - 7.32 (m, 5H), 6.81 
(d, J = 8.58 Hz, 2H), 4.26 (s, 2H), 3.77 (s, 3H), 3.36 - 3.70 (m, 7H), 1.16 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 167.6, 158.1, 139.4, 136.3, 130.3, 129.3, 125.2, 
121.5, 120.2, 119.1, 113.9, 110.7, 109.2, 55.2, 41.0, 30.4, 29.9, 13.8. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2970, 2933, 2360, 2341, 1740, 1735, 1609, 1585, 
1570, 1558, 1541, 1510, 1465, 1457, 1436, 1424, 1399, 1377, 1366, 1328, 1302, 1275, 1242, 
1218, 1176, 1152, 1129, 1121, 1099, 1068, 1032, 1015, 858, 846, 816, 779, 741, 720. 
MS (EI, 70 eV): m/z (%) = 350 (M+, 18), 279 (13), 277 (100), 262 (30), 247 (26), 234 (24), 
218 (15), 206 (11). 
HRMS (C22H26N2O2): calc.: 350.1994; found: 350.1990 (M+). 
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Synthesis of 2-(4-methoxybenzyl)-1-(methoxymethyl)-1H-benzo[d]imidazole (30):  
 
 
TMPZnCl·LiCl (7: 1.37 M in THF, 1.10 mL, 1.50 equiv) was added to a solution of 1-
(methoxymethyl)-2-methyl-1H-benzo[d]imidazole (28: 176 mg, 1.0 mmol, 1.00 equiv) in 
THF  (2 mL) at 25 °C and the reaction mixture was then stirred at this temperature for 1 h. 
Pd(OAc)2 (11 mg, 5 mol%), SPhos (33 mg, 8 mol%) and 1-bromo-4-methoxybenzene (9b: 
168 mg, 0.9 mmol, 0.9 equiv) were added to the reaction mixture. The resulting mixture was 
stirred for 12 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane/EtOAc, 1:1) furnished 2-(4-methoxybenzyl)-
1-(methoxymethyl)-1H-benzo[d]imidazole (30: 173 mg, 68%) as a slightly yellow oil. 
 
1H-NMR (300 MHz, CDCl3): δ / ppm: 7.74 - 7.80 (m, 1H), 7.36 - 7.43 (m, 1H), 7.23 - 7.29 
(m, 2H), 7.20 (m, J = 8.57 Hz, 2H), 6.82 (m, J = 8.85 Hz, 2H), 5.31 (s, 2H), 4.31 (s, 2H), 3.75 
(s, 3H), 3.16 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ / ppm = 158.6, 153.8, 142.3, 135.5, 129.5, 128.0, 122.8, 
122.4, 119.5, 114.2, 109.4, 74.3, 56.1, 55.2, 33.5. 
IR (Diamond-ATR, neat): ν~  / cm-1 = 2998, 2933, 2835, 2360, 2340, 1735, 1718, 1652, 
1612, 1585, 1510, 1456, 1425, 1410, 1387, 1364, 1328, 1302, 1279, 1244, 1203, 1176, 1153, 
1118, 1094, 1062, 1031, 1009, 966, 917, 846, 830, 815, 775, 741, 725, 704. 
MS (EI, 70 eV): m/z (%) = 282 (M+, 71), 268 (12), 251 (36), 239 (100), 237 (38), 221 (11), 
219 (27), 131 (58), 121 (88). 
HRMS (C17H18N2O2): calc.: 282.1368; found: 282.1366 (M+). 
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5. Iron-Catalyzed Cross-Coupling of N-Heterocylic Chlorides and 
Bromides with Arylmagnesium Reagents Using tBuOMe as Solvent 
 
Synthesis of 2-phenylpyridine (33a): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloro- or 2-bromo-pyridine (31a or 31b; 1.0 mmol, 1.0 equiv) and iron (III) 
bromide (3 mol%) were dissolved in dry t-BuOMe (5 mL) following TP2. Then, 
phenylmagnesium chloride (32a; 2.3 equiv, 1.7 M) dissolved in THF was added dropwise at 
room temperature while stirring the reaction mixture for 1.5 h (for 2-chloropyridine) or        
70 min (for 2-bromopyridine). The reaction mixture was quenched with brine and extracted 
with EtOAc. The organic phase was separated and dried over Na2SO4. The product was 
obtained in 82% yield (for 2-chloropyridine) or in 83% yield (for 2-bromopyridine) as a 
colorless oil after purification by flash chromatography (silica gel, 6:1 i-hexane/ethyl acetate 
+ 0.5% triethylamine) 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.23 (m, 1 H), 7.45 (m, 3 H), 7.75 (m, 2 H), 8.01 (m, 2 
H), 8.70 (d, J=4.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 120.60 (s, 1 C), 122.10 (s, 1 C), 126.92 (s, 1 C), 128.74 
(s, 1 C), 128.99 (s, 1 C), 136.84 (s, 1 C), 139.24 (s, 1 C), 149.53 (s, 1 C), 157.39 (s, 1 C). 
MS (70 eV, EI) m/z (%): 155 (100) [M]+, 154 (60), 128 (10), 127 (10), 77 (9), 59 (10), 43 
(7). 
IR ATR ν (cm-1): 3062, 3036, 3008, 2927, 1586, 1580, 1564, 1468, 1449, 1424, 1293, 1152, 
1074, 1020, 988, 800, 737, 692. 
HRMS (EI) for C11H9N (155.1735) [M]+: 155.1731. 
 
Synthesis of 4-methyl-2-phenylpyridine (33b): 
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In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloro-4-methylpyridine (31c; 1.0 mmol, 1.0 equiv) and iron (III) bromide            
(3 mol%) were dissolved in dry t-BuOMe (5 mL) following TP2. Then, phenylmagnesium 
chloride (32a; 2.3 equiv, 1.7 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 2 h. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained in 84% yield as a colorless oil after purification by flash chromatography (silica 
gel, 6:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.41 (s, 3 H), 7.06 (d, J=4.1 Hz, 1 H), 7.44 (m, 3 H), 
7.55 (s, 1 H), 7.98 (d, J=7.2 Hz, 2 H), 8.55 (d, J=4.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 21.24 (s, 1 C), 121.59 (s, 1 C), 123.14 (s, 1 C), 126.94 
(s, 1 C), 128.68 (s, 1 C), 128.88 (s, 1 C), 139.26 (s, 1 C), 147.99 (s, 1 C), 149.18 (s, 1 C), 
157.21 (s, 1 C). 
MS (70 eV, EI) m/z (%): 169 (100) [M]+, 168 (38), 128 (10), 167 (18), 154 (27), 115 (6), 77 
(3). 
IR ATR ν (cm-1): 3058, 2921, 1601, 1582, 1557, 1472, 1446, 1400, 1386, 1377, 1073, 1030, 
989, 866, 826, 774, 734, 692. 
HRMS (EI) for C12H11N (169.0891) [M]+: 169.0884. 
 
Synthesis of 5-chloro-2-phenylpyridine (33c): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-bromo-5-chloropyridine (31d; 1.0 mmol, 1.0 equiv) and iron (III) bromide            
(3 mol%) were dissolved in dry t-BuOMe (5 mL) following TP2. Then, phenylmagnesium 
chloride (32a; 2.3 equiv, 1.7 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 70 min. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The 
product was obtained in 78% yield as a white solid after purification by flash chromatography 
(silica gel, 30:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
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m.p.: 65.1 – 66.8 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.47 (m, 3 H), 7.71 (m, 2 H), 7.95 (s, 1 H), 7.98 (d, 
J=1.4 Hz, 1 H), 8.65 (d, J=1.9 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 121.17 (s, 1 C), 126.82 (s, 1 C), 128.85 (s, 1 C), 129.33 
(s, 1 C), 130.63 (s, 1 C), 136.60 (s, 1 C), 138.00 (s, 1 C), 148.34 (s, 1 C), 155.48 (s, 1 C). 
MS (70 eV, EI) m/z (%): 189 (100) [M]+, 188 (18), 154 (37), 153 (8), 127 (13), 126 (7), 77 
(8). 
IR ATR ν (cm-1): 3059, 3033, 2921, 1573, 1554, 1459, 1442, 1365, 1290, 1136, 1111, 1074, 
1006, 920, 835, 774, 730, 691. 
HRMS (EI) for C11H8ClN (189.0345) [M]+: 189.0339. 
 
Synthesis of tert-butyl 2-phenylnicotinate (33d): 
N
Ot-Bu
O
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, tert-butyl 2-chloronicotinate (31e; 1.0 mmol, 1.0 equiv) and iron (III) bromide         
(3 mol%) were dissolved in dry t-BuOMe (5 mL) following TP2. Then, phenylmagnesium 
chloride (32a; 2.3 equiv, 1.7 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The 
product was obtained in 60% yield as a white solid after purification by flash chromatography 
(silica gel, 8:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 70.2 – 72.2 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.29 (s, 9 H), 7.31 (dd, J=7.7, 4.7 Hz, 1 H), 7.42 (m, 3 
H), 7.52 (m, 2 H), 8.07 (dd, J=7.7, 1.7 Hz, 1 H), 8.73 (dd, J=5.0, 1.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 27.51 (s, 1 C), 82.17 (s, 1 C), 121.54 (s, 1 C), 128.03 (s, 
1 C), 128.38 (s, 1 C), 128.67 (s, 1 C), 128.93 (s, 1 C), 137.73 (s, 1 C), 140.64 (s, 1 C), 150.68 
(s, 1 C), 158.75 (s, 1 C), 167.20 (s, 1 C). 
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MS (70 eV, EI) m/z (%): 255 (19) [M]+ , 200 (23), 199 (100), 198 (40), 182 (28), 155 (62), 
154 (26), 127 (16), 57 (10). 
IR ATR ν (cm-1): 2977, 2362, 2349, 1701, 1580, 1560, 1428, 1369, 1311, 1293, 1255, 1168, 
1128, 1077, 1056, 850, 792, 755, 732, 701. 
HRMS (EI) for C16H17NO2 (255.1259) [M]+: 255.1247. 
 
Synthesis of 2-phenylquinoline (33e): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, phenylmagnesium chloride (32a;        
2.3 equiv, 1.7 M) dissolved in THF was added dropwise at room temperature while stirring 
the reaction mixture for 5 min. The reaction mixture was quenched with brine and extracted 
with EtOAc. The organic phase was separated and dried over Na2SO4. The product was 
obtained in 88% yield as a beige solid after purification by flash chromatography (silica gel, 
10:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 81.9 – 83.6 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.50 (m, 4 H), 7.75 (m, 1 H), 7.86 (m, 2 H), 8.22 (m, 4 
H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 119.04 (s, 1 C), 126.38 (s, 1 C), 127.18 (s, 1 C), 127.45 
(s, 1 C), 127.65 (s, 1 C), 128.85 (s, 1 C), 129.44 (s, 1 C), 129.52 (s, 1 C), 129.81 (s, 1 C), 
137.03 (s, 1 C), 139.35 (s, 1 C), 147.98 (s, 1 C), 157.27 (s, 1 C). 
MS (70 eV, EI) m/z (%): 206 (20), 205 (100) [M]+, 204 (70), 203 (13), 175 (12), 169 (15), 
102 (9), 84 (8), 44 (27). 
IR ATR ν (cm-1): 2923, 2853, 2362, 1740, 1596, 1490, 1446, 1318, 1240, 1213, 1186, 1126, 
1050, 1024, 923, 829, 770, 747, 690, 676. 
HRMS (EI) for C15H11N (205.0891) [M]+: 205.0884. 
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Synthesis of 1-phenylisoquinoline (33f): 
N
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 1-chloroisoquinoline (31g; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) 
were dissolved in dry t-BuOMe (5 mL) following TP2. Then, phenylmagnesium chloride 
(32a; 2.3 equiv, 1.7 M) dissolved in THF was added dropwise at room temperature while 
stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained in 90% yield as a white solid after purification by flash chromatography (silica 
gel, 10:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 97.6 – 99.5 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.53 (m, 4 H), 7.69 (m, 4 H), 7.89 (d, J=8.3 Hz, 1 H), 
8.12 (d, J=8.6 Hz, 1 H), 8.62 (d, J=5.5 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 120.01 (s, 1 C), 126.68 (s, 1 C), 126.99 (s, 1 C), 127.26 
(s, 1 C), 127.64 (s, 1 C), 128.36 (s, 1 C), 128.69 (s, 1 C), 129.93 (s, 1 C), 130.16 (s, 1 C), 
136.93 (s, 1 C), 139.23 (s, 1 C), 141.86 (s, 1 C), 160.60 (s, 1 C). 
MS (70 eV, EI) m/z (%): 206 (7), 205 (46) [M]+, 204 (100), 203 (13), 176 (7), 102 (8).  
IR ATR ν (cm-1): 3053, 2921, 2364, 2337, 1618, 1582, 1552, 1500, 1440, 1380, 1352, 1319, 
1304, 1167, 1020, 973, 954, 875, 823, 803, 798, 767, 754, 706, 699, 675. 
HRMS (EI) for C15H11N (205.0891) [M]+: 205.0864. 
 
Synthesis of 4,6-dimethyl-2-phenylpyrimidine (33g): 
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In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloro-4,6-dimethylpyrimidine (31h; 1.0 mmol, 1.0 equiv) and iron (III) bromide       
(3 mol%) were dissolved in dry t-BuOMe (5 mL) following TP2. Then, phenylmagnesium 
chloride (32a; 2.3 equiv, 1.7 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 2 h. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained in 76% yield as a white solid after purification by flash chromatography (silica 
gel, 10:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 82.8 – 84.0 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.54 (s, 6 H), 6.92 (s, 1 H), 7.47 (m, 3 H), 8.43 (d, J=1.9 
Hz, 1 H), 8.45 (d, J=4.4 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 24.11 (s, 1 C), 117.97 (s, 1 C), 128.24 (s, 1 C), 128.42 
(s, 1 C), 130.31 (s, 1 C), 137.94 (s, 1 C), 164.06 (s, 1 C), 166.77 (s, 1 C). 
MS (70 eV, EI) m/z (%): 185 (16), 184 (100) [M]+ , 169 (20), 104 (19), 103 (27), 77 (6). 
IR ATR ν (cm-1): 3068, 2924, 2853, 2361, 1595, 1574, 1550, 1534, 1442, 1434, 1379, 1364, 
1342, 1173, 1025, 932, 854, 749, 693, 662. 
HRMS (EI) for C12H12N2 (184.1000) [M]+: 184.0995. 
 
Synthesis of 2-(m-tolyl)pyridine (33j): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-bromopyridine (31b; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, m-tolyl-magnesium bromide (32b;      
2.3 equiv, 1.1 M) dissolved in THF was added dropwise at room temperature while stirring 
the reaction mixture for 1.5 h. The reaction mixture was quenched with brine and extracted 
with EtOAc. The organic phase was separated and dried over Na2SO4. The product was 
obtained in 80% yield as a yellow oil after purification by flash chromatography (silica gel, 
5:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
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1H NMR (300 MHz, CDCl3) δ/ppm: 2.44 (s, 3 H), 7.22 (m, 2 H), 7.37 (t, J=7.6 Hz, 1 H), 
7.73 (m, 3 H), 7.85 (s, 1 H), 8.69 (d, J=4.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 21.51 (s, 1 C), 120.61 (s, 1 C), 121.61 (s, 1 C), 123.99 
(s, 1 C), 127.64 (s, 1 C), 128.62 (s, 1 C), 129.70 (s, 1 C), 136.67 (s, 1 C), 138.39 (s, 1 C), 
139.35 (s, 1 C), 149.58 (s, 1 C), 157.63 (s, 1 C). 
MS (70 eV, EI) m/z (%): 170 (14), 168 (52), 167 (23), 154 (10), 115 (5). 
IR ATR ν (cm-1): 3049, 3008, 2918, 2860, 1584, 1565, 1473, 1460, 1431, 1302, 1293, 1152, 
1087, 1043, 991, 883, 804, 762, 742, 724, 694. 
HRMS (EI) for C12H11N (169.0891) [M+H]+: 169.0886. 
 
Synthesis of 1-(p-tolyl)isoquinoline (33k): 
N
CH3
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 1-chloroisoquinoline (31g; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) 
were dissolved in dry t-BuOMe (5 mL) following TP2. Then, p-tolyl-magnesium bromide 
(32b; 2.3 equiv, 1.2 M) dissolved in THF was added dropwise at room temperature while 
stirring the reaction mixture for 2 min. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained in 93% yield as a yellow oil after purification by flash chromatography (silica 
gel, 12:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.47 (s, 3 H), 7.35 (d, J=8.0 Hz, 2 H), 7.54 (t, J=7.6 Hz, 
1 H), 7.66 (m, 4 H), 7.88 (d, J=8.0 Hz, 1 H), 8.14 (d, J=8.6 Hz, 1 H), 8.61 (d, J=5.8 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 21.35 (s, 1 C), 119.77 (s, 1 C), 126.72 (s, 1 C), 126.96 
(s, 1 C), 127.13 (s, 1 C), 127.74 (s, 1 C), 129.04 (s, 1 C), 129.87 (s, 1 C), 130.07 (s, 1 C), 
136.37 (s, 1 C), 136.94 (s, 1 C), 138.58 (s, 1 C), 141.86 (s, 1 C), 160.66 (s, 1 C). 
MS (70 eV, EI) m/z (%): 219 (80) [M]+, 218 (100), 217 (21), 216 (20), 205 (11), 204 (59), 
203 (11), 175 (9), 108 (13), 43 (13). 
 139 
IR ATR ν (cm-1): 3049, 2919, 2852, 1618, 1583, 1552, 1497, 1452, 1384, 1355, 1320, 1305, 
1182, 1166, 1138, 1111, 1021, 974, 873, 848, 821, 799, 787, 749, 722, 677. 
HRMS (EI) for C16H13N (219.1048) [M]+: 219.1023. 
 
Synthesis of 2-(o-tolyl)quinoline (33l): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, o-tolyl-magnesium bromide (32b;       
2.3 equiv, 0.9 M) dissolved in THF was added dropwise at room temperature while stirring 
the reaction mixture for 45 min. The reaction mixture was quenched with brine and extracted 
with EtOAc. The organic phase was separated and dried over Na2SO4. The product was 
obtained in 84% yield as a beige solid after purification by flash chromatography (silica gel, 
5:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 78.3 – 80.4 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.43 (s, 3 H), 7.34 (s, 3 H), 7.54 (m, 3 H), 7.75 (t, J=7.7 
Hz, 1 H), 7.87 (d, J=8.3 Hz, 1 H), 8.21 (m, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 20.34 (s, 1 C), 122.37 (s, 1 C), 126.01 (s, 1 C), 126.44 
(s, 1 C), 126.73 (s, 1 C), 127.49 (s, 1 C), 128.54 (s, 1 C), 129.50 (s, 1 C), 129.68 (s, 1 C), 
129.70 (s, 1 C), 130.86 (s, 1 C), 136.00 (s, 1 C), 136.18 (s, 1 C), 140.56 (s, 1 C), 147.75 (s, 1 
C), 160.22 (s, 1 C). 
MS (70 eV, EI) m/z (%): 218 (100) [M-H]+, 217 (27), 216 (8), 85 (27), 83 (35). 
IR ATR ν (cm-1): 2951, 2921, 2852, 1740, 1602, 1592, 1553, 1501, 1485, 1455, 1420, 1378, 
1334, 1311, 1276, 1264, 1238, 1217, 1204, 1118, 1037, 1014, 976, 941, 836, 798, 772, 762, 
754, 722, 688, 674. 
HRMS (EI) for C16H13N (219.1048) [M+H]+: 219.0957. 
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Synthesis of 2-(3-(trifluoromethyl)phenyl)quinoline (33m): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (3-
(trifluoromethyl)phenyl)magnesium bromide (32e; 2.3 equiv, 0.9 M) dissolved in THF was 
added dropwise at room temperature while stirring the reaction mixture for 15 min. The 
reaction mixture was quenched with brine and extracted with EtOAc. The organic phase was 
separated and dried over Na2SO4. The product was obtained in 92% yield as a beige solid 
after purification by flash chromatography (silica gel, 5:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
 
m.p.: 76.5 – 78.5 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.56 (t, J=7.5 Hz, 1 H), 7.64 (t, J=7.7 Hz, 1 H), 7.75 (m, 
2 H), 7.86 (m, 2 H), 8.22 (dd, J=15.5, 8.6 Hz, 2 H), 8.36 (d, J=7.7 Hz, 1 H), 8.48 (s, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 118.52 (s, 1 C), 124.16 (q, J=272.65 Hz), 124.39 (q, 
J=3.92 Hz), 125.84 (q, J=3.93 Hz), 126.74 (s, 1 C), 127.37 (s, 1 C), 127.48 (s, 1 C), 129.27 (s, 
1 C), 129.81 (s, 1 C), 129.94 (s, 1 C), 130.66 (s, 1 C), 131.23 (q, J=32.26 Hz), 137.11 (s, 1 C), 
140.35 (s, 1 C), 148.24 (s, 1 C), 155.52 (s, 1 C). 
MS (70 eV, EI) m/z (%): 274 (19), 273 (100) [M]+, 272 (29), 252 (10), 204 (21), 203 (6). 
IR ATR ν (cm-1): 3060, 2362, 1741, 1592, 1509, 1483, 1466, 1428, 1336, 1274, 1261, 1236, 
1168, 1142, 1115, 1096, 1074, 1051, 806, 786, 757, 704, 693, 652. 
HRMS (EI) for C16H10F3N (273.0765) [M]+: 273.0763. 
 
Synthesis of 2-(3-(trifluoromethyl)phenyl)pyridine (33n): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-bromopyridine (31b; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
 141 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (3-
(trifluoromethyl)phenyl)magnesium bromide (32e; 2.3 equiv, 0.9 M) dissolved in THF was 
added dropwise at room temperature while stirring the reaction mixture for 2 h. The reaction 
mixture was quenched with brine and extracted with EtOAc. The organic phase was separated 
and dried over Na2SO4. The product was obtained in 66% yield as a yellow oil after 
purification by flash chromatography (silica gel, 5:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.28 (m, 1 H), 7.58 (t, J=7.7 Hz, 1 H), 7.67 (m, 1 H), 
7.78 (m, 2 H), 8.18 (d, J=7.7 Hz, 1 H), 8.29 (s, 1 H), 8.72 (d, J=4.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 120.55 (s, 1C), 122.79 (s, 1C), 123.76 (q, J=3.93 Hz), 
124.16 (q, J=272.36 Hz), 125.50 (q, J=3.93 Hz), 129.18 (s, 1C), 130.01 (s, 1C), 131,20 (q, 
J=32.54 Hz), 136.95 (s, 1C), 140.10 (s, 1C), 149,86 (s, 1C), 155.81 (s, 1C). 
MS (70 eV, EI) m/z (%): 224 (10), 223 (100) [M]+, 222 (12), 202 (7), 154 (21). 
IR ATR ν (cm-1): 3074, 3054, 3011, 1586, 1464, 1437, 1418, 1333, 1272, 1262, 1163, 1117, 
1094, 1073, 1064, 1040, 991, 919, 826, 811, 773, 739, 696, 662. 
HRMS (EI) for C12H8F3N (223.0609) [M]+: 223.0509. 
 
Synthesis of 1-(3,5-bis(trifluoromethyl)phenyl)isoquinoline (33o): 
N
F3C CF3
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 1-chloroisoquinoline (31g; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) 
were dissolved in dry t-BuOMe (5 mL) following TP2. Then, (3,5-
bis(trifluoromethyl)phenyl)magnesium bromide (32f; 2.3 equiv, 1.0 M) dissolved in THF was 
added dropwise at room temperature while stirring the reaction mixture for 5 h. The reaction 
mixture was quenched with brine and extracted with EtOAc. The organic phase was separated 
and dried over Na2SO4. The product was obtained in 75% yield as a beige solid after 
purification by flash chromatography (silica gel, 10:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
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m.p.: 75.0 – 76.6 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.63 (t, J=7.9 Hz, 1 H), 7.76 (m, 2 H), 7.95 (d, J=8.3 
Hz, 2 H), 8.03 (s, 1 H), 8.20 (s, 2 H), 8.65 (d, J=5.8 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 121.17 (s, 1C), 122.38 (m), 123.27 (q, J=272.72 Hz), 
126.07 (s, 1C), 126.32 (s,1C), 127.44 (s, 1C), 128.19 (s, 1C), 130.14 (m), 130.52 (s, 1C), 
131.83 (q, J=37.59 Hz), 136.95 (s, 1C), 141.56 (s, 1C), 142.29 (s, 1C), 157.22 (s, 1C). 
MS (70 eV, EI) m/z (%): 342 (62), 341 (100) [M]+ , 320 (8), 272 (15), 271 (7). 
IR ATR ν (cm-1): 3059, 2360, 1623, 1567, 1368, 1335, 1275, 1184, 1164, 1123, 1107, 1069, 
898, 877, 846, 829, 746, 714, 703, 690, 678. 
HRMS (EI) for C17H9F6N (341. 0639) [M]+: 341.0549. 
 
Synthesis of 2-(4-fluorophenyl)pyridine (33p): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-bromopyridine (31b; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (4-fluorophenyl)magnesium bromide 
(32g; 2.3 equiv, 1.0 M) dissolved in THF was added dropwise at room temperature while 
stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained in 68% yield as a beige solid after purification by flash chromatography (silica 
gel, 6:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 40.6 – 41.8 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.20 (m, 3 H), 7.72 (m, 2 H), 7.98 (m, 2 H), 8.67 (d, 
J=4.4 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 115.62 (d, J=21.63 Hz), 120.17 (s, 1C), 122,00 (s, 1C), 
128.65 (d, J=8.26 Hz), 135.54 (d, J=4.4 Hz), 136.77 (s, 1C), 149.66 (s, 1C), 156.44 (s, 1C), 
163.47 (d, J=248.25 Hz). 
MS (70 eV, EI) m/z (%): 174 (11), 173 (100) [M]+, 172 (50), 146 (7), 145 (5). 
IR ATR ν (cm-1): 3053, 2924, 2854, 1599, 1584, 1567, 1510, 1466, 1434, 1409, 1393, 1297, 
1219, 1160, 1152, 1098, 989, 844, 826, 818, 773, 737, 724, 706. 
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HRMS (EI) for C11H8FN (173.0641) [M]+: 173.0641. 
  
Synthesis of 1-(4-fluorophenyl)isoquinoline (33q): 
N
F
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 1-chloroisoquinoline (31g; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) 
were dissolved in dry t-BuOMe (5 mL) following TP2. Then, ((4-fluorophenyl)magnesium 
bromide (32g; 2.3 equiv, 1.0 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The 
product was obtained in 90% yield as a beige solid after purification by flash chromatography 
(silica gel, 8:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 79.8 – 81.5 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.22 (t, J=8.7 Hz, 2 H), 7.54 (t, J=7.6 Hz, 1 H), 7.68 (m, 
4 H), 7.88 (d, J=8.3 Hz, 1 H), 8.06 (d, J=8.6 Hz, 1 H), 8.60 (d, J=5.8 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 115.37 (d, J=21.64 Hz), 120.00 (s, 1C), 126.64 (s, 1C), 
127.06 (s, 1C), 127.24 (s, 1C), 127.30 (s, 1C), 130.06 (s, 1C), 131.70 (d, J=8.26 Hz), 135.65 
(d, J=3.41 Hz), 136.88 (s, 1C), 142.17 (s, 1C), 159.59 (s, 1C), 163.08 (d, J=247.96 Hz). 
MS (70 eV, EI) m/z (%): 223 (100) [M+H]+, 202 (7), 194 (4), 111 (3), 83 (22). 
IR ATR ν (cm-1): 3056, 2924, 2854, 1795, 1604, 1582, 1553, 1509, 1498, 1384, 1353, 1233, 
1221, 1159, 975, 877, 844, 834, 804, 798, 757, 724, 674. 
HRMS (EI) for C15H10FN (223.0797) [M+H]+: 223.0701. 
 
Synthesis of 2-(4-chlorophenyl)quinoline (33r): 
 
 
 144 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (4-chlorophenyl)magnesium bromide 
(32h; 2.3 equiv, 1.2 M) dissolved in THF was added dropwise at room temperature while 
stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The product 
was obtained in 84% yield as a white solid after purification by flash chromatography (silica 
gel, 10:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 114.8 – 116.2 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.52 (m, 3 H), 7.76 (m, 3 H), 8.15 (m, 4 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 118.49 (s, 1 C), 126.47 (s, 1 C), 127.20 (s, 1 C), 127.47 
(s, 1 C), 128.79 (s, 1 C), 129.99 (s, 1 C), 129.70 (s, 1 C), 129.81 (s, 1 C), 135.53 (s, 1 C), 
136.91 (s, 1 C), 138.02 (s, 1 C), 148.22 (s, 1 C), 155.93 (s, 1 C).  
MS (70 eV, EI) m/z (%): 241 (5), 239 (100) [M]+, 203 (2), 102 (1). 
IR ATR ν (cm-1): 3055, 2361, 2338, 1596, 1588, 1577, 1552, 1486, 1430, 1399, 1285, 1089, 
1050, 1008, 939, 815, 788, 770, 752, 732, 715, 672, 652. 
HRMS (EI) for C15H10ClN (239.0502) [M]+: 239.0507. 
 
Synthesis of 2-(4-methoxyphenyl)pyridine (33s): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-bromopyridine (31b; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (4-methoxyphenyl)magnesium 
bromide (32i; 2.3 equiv, 1.3 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 10 min. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The 
product was obtained in 82% yield as a white solid after purification by flash chromatography 
(silica gel, 5:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 58.7 – 60.4 ºC. 
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1H NMR (300 MHz, CDCl3) δ/ppm: 3.86 (s, 3 H), 7.00 (d, J=8.8 Hz, 2 H), 7.18 (m, 1 H), 
7.71 (m, 2 H), 7.95 (d, J=8.8 Hz, 2 H), 8.66 (d, J=4.4 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.34 (s, 1 C), 114.14 (s, 1 C), 119.91 (s, 1 C), 121.42 
(s, 1 C), 128.21 (s, 1 C), 131.71 (s, 1 C), 136.87 (s, 1 C), 149.28 (s, 1 C), 156.98 (s, 1 C), 
160.53 (s, 1 C). 
MS (70 eV, EI) m/z (%): 186 (13), 185 (100) [M]+, 142 (26), 141 (16), 115 (5). 
IR ATR ν (cm-1): 3062, 2997, 2963, 2837, 1601, 1586, 1579, 1562, 1513, 1458, 1431, 1407, 
1306, 1302, 1272, 1243, 1176, 1151, 1113, 1058, 1036, 1021, 1005, 838, 776, 736, 718. 
HRMS (EI) for C12H11NO (185.0841) [M]+: 185.0840. 
 
Synthesis of 2-(4-methoxyphenyl)quinoline (33t): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (4-methoxyphenyl)magnesium 
bromide (32i; 2.3 equiv, 1.3 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The 
product was obtained in 87% yield as a white solid after purification by flash chromatography 
(silica gel, 7:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 123.7 – 125.6 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.87 (s, 3 H), 7.05 (d, J=8.8 Hz, 2 H), 7.49 (t, J=7.5 Hz, 
1 H), 7.75 (m, 3 H), 8.16 (m, 4 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.37 (s, 1 C), 114.23 (s, 1 C), 118.51 (s, 1 C), 125.90 
(s, 1 C), 126.90 (s, 1 C), 127.43 (s, 1 C), 128.89 (s, 1 C), 129.49 (s, 1 C), 129.57 (s, 1 C), 
132.18 (s, 1 C), 136.63 (s, 1 C), 148.24 (s, 1 C), 156.85 (s, 1 C), 160.84 (s, 1 C). 
MS (70 eV, EI) m/z (%): 235 (100) [M]+, 220 (18), 192 (17), 191 (18), 95 (3). 
IR ATR ν (cm-1): 3047, 2961, 2841, 1603, 1595, 1582, 1497, 1468, 1430, 1321, 1290, 1284, 
1247, 1175, 1156, 1124, 1112, 1028, 1013, 948, 847, 834, 816, 789, 770, 761, 748, 726, 678. 
HRMS (EI) for C16H13NO (235.0997) [M]+: 235. 0993. 
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Synthesis of 1-(3,5-dimethoxyphenyl)isoquinoline (33u): 
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 1-chloroisoquinoline (31g; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) 
were dissolved in dry t-BuOMe (5 mL) following TP2. Then, (3,5-
dimethoxyphenyl)magnesium bromide (32j; 2.3 equiv, 1.2 M) dissolved in THF was added 
dropwise at room temperature while stirring the reaction mixture for 5 min. The reaction 
mixture was quenched with brine and extracted with EtOAc. The organic phase was separated 
and dried over Na2SO4. The product was obtained in 71% yield as a yellow oil after 
purification by flash chromatography (silica gel, 10:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.84 (s, 6 H), 6.61 (t, J=2.3 Hz, 1 H), 6.83 (d, J=2.4 Hz, 
2 H), 7.52 (m, 1 H), 7.67 (m, 2 H), 7.86 (d, J=8.3 Hz, 1 H), 8.14 (d, J=8.6 Hz, 1 H), 8.59 (d, 
J=5.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 55.48 (s, 1 C), 101.04 (s, 1 C), 107.98 (s, 1 C), 120.08 
(s, 1 C), 126.66 (s, 1 C), 126.91 (s, 1 C), 127.18 (s, 1 C), 127.57 (s, 1 C), 130.05 (s, 1 C), 
136.80 (s, 1 C), 141.39 (s, 1 C), 141.99 (s, 1 C), 160.55 (s, 1 C), 160.66 (s, 1 C). 
MS (70 eV, EI) m/z (%): 266 (13), 265 (100) [M]+, 264 (91), 250 (19), 235 (14), 234 (22), 
206 (11), 191 (13). 
IR ATR ν (cm-1): 3051, 3000, 2936, 2838, 1591, 1585, 1557, 1453, 1424, 1383, 1358, 1318, 
1203, 1151, 1061, 1051, 1003, 927, 824, 799, 775, 750, 700, 686, 654. 
HRMS (EI) for C17H15NO2 (265.1103) [M]+: 265.1090. 
 
Synthesis of 2-(benzo[d][1,3]dioxol-5-yl)quinoline (33v): 
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In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, benzo[d][1,3]dioxol-5-ylmagnesium 
bromide (32k; 2.3 equiv, 1.2 M) dissolved in THF was added dropwise at room temperature 
while stirring the reaction mixture for 5 min. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was separated and dried over Na2SO4. The 
product was obtained in 81% yield as a white solid after purification by flash chromatography 
(silica gel, 10:1 i-hexane/ethyl acetate + 0.5% triethylamine). 
 
m.p.: 97.9 – 99.1 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 6.03 (s, 2 H), 6.95 (d, J=8.3 Hz, 1 H), 7.50 (t, J=7.0 Hz, 
1 H), 7.72 (m, 5 H), 8.14 (dd, J=8.4, 4.0 Hz, 2 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 101.35 (s, 1 C), 107.91 (s, 1 C), 108.45 (s, 1 C), 118.56 
(s, 1 C), 121.73 (s, 1 C), 126.03 (s, 1 C), 126.98 (s, 1 C), 127.39 (s, 1 C), 129.54 (s, 1 C), 
129.62 (s, 1 C), 134.11 (s, 1 C), 136.64 (s, 1 C), 148.17 (s, 1 C), 148.38 (s, 1 C), 148.82 (s, 1 
C), 156.62 (s, 1 C). 
MS (70 eV, EI) m/z (%): 250 (15), 249 (100) [M]+, 248 (15), 191 (12), 190 (9), 163 (2). 
IR ATR ν (cm-1): 3051, 3008, 2895, 2780, 1594, 1494, 1486, 1454, 1443, 1425, 1353, 1290, 
1251, 1245, 1233, 1222, 1206, 1116, 1108, 1097, 1035, 930, 916, 906, 892, 837, 826, 813, 
799, 782, 742, 718, 682. 
HRMS (EI) for C16H11NO2 (249. 0790) [M]+: 249.0782. 
 
Synthesis of 4-(isoquinolin-1-yl)phenyl pivalate (33w): 
N
OPiv
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 1-chloroisoquinoline (31g; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) 
were dissolved in dry t-BuOMe (5 mL) following TP2. Then, (4-
(pivaloyloxy)phenyl)magnesium bromide (32l; 2.3 equiv, 0.8 M) dissolved in THF was added 
dropwise at room temperature while stirring the reaction mixture for 15 min. The reaction 
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mixture was quenched with brine and extracted with EtOAc. The organic phase was separated 
and dried over Na2SO4. The product was obtained in 80% yield as a white solid after 
purification by flash chromatography (silica gel, 4:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
 
m.p.: 97.1 – 96.3 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.41 (s, 9 H), 7.25 (d, J=8.6 Hz, 2 H), 7.54 (t, J=7.2 Hz, 
1 H), 7.70 (m, 4 H), 7.88 (d, J=8.0 Hz, 1 H), 8.11 (d, J=8.3 Hz, 1 H), 8.60 (d, J=5.5 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 27.16 (s, 1 C), 39.17 (s, 1 C), 120.19 (s, 1 C), 121.50 (s, 
1 C), 126.71 (s, 1 C), 127.01 (s, 1 C), 127.39 (s, 1 C), 127.52 (s, 1 C), 130.23 (s, 1 C), 131.01 
(s, 1 C), 136.59 (s, 1 C), 136.93 (s, 1 C), 141.80 (s, 1 C), 151.58 (s, 1 C), 159.77 (s, 1 C), 
177.00 (s, 1 C). 
MS (70 eV, EI) m/z (%): 305 (68) [M]+ , 222 (12), 221 (70), 220 (100), 204 (22), 192 (20), 
191 (35), 110 (26), 57 (32). 
IR ATR ν (cm-1): 3469, 2974, 2872, 1749, 1740, 1554, 1498, 1478, 1457, 1384, 1354, 1275, 
1199, 1164, 1111, 1026, 1016, 974, 900, 882, 858, 844, 834, 820, 798, 788, 754, 726, 678. 
HRMS (EI) for C20H19NO2 (305. 1416) [M]+: 305. 1409. 
 
Synthesis of tert-butyl 3-(quinolin-2-yl)phenyl carbonate (33x): 
N
OBoc
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (3-(tert-
butoxycarbonyloxy)phenyl)magnesium bromide (32m; 2.3 equiv, 0.7 M) dissolved in THF 
was added dropwise at room temperature while stirring the reaction mixture for 15 min. The 
reaction mixture was quenched with brine and extracted with EtOAc. The organic phase was 
separated and dried over Na2SO4. The product was obtained in 84% yield as a white solid 
after purification by flash chromatography (silica gel, 4:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
 
m.p.: 95.1 – 96.3 ºC. 
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1H NMR (300 MHz, CDCl3) δ/ppm: 1.60 (s, 9 H), 7.29 (m, 1 H), 7.53 (t, J=7.9 Hz, 2 H), 
7.73 (m, 1 H), 7.83 (m, 2 H), 8.04 (dd, J=4.1, 2.2 Hz, 2 H), 8.19 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 27.75 (s, 1 C), 83.58 (s, 1 C), 118.80 (s, 1 C), 120.43 (s, 
1 C), 122.23 (s, 1 C), 124.80 (s, 1 C), 126.50 (s, 1 C), 127.30 (s, 1 C), 127.45 (s, 1 C), 129.71 
(s, 1 C), 129.77 (s, 1 C), 136.93 (s, 1 C), 141.13 (s, 1 C), 148.12 (s, 1 C), 151.67 (s, 1 C), 
151.83 (s, 1 C), 156.03 (s, 1 C). 
MS (70 eV, EI) m/z (%): 321 (9) [M]+, 222 (13), 221 (100), 220 (82), 204 (22), 191 (16), 57 
(26). 
IR ATR ν (cm-1): 3496, 3076, 2982, 1747, 1598, 1454, 1445, 1369, 1295, 1274, 1264, 1252, 
1242, 1183, 1142, 1083, 1047, 928, 869, 825, 804, 787, 780, 769, 742, 692, 686. 
HRMS (EI) for C20H19NO3 (321. 1365) [M]+: 321. 1360. 
 
N,N-dimethyl-4-(quinolin-2-yl)aniline (3y) (CAS Number: 16032-41-0): 
N
N CH3
CH3
 
 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a 
septum, 2-chloroquinoline (31f; 1.0 mmol, 1.0 equiv) and iron (III) bromide (3 mol%) were 
dissolved in dry t-BuOMe (5 mL) following TP2. Then, (4-
(dimethylamino)phenyl)magnesium bromide (32n; 2.3 equiv, 1.3 M) dissolved in THF was 
added dropwise at room temperature while stirring the reaction mixture for 5 min. The 
reaction mixture was quenched with brine and extracted with EtOAc. The organic phase was 
separated and dried over Na2SO4. The product was obtained in 82% yield as a red solid after 
purification by flash chromatography (silica gel, 9:1 i-hexane/ethyl acetate + 0.5% 
triethylamine). 
 
m.p.: 175.8 – 177.5 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.04 (s, 6 H), 6.84 (d, J=8.8 Hz, 2 H), 7.46 (t, J=7.2 Hz, 
1 H), 7.69 (m, 1 H), 7.77 (d, J=7.9 Hz, 1 H), 7.83 (d, J=8.6 Hz, 1 H), 8.12 (dd, J=8.5, 6.6 Hz, 
4 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: 40.34 (s, 1 C), 112.24 (s, 1 C), 118.26 (s, 1 C), 125.33 
(s, 1 C), 126.69 (s, 1 C), 127.33 (s, 1 C), 127.37 (s, 1 C), 128.46 (s, 1 C), 129.33 (s, 1 C), 
136.26 (s, 1 C), 148.41 (s, 1 C), 151.35 (s, 1 C), 157.33 (s, 1 C). 
MS (70 eV, EI) m/z (%): 248 (100) [M]+, 247 (35), 204 (11), 124 (4). 
IR ATR ν (cm-1): 3058, 2887, 2809, 1595, 1564, 1545, 1539, 1498, 1434, 1360, 1326, 1286, 
1226, 1198, 1168, 1140, 1130, 1120, 947, 811, 789, 762. 
HRMS (EI) for C17H16N2 (248. 1313) [M]+: 248.1309. 
 
 
6. Ligand-Accelerated Fe- and Co-Catalyzed Cross-Coupling Reactions 
between N-Heterocyclic Halides and Arylmagnesium Reagents 
6.1. Preparation of the Starting Materials 
 
Synthesis of 2-bromo-3-(4-chlorophenyl)pyridine (35b): 
 
 
Diisopropylamine (1.0 equiv, 20 mmol) in THF (50 mL) was cooled to -78 °C, and n-BuLi       
(1.0 equiv, 20 mmol) was added dropwise at -78 °C. The reaction mixture was stirred for     
15 min at -78 °C, slowly warmed up to -5 °C and then cooled to -95 °C. A solution of 2-
bromo-pyridine (1 equiv, 20 mmol) in THF (20 mL) was added dropwise, and the reaction 
mixture was stirred for 4 h at -95 °C. A solution of ZnCl2 (1.1 equiv, 22 mmol, 1 M in THF) 
was added dropwise and the reaction mixture was warmed up to 25 °C. 1-Chloro-4-
iodobenzene (0.75 equiv, 15 mmol) and Pd(Ph3P)4 (5 mol%) were added and the reaction 
mixture was heated to 50 °C for 2 h. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was dried with Na2SO4 and the crude material was 
purified by column chromatography (silica gel, 10:1 i-hexane/ethyl acetate) to furnish 2.01 g 
(50%) of the product as a pink solid. 
 
m.p.: 136 – 139 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.29 - 7.48 (m, 5 H), 7.59 (dd, J=7.46, 1.66 Hz, 1 H), 
8.38 (dd, J=4.56, 1.52 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: 122.74 (s, 1 C), 128.56 (s, 1 C), 130.62 (s, 1 C), 134.56 
(s, 1 C), 137.24 (s, 1 C), 138.60 (s, 1 C), 138.90 (s, 1 C), 142.21 (s, 1 C), 149.01 (s, 1 C) 
MS (70 eV, EI) m/z (%): 267 (48), 190 (27), 188 (100), 153 (52), 152 (27), 126 (15). 
IR ATR ν (cm-1): 3045, 3036, 2000, 1911, 1572, 1554, 1494, 1442, 1408, 1376, 1301, 1098, 
1090, 1053, 1020, 997, 833, 822, 803, 778, 744, 715, 700. 
HRMS (EI) for C11H7BrClN (266.9450) [M]+: 266.9444. 
 
Synthesis of 2-bromo-4-(3-bromophenyl)-5-chloropyridine (35e): 
N Br
Br
Cl
 
 
Diisopropylamine (1.1 equiv, 16.5 mmol) in THF (24 mL) was cooled to -78 °C and n-BuLi      
(1.1 equiv, 16.5 mmol) was added dropwise at -78 °C. The reaction mixture was stirred for 15 
minutes at -78 °C, slowly warmed up to -5 °C and then cooled to -78 °C. A solution of 2-
bromo-5-chloropyridine (1 equiv, 15 mmol) in THF (7 mL) was added dropwise, and the 
reaction mixture was stirred for 2 h. A solution of ZnCl2 (1.2 equiv, 18 mmol, 1 M in THF) 
was added at -78 °C and the reaction mixture was allowed to warm up to 25 °C. 1-Bromo-3-
iodobenzene (1.1 equiv, 16.5 mmol) and Pd(Ph3P)4 (5 mol%) were added, and the reaction 
mixture was heated to 50 °C over night. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was dried with Na2SO4 and the crude material was 
purified by column chromatography (silica gel, 11:1 i-hexane/ethyl acetate) to furnish 3.6 g 
(68%) of the product as a yellow solid.  
 
m.p.: 109 – 111 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.34 - 7.42 (m, 2 H), 7.47 (s, 1 H), 7.58 - 7.65 (m, 2 H), 
8.45 (s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 122.60 (s, 1 C), 127.47 (s, 1 C), 129.13 (s, 1 C), 129.74 
(s, 1 C), 130.11 (s, 1 C), 131.68 (s, 1 C), 132.45 (s, 1 C), 137.09 (s, 1 C), 140.03 (s, 1 C), 
148.61 (s, 1 C), 150.05 (s, 1 C). 
MS (70 eV, EI) m/z (%): 345 (18), 268 (20), 267 (16), 187 (47), 152 (12). 
IR ATR ν (cm-1): 3045, 2361, 1564, 1512, 1443, 1412, 1322, 1282, 1112, 1095, 1067, 1023, 
995, 920, 890, 880, 784, 746, 730, 691, 664. 
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HRMS (EI) for C11H6Br2ClN (344.8556) [M]+: 344.8541. 
 
Synthesis of 2-bromo-5-chloro-4-(4-fluorophenyl)pyridine (35h): 
N Br
Cl
F
 
 
Diisopropylamine (1.1 equiv, 16.5 mmol) in THF (24 mL) was cooled to -78 °C and n-BuLi       
(1.1 equiv, 16.5 mmol) was added dropwise at -78 °C. The reaction mixture was stirred for        
15 minutes at -78 °C, slowly warmed up to -5 °C and then cooled to -78 °C. A solution of 2-
bromo-5-chloropyridine (1 equiv, 15 mmol) in THF (7 mL) was added dropwise, and the 
reaction mixture was stirred for 2 h. A solution of ZnCl2 (1.2 equiv, 18 mmol, 1 M in THF) 
was added at -78 °C and reaction mixture was allowed to warm up to 25 °C. 1-Fluoro-4-
iodobenzene (1.1 equiv, 16.5 mmol) and Pd(Ph3P)4 (5 mol%) were added. The reaction 
mixture was heated to 50 °C over night. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was dried with Na2SO4 and the crude material was 
purified by column chromatography (silica gel, 10:1 i-hexane/ethyl acetate) to furnish 3 g 
(70%) of the product as a white solid. 
 
m.p.: 130 – 132 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 11.25 (t, J=8.67 Hz, 2 H), 11.51 - 11.56 (m, 3 H), 12.50 
(s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 115.78 (d, J=21.88 Hz, 1 C) 129.22 (s, 1 C), 129.83 (s, 1 
C), 130.82 (d, J=8.45 Hz, 1 C), 131.18 (d, J=3.07 Hz, 1 C), 139.99 (s, 1 C), 149.15 (s, 1 C), 
149.99 (s, 1 C), 163.30 (d, J=250.29 Hz, 1 C). 
MS (70 eV, EI) m/z (%): 285 (34), 206 (37), 171 (50), 144 (13), 73 (29), 61 (100). 
IR ATR ν (cm-1): 3076, 3041, 2362, 1907, 1773, 1604, 1569, 1507, 1446, 1334, 1234, 1223, 
1159, 1109, 1098, 1020, 886, 843, 832. 
HRMS (EI) for C11H6BrClFN (284.9356) [M]+: 284.9332. 
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Synthesis of 2-bromo-3-(4-methoxyphenyl)quinoline (35i): 
 
 
Diisopropylamine (1.1 equiv, 8.8 mmol) in THF (13 mL) was cooled to -78 °C and n-BuLi        
(1.1 equiv, 8.8 mmol) was added dropwise at -78 °C. The reaction mixture was stirred for          
15 minutes at -78 °C, slowly warmed up to -5 °C and then cooled to -90 °C. A solution of 2-
bromoquinoline (1 equiv, 8 mmol) in THF (4 mL) was added dropwise, and the reaction 
mixture was stirred for 4 h. A Solution of ZnCl2 (1.2 equiv, 9.6 mmol, 1 M in THF) was 
added at -90 °C and reaction mixture was allowed to warm up to 25 °C. 1-Iodo-4-
methoxybenzene (1.1 equiv,   8.8 mmol) and Pd(Ph3P)4 (5 mol%) were added. The reaction 
mixture was heated to 50 °C over night. The reaction mixture was quenched with brine and 
extracted with EtOAc. The organic phase was dried with Na2SO4, and the crude material was 
purified by column chromatography (silica gel, 12:1 i-hexane/ethyl acetate) to produce 0.5 g 
(20%) of the product as a white solid. 
 
m.p.: 91 – 95 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.89 (s, 3 H), 7.01 (m, 2 H), 7.44 (m, 2 H), 7.58 (ddd, 
J=8.11, 6.91, 1.19 Hz, 1 H), 7.73 (ddd, J=8.52, 6.97, 1.43 Hz, 1 H), 7.81 (dd, J=8.11, 1.19 Hz, 
1 H), 8.03 (s, 1 H), 8.06 - 8.12 (m, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.34 (s, 1 C), 113.64 (s, 1 C), 127.32 (s, 1 C), 127.34 
(s, 1 C), 127.52 (s, 1 C), 128.41 (s, 1 C), 130.22 (s, 1 C), 130.94 (s, 1 C), 131.39 (s, 1 C), 
136.77 (s, 1 C), 137.80 (s, 1 C), 143.23 (s, 1 C), 147.35 (s, 1 C), 159.67 (s, 1 C). 
MS (70 eV, EI) m/z (%): 313 (31), 234 (22), 219 (14), 191 (11), 190 (14). 
IR ATR ν (cm-1): 3044, 2965, 2914, 2839, 1608, 1584, 1512, 1484, 1390, 1340, 1285, 1238, 
1177, 1133, 1078, 1027, 1014, 958, 878, 827, 810, 794, 781, 767, 656. 
HRMS (EI) for C16H12BrNO (313.0102) [M]+: 313.0091. 
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Synthesis of 2-bromo-4-(4-chloro-2-fluorophenyl)pyrimidine (35l): 
 
 
2-Bromopyridine (1 equiv, 6 mmol) in THF (6 mL) was reacted with a solution of 
TMPMgCl⋅LiCl (1.1 equiv, 6.6 mmol, 1.00 M in THF) at -55 °C for 1.5 h. A solution of 
ZnCl2 (1.2 equiv, 7.2 mmol, 1 M in THF) was added, and the reaction mixture was allowed to 
warm up to 25 °C. 4-Chloro-2-fluoro-1-iodobenzene (1.3 equiv, 7.8 mmol), Pd(dba)2            
(3 mol%) and P(o-furyl)3 (6 mol%) were added, and the reaction mixture was heated to 50 °C 
over night. The reaction mixture was quenched with brine and extracted with EtOAc. The 
organic phase was dried with Na2SO4 and the crude material was purified by column 
chromatography (silica gel, 5:1 i-hexane/ethyl acetate) to furnish 1.7 g (78%) of the product 
as a white solid. 
 
m.p.: 125 - 127 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.22 - 7.35 (m, 2 H), 7.83 (dd, J=5.36, 1.55 Hz, 1 H), 
8.23 (t, J=8.46 Hz, 1 H), 8.62 (d, J=5.25 Hz, 1 H) 
13C NMR (75 MHz, CDCl3) δ/ppm: 117.32 (d, J=26.37 Hz, 1 C), 119.33 (d, J=13.46 Hz, 1 
C), 125.55 (s, 1 C), 131.84 (s, 1 C), 138.74 (d, J=10.94 Hz, 1 C), 153.29 (s, 1 C), 159.84 (s, 1 
C), 161.19 (d, J=256.93 Hz), 161.63 (s, 1 C), 161.68 (s, 1 C). 
MS (70 eV, EI) m/z (%): 285 (1), 88 (5), 73 (5), 70 (10), 61 (17). 
IR ATR ν (cm-1): 3112, 3101, 3032, 2360, 1612, 1561, 1527, 1483, 1418, 1402, 1348, 1345, 
1340, 1212, 1191, 1172, 1086, 901, 858, 845, 820, 788, 771, 706, 661. 
HRMS (EI) for C10H5BrClFN2 (285.9309) [M]+: 285.9307. 
 
Synthesis of 2-bromo-4-(4-(trifluoromethyl)phenyl)pyrimidine (35m): 
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2-Bromopyridine (1 equiv, 6 mmol) in THF (6 mL) was reacted with a solution of 
TMPMgCl⋅LiCl (1.1 equiv, 6.6 mmol, 1.00 M in THF) at -55 °C for 1.5 h. A solution of 
ZnCl2 (1.2 equiv., 7.2 mmol, 1 M in THF) was added and the reaction mixture was allowed to 
warm up to 25 °C. 1-Iodo-4-(trifluoromethyl)benzene (1.3 equiv, 7.8 mmol), Pd(dba)2          
(3 mol%) and P(o-furyl)3 (6 mol%) were added and the reaction mixture was heated to 50 °C 
over night. The reaction mixture was quenched with brine and extracted with EtOAc. The 
organic phase was dried with Na2SO4 and the crude material was purified by column 
chromatography (silica gel, 4:1 i-hexane/ethyl acetate) to furnish 1.3 g (70%) of the product 
as a white solid. 
 
m.p.: 89 – 93 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.73 (d, J=5.24 Hz, 1 H), 7.78 (m, J=8.23 Hz, 2 H), 
8.20 (m, J=8.04 Hz, 2 H), 8.65 (d, J=5.05 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 115.87 (s, 1 C), 123.67 (q, J=272.36 Hz, 1 C), 126.07 (q, 
J=3.93 Hz, 1 C), 127.80 (s, 1 C), 133.46 (q, J=32.82 Hz, 1 C), 138.27 (s, 1 C), 153.80 (s, 1 C), 
160.03 (s, 1 C), 165.32 (s, 1 C). 
MS (70 eV, EI) m/z (%): 223 (4), 171 (1), 88 (4), 73 (4), 70 (9). 
IR ATR ν (cm-1): 3132, 3060, 2362, 2332, 1563, 1430, 1320, 1180, 1171, 1162, 1119, 1077, 
1055, 1018, 982, 842, 830, 816, 770, 764, 740, 702. 
HRMS (EI) for C11H6BrF3N2 (301.9666) [M]+: 303.9646. 
 
Synthesis of 2-chloro-4,6-bis(ethylthio)-1,3,5-triazine (35q): 
 
 
BuLi (2.2 equiv, 475 mmol) was added to a solution of EtSH (2.5 equiv, 534 mmol) in THF 
(200 mL) at -78 °C.  The mixture was immediately warmed to 25 °C. The milky-white 
mixture was transferred via syringe to a solution of cyanuric chloride (1 equiv, 216 mmol) in 
THF   (50 mL) at -78 °C. The mixture was immediately warmed to 25 °C and quenched with 
NH4Cl sat. aq. The mixture was extracted with Et2O, dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude substance as an orange oil, which was composed of 
the title compound mixed with 2,4,6-tris(ethylthio)-1,3,5-triazine. Purification was 
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accomplished using vacuum distillation (bp 97-98 °C, 0.001 mbar) to provide the titled 
compound as a pale yellow oil that was 18.7 g (37%) pure by GC analysis. 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.35 (td, J=7.26, 2.90 Hz, 6 H), 2.93 - 3.26 (m, J=7.36, 
7.36, 7.26, 2.90 Hz, 4 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 14.03 (s, 1 C), 25.13 (s, 1 C), 167.95 (s, 1 C), 182.82 (s, 
1 C). 
MS (70 eV, EI) m/z (%): 235 (100), 206 (18), 202 (23), 172 (40), 146 (60), 88 (30). 
IR ATR ν (cm-1): 2972, 2930, 2873, 1499, 1453, 1412, 1374, 1279, 1233, 1152, 1135, 1056, 
966, 838, 787, 750. 
HRMS (EI) for C7H10ClN3S2 (235.0005) [M]+: 234.9994. 
 
Synthesis of 2-bromo-4-((trimethylsilyl)ethynyl)pyridine (35r): 
N Br
TMS
 
 
Triethylamine (60 mL) and toluene (30 mL) were added to 2-bromo-4-iodopyridine (1 equiv,      
9 mmol). Pd(Ph3P)4 (5 mol%) and CuI (10 mol%) were added and the reaction mixture was 
cooled to 0 °C. Trimethylsilylacetylene (1 equiv, 9 mmol) was added and the reaction mixture 
was stirred at room temperature over night. The reaction mixture was quenched with brine 
and extracted with EtOAc. The organic phase was dried with Na2SO4 and the crude material 
was purified by column chromatography (silica gel, 9:1 i-hexane/ethyl acetate) to furnish  
1.37 g (60%) of the product as a slightly yellow liquid. 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.26 (s, 9 H), 7.24 (dd, J=5.11, 1.24 Hz, 1 H), 7.51 (s, 1 
H), 8.30 (d, J=4.98 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -0.43 (s, 1 C), 100.32 (s, 1 C), 101.96 (s, 1 C), 124.71 (s, 
1 C), 130.03 (s, 1 C), 133.74 (s, 1 C), 142.13 (s, 1 C), 149.82 (s, 1 C). 
MS (70 eV, EI) m/z (%): 252 (5), 240 (63), 239 (10), 144 (5), 131 (4), 80 (9). 
IR ATR ν (cm-1): 2960, 2900, 2172, 1580, 1570, 1518, 1456, 1365, 1250, 1112, 1077, 983, 
873, 835, 759, 710. 
HRMS (EI) for C10H12BrNSi (252.9922) [M]+: 253.9824. 
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Synthesis of 2-bromo-3-(but-3-en-1-yl)pyridine (35s): 
 
 
2-Bromo-3-(bromomethyl)pyridine (1 equiv, 1 mmol) was dissolved in THF (3 mL) and a 
solution of allyl magnesium chloride (1.1 equiv, 1.1 mmol, 1.2 M in THF) was added 
dropwise at -78 °C. The reaction mixture was allowed to warm up to room temperature over 
night. The reaction mixture was quenched with brine and extracted with EtOAc. The organic 
phase was dried with Na2SO4 and the crude material was purified by column chromatography 
(silica gel, 6:1 i-hexane/ethyl acetate) to furnish 81 mg (38%) of the product as a colorless 
liquid. 
 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.40 (q, J=7.31 Hz, 2 H), 2.81 (t, J=7.75 Hz, 2 H), 4.84 
- 5.22 (m, 2 H), 5.73 - 5.96 (m, J=16.96, 10.28, 6.65, 6.65 Hz, 1 H), 7.18 (dd, J=7.39, 4.77 
Hz, 1 H), 7.48 (dd, J=7.39, 1.43 Hz, 1 H), 8.21 (dd, J=4.53, 1.67 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 33.08 (s, 1 C), 34.59 (s, 1 C), 115.86 (s, 1 C), 122.72 (s, 
1 C), 136.82 (s, 1 C), 138.18 (s, 1 C), 138.32 (s, 1 C), 144.37 (s, 1 C), 147.63 (s, 1 C). 
MS (70 eV, EI) m/z (%): 170 (100), 132 (82), 131 (39), 91 (24), 90 (18). 
IR ATR ν (cm-1): 3077, 2979, 2930, 2862, 1641, 1578, 1557, 1446, 1401, 1180, 1088, 1064, 
1049, 994, 912, 796, 740, 674, 659. 
HRMS (EI) for C9H10BrN (210.9997) [M]+: 211.0013. 
 
6.2. Preparation of the Title Compounds Using TP3: 
 
Synthesis of 4,6-dimethyl-2-phenylpyrimidine (33g): 
N
N
CH3
H3C
 
 
A solution of 32a in THF (1.0 mmol, 2.0 equiv, 1.7 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 31h (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 
25 °C for 5 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
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CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 33g as a white powder. 
 
Isolated yield: with FeBr3: 89% (82 mg). 
Reaction time: 5 min. 
Solvent for purification: 10:1 i-hexane/ethyl acetate + 0.5 % triethylamine.  
m.p.: 82.8 – 84.0 ºC. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.54 (s, 6 H), 6.92 (s, 1 H), 7.47 (m, 3 H), 8.43 (d, J=1.9 
Hz, 1 H), 8.45 (d, J=4.4 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 24.11 (s, 1 C), 117.97 (s, 1 C), 128.24 (s, 1 C), 128.42 
(s, 1 C), 130.31 (s, 1 C), 137.94 (s, 1 C), 164.06 (s, 1 C), 166.77 (s, 1 C). 
MS (70 eV, EI) m/z (%): 185 (16), 184 (100) [M]+ , 169 (20), 104 (19), 103 (27), 77 (6). 
IR ATR ν (cm-1): 3068, 2924, 2853, 2361, 1595, 1574, 1550, 1534, 1442, 1434, 1379, 1364, 
1342, 1173, 1025, 932, 854, 749, 693, 662. 
HRMS (EI) for C12H12N2 (184.1000) [M]+: 184.0995. 
 
Synthesis of 2-phenylpyridine (33a): 
N
 
A solution of 32a in THF (1.0 mmol, 2.0 equiv, 1.7 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 31a (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 
25 °C for 15 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 33a as a colorless oil. 
 
Isolated yield: with FeBr3: 89% (69 mg). 
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Reaction time: 15 min. 
Solvent for purification: 6:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.23 (m, 1 H), 7.45 (m, 3 H), 7.75 (m, 2 H), 8.01 (m, 2 
H), 8.70 (d, J=4.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 120.60 (s, 1 C), 122.10 (s, 1 C), 126.92 (s, 1 C), 128.74 
(s, 1 C), 128.99 (s, 1 C), 136.84 (s, 1 C), 139.24 (s, 1 C), 149.53 (s, 1 C), 157.39 (s, 1 C). 
MS (70 eV, EI) m/z (%): 155 (100) [M]+, 154 (60), 128 (10), 127 (10), 77 (9), 59 (10), 43 
(7). 
IR ATR ν (cm-1): 3062, 3036, 3008, 2927, 1586, 1580, 1564, 1468, 1449, 1424, 1293, 1152, 
1074, 1020, 988, 800, 737, 692. 
HRMS (EI) for C11H9N (155.1735) [M]+: 155.1731. 
 
Synthesis of 2-(4-methoxyphenyl)-3-(trimethylsilyl)pyridine (34a): 
 
 
A solution of 32i in THF (1.0 mmol, 2.0 equiv, 1.3 M) was added dropwise to a suspension of 
FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35a (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34a as a colorless oil. 
 
Isolated yield: with FeBr3: 91% (117 mg). 
                         with CoCl2: 85% (109 mg). 
Reaction time: 15 min. 
Solvent for purification: 4:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
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1H NMR (300 MHz, CDCl3) δ/ppm: 0.05 (s, 9 H), 3.84 (s, 3 H), 6.94 (m, J=8.85 Hz, 2 H), 
7.20 (dd, J=7.46, 4.70 Hz, 1 H), 7.34 (m, J=8.57 Hz, 2 H), 7.89 (dd, J=7.60, 1.80 Hz, 1 H), 
8.59 (dd, J=4.70, 1.94 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 0.25 (s, 1 C), 55.29 (s, 1 C), 113.29 (s, 1 C), 121.02 (s, 1 
C), 130.11 (s, 1 C), 133.30 (s, 1 C), 136.29 (s, 1 C), 143.17 (s, 1 C), 148.91 (s, 1 C), 159.62 
(s, 1 C), 165.10 (s, 1 C). 
MS (70 eV, EI) m/z (%): 257 (91), 242 (100), 227 (23), 211 (6), 199 (13). 
IR ATR ν (cm-1): 3045, 2954, 2898, 2836, 1609, 1548, 1515, 1402, 1298, 1245, 1172, 1038, 
1025, 832, 809, 787, 753, 731, 688, 656. 
HRMS (EI) for C15H19NOSi (257.1236) [M]+: 257.1222. 
 
Synthesis of 4-(3-(4-chlorophenyl)pyridin-2-yl)-N,N-dimethylaniline (34b): 
 
 
A solution of 32n in THF (1.0 mmol, 2.0 equiv, 1.2 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35b (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34b as a slightly yellow oil. 
 
Isolated yield: with FeBr3: 82% (127 mg) 
                         with CoCl2: 77% (119 mg) 
Reaction time: 15 min. 
Solvent for purification: 9:1 dichloromethane/ethyl acetate + 0.5% triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.95 (s, 6 H), 6.59 (d, J=8.85 Hz, 2 H), 7.08 - 7.35 (m, 7 
H), 7.61 (dd, J=7.74, 1.66 Hz, 1 H), 8.65 (dd, J=4.70, 1.66 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: 40.28 (s, 1 C), 111.63 (s, 1 C), 120.91 (s, 1 C), 127.49 
(s, 1 C), 128.56 (s, 1 C), 130.75 (s, 1 C), 130.85 (s, 1 C), 132.97 (s, 1 C), 133.96 (s, 1 C), 
138.32 (s, 1 C), 139.32 (s, 1 C), 148.51 (s, 1 C), 150.10 (s, 1 C), 157.19 (s, 1 C). 
MS (70 eV, EI) m/z (%): 308 (100), 307 (45), 291 (19), 153 (9), 136 (12). 
IR ATR ν (cm-1): 3037, 2885, 2855, 2801, 1606, 1576, 1524, 1489, 1425, 1394, 1353, 1193, 
1168, 1090, 999, 945, 834, 821, 799, 778, 758, 728, 718, 704. 
HRMS (EI) for C19H17ClN2 (308.1080) [M]+: 308.1060. 
 
4-(thiophen-2-yl)-2-(4-(trimethylsilyl)phenyl)pyridine (34c): 
N
S
TMS
 
 
A solution of 32o in THF (1.0 mmol, 2.0 equiv, 1.2 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35c (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34c as a slightly yellow oil. 
 
Isolated yield: with FeBr3: 65% (101 mg). 
                         with CoCl2: 70% (108 mg). 
Reaction time: 15 min. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.33 (s, 9 H), 7.17 (dd, J=5.13, 3.70 Hz, 1 H), 7.44 (d, 
J=5.25 Hz, 2 H), 7.54 - 7.60 (m, 1 H), 7.67 (m, J=8.11 Hz, 2 H), 7.92 (s, 1 H), 8.02 (m, 
J=8.11 Hz, 2 H), 8.68 (d, J=5.01 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: -1.12 (s, 1 C), 117.00 (s, 1 C), 118.52 (s, 1 C), 125.31 (s, 
1 C), 126.19 (s, 1 C), 127.10 (s, 1 C), 128.43 (s, 1 C), 133.79 (s, 1 C), 139.57 (s, 1 C), 141.53 
(s, 1 C), 141.67 (s, 1 C), 142.16 (s, 1 C), 150.26 (s, 1 C), 158.32 (s, 1 C). 
MS (70 eV, EI) m/z (%): 309 (20), 296 (9), 295 (27), 294 (100). 
IR ATR ν (cm-1): 3073, 3021, 2953, 2895, 1593, 1554, 1467, 1405, 1246, 1107, 989, 837, 
815, 799, 785, 759, 754, 720, 699, 679. 
HRMS (EI) for C18H19NSSi (309.1007) [M]+: 309.0977. 
 
Synthesis of 2-(3-((tert-butyldimethylsilyl)oxy)phenyl)-4-(4-fluorophenyl)pyridine (34d): 
N
F
OTBS
 
 
A solution of 32p in THF (1.0 mmol, 2.0 equiv, 1.05 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35d (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34d as a slightly yellow oil. 
 
Isolated yield: with FeBr3: 71% (131 mg). 
                         with CoCl2: 79% (145 mg). 
Reaction time: 15 min. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.26 (s, 6 H), 1.03 (s, 9 H), 6.93 (dd, J=7.99, 1.79 Hz, 1 
H), 7.21 (t, J=8.58 Hz, 2 H), 7.31 - 7.44 (m, 2 H), 7.54 (d, J=2.15 Hz, 1 H), 7.58 - 7.74 (m, 3 
H), 7.84 (s, 1 H), 8.73 (d, J=5.25 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm:  -4.32 (s, 1 C), 18.23 (s, 1 C), 25.73 (s, 1 C), 116.15 (d, 
J=21.60 Hz, 1 C), 118.63 (s, 1 C), 118.88 (s, 1 C), 120.08 (s, 1 C), 120.69 (s, 1 C), 128.85 (d, 
J=8.41 Hz, 1 C), 129.70 (s, 1 C), 134.63 (s, 1 C), 134.68 (s, 1 C), 140.94 (s, 1 C), 148.18 (s, 1 
C), 150.11 (s, 1 C), 156.15 (s, 1 C), 157.99 (s, 1 C), 163.42 (d, J=249.08 Hz, 1 C). 
MS (70 eV, EI) m/z (%): 322 (100), 281 (41), 209 (13), 207 (83), 97 (12). 
IR ATR ν (cm-1): 3064, 2955, 2930, 2895, 2858, 1597, 1581, 1512, 1464, 1444, 1270, 1253, 
1233, 1204, 1160, 948, 825, 779, 724, 693, 666. 
HRMS (EI) for C23H26FNOSi (379.1768) [M]+: 379.1756. 
 
Synthesis of 4-(3-bromophenyl)-5-chloro-2-mesitylpyridine (34e): 
N
Me
Br
Cl
Me
Me
 
 
A solution of 32q in THF (1.0 mmol, 2.0 equiv, 1.1 M) was added dropwise to a suspension 
of CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 35e (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at  
25 °C for 5 h before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 34e as a slightly yellow oil. 
 
Isolated yield: with CoCl2: 82% (159 mg). 
Reaction time: 5 h. 
Solvent for purification: 10:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.04 - 2.13 (m, 6 H), 2.34 (s, 3 H), 6.95 (s, 2 H), 7.21 - 
7.24 (m, 1 H), 7.33 - 7.41 (m, 1 H), 7.44 - 7.51 (m, 1 H), 7.55 - 7.65 (m, 1 H), 7.65 - 7.73 (m, 
1 H), 8.76 - 8.81 (m, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 20.33 (s, 1 C), 21.18 (s, 1 C), 122.53 (s, 1 C), 126.20 (s, 
1 C), 127.80 (s, 1 C), 128.01 (s, 1 C), 128.54 (s, 1 C), 130.06 (s, 1 C), 132.01 (s, 1 C), 135.59 
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(s, 1 C), 135.69 (s, 1 C), 136.29 (s, 1 C), 137.98 (s, 1 C), 138.58 (s, 1 C), 146.11 (s, 1 C), 
150.09 (s, 1 C), 158.85 (s, 1 C). 
MS (70 eV, EI) m/z (%): 386 (100), 384 (74), 255 (5), 230 (24), 127 (8). 
IR ATR ν (cm-1): 2966, 2918, 2858, 1612, 1577, 1563, 1525, 1478, 1455, 1355, 1106, 1093, 
1073, 1025, 996, 907, 881, 851, 840, 786, 732, 697, 679, 658. 
HRMS (EI) for C20H17BrClN (385.0233) [M]+:384.0152. 
 
Synthesis of 5-(6-methoxypyridin-2-yl)-1-methyl-1H-indole (34f): 
 
 
A solution of 32r in THF (1.0 mmol, 2.0 equiv, 0.9 M) was added dropwise to a suspension 
of CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 35f (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at  
25 °C for 1 h before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 34f as a slightly yellow solid. 
 
Isolated yield: with CoCl2: 65% (77 mg). 
Reaction time: 1 h. 
Solvent for purification: 4:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 99 – 108 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.83 (s, 3 H), 4.10 (s, 3 H), 6.59 (dd, J=3.04, 0.83 Hz, 1 
H), 6.65 (dd, J=8.16, 0.69 Hz, 1 H), 7.09 (d, J=3.04 Hz, 1 H), 7.37 - 7.43 (m, 2 H), 7.63 (dd, 
J=8.02, 7.46 Hz, 1 H), 7.99 (dd, J=8.57, 1.66 Hz, 1 H), 8.37 (dd, J=1.66, 0.55 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 32.93 (s, 1 C), 53.17 (s, 1 C), 101.85 (s, 1 C), 107.76 (s, 
1 C), 109.18 (s, 1 C), 112.39 (s, 1 C), 119.54 (s, 1 C), 120.79 (s, 1 C), 128.77 (s, 1 C), 129.51 
(s, 1 C), 130.75 (s, 1 C), 137.32 (s, 1 C), 139.04 (s, 1 C), 156.15 (s, 1 C), 163.63 (s, 1 C). 
MS (70 eV, EI) m/z (%): 238 (64), 237 (48), 209 (12), 207 (13), 104 (5). 
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IR ATR ν (cm-1): 3001, 2944, 1591, 1580, 1566, 1463, 1446, 1428, 1419, 1410, 1335, 1321, 
1278, 1243, 1178, 1150, 1081, 1061, 1020, 986, 940, 893, 859, 788, 767, 735, 726, 662. 
HRMS (EI) for C15H14N2O (238.1106) [M]+:238.1097. 
 
Synthesis of 2-(4-fluorophenyl)-3-(2-methoxyphenyl)pyridine (34g): 
 
 
A solution of 32g in THF (1.0 mmol, 2.0 equiv, 1.05 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35g (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34g as a slightly yellow oil. 
 
Isolated yield: with FeBr3: 77% (108 mg). 
                         with CoCl2: 79% (110 mg). 
Reaction time: 15 min. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.42 (s, 3 H), 6.78 (d, J=8.22 Hz, 1 H), 6.84 - 7.05 (m, 3 
H), 7.16 (dd, J=7.40, 1.53 Hz, 1 H), 7.23 - 7.41 (m, 4 H), 7.69 (dd, J=7.63, 1.53 Hz, 1 H), 
8.67 (dd, J=4.75, 1.47 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 54.96 (s, 1 C), 111.05 (s, 1 C), 114.42 (d, J=21.35 Hz, 1 
C), 120.84 (s, 1 C), 121.87 (s, 1 C), 128.75 (s, 1 C), 129.36 (s, 1 C), 130.54 (d, J=8.26 Hz, 1 
C), 131.14 (s, 1 C), 132.73 (s, 1 C), 137.06 (s, 1 C), 139.10 (s, 1 C), 148.21 (s, 1 C), 155.98 
(s, 1 C), 157.02 (s, 1 C), 162.36 (d, J=246.54 Hz, 1 C). 
MS (70 eV, EI) m/z (%): 279 (15), 278 (15), 264 (4), 248 (9), 235 (4). 
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IR ATR ν (cm-1): 3050, 2958, 2936, 2836, 1895, 1599, 1580, 1510, 1495, 1462, 1436, 1420, 
1273, 1220, 1181, 1157, 1124, 1107, 1094, 1050, 1025, 1015, 999, 839, 824, 811, 802, 780, 
751, 718, 678. 
HRMS (EI) for C18H14FNO (279.1059) [M]+: 278.0958. 
 
Synthesis of 4-(5-chloro-4-(4-fluorophenyl)pyridin-2-yl)phenyl pivalate (34h): 
 
 
A solution of 32l in THF (1.0 mmol, 2.0 equiv, 0.8 M) was added dropwise to a suspension of 
FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 
35h (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 25 °C 
for 15 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 
and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 15 min, 
before being filtered through a pad of Celite®. After washing the pad of Celite® with CH2Cl2, 
NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic layer was 
dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which 
was purified by column chromatography to yield 34h as a white thick oil. 
 
Isolated yield: with FeBr3: 65% (125 mg). 
Reaction time: 15 min. 
Solvent for purification: 15:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.39 (s, 9 H), 7.12 - 7.25 (m, 4 H), 7.48 - 7.56 (m, 2 H), 
7.64 - 7.69 (m, 1 H), 8.02 (d, J=8.57 Hz, 2 H), 8.72 (s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 27.13 (s, 1 C), 39.15 (s, 1 C), 115.60 (d, J=21.64 Hz, 1 
C), 121.93 (s, 1 C), 127.45 (s, 1 C), 127.91 (s, 1 C), 128.03 (s, 1 C), 128.71 (s, 1 C), 130.86 
(d, J=8.26 Hz, 1 C), 132.74 (s, 1 C), 132.79 (s, 1 C), 135.47 (s, 1 C), 147.19 (s, 1 C), 149.83 
(s, 1 C), 152.19 (s, 1 C), 155.15 (s, 1 C), 163.07 (d, J=249.10 Hz, 1 C), 176.88 (s, 1 C). 
MS (70 eV, EI) m/z (%): 383 (14), 300 (18), 299 (100), 264 (11), 85 (14). 
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IR ATR ν (cm-1): 2975, 2874, 1747, 1606, 1507, 1480, 1460, 1366, 1276, 1231, 1200, 1163, 
1102, 1022, 1014, 908, 895, 856, 836, 816, 800, 788, 757, 729. 
HRMS (EI) for C22H19ClFNO2 (383.1088) [M]+: 383.1083. 
 
Synthesis of 2,3-bis(4-methoxyphenyl)quinoline (34i): 
 
 
A solution of 32i in THF (1.0 mmol, 2.0 equiv, 1.3 M) was added dropwise to a suspension of 
CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 
35i (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 25 °C 
for 15 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 
and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 15 min, 
before being filtered through a pad of Celite®. After washing the pad of Celite® with CH2Cl2, 
NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic layer was 
dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which 
was purified by column chromatography to yield 34i as a slightly yellow oil. 
 
Isolated yield: with CoCl2: 78% (133 mg). 
Reaction time: 15 min. 
Solvent for purification: 4:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.81 (s, 3 H), 3.82 (s, 3 H), 6.77 - 6.90 (m, 5H), 7.16 - 
7.19 (m, 2 H), 7.42 - 7.44 (m, 2 H), 7.54 (ddd, J=8.04, 6.97, 1.17 Hz, 1 H), 7.70 - 7.75 (m, 1 
H), 7.84 (dd, J=8.19, 1.17 Hz, 1 H), 8.14 (s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 59.35 (s, 1 C), 59.42 (s, 1 C), 117.57 (s, 1 C), 117.90 (s, 
1 C), 130.74 (s, 1 C), 131.28 (s, 1 C), 131.42 (s, 1 C), 132.80 (s, 1 C), 133.76 (s, 1 C), 134.89 
(s, 1 C), 135.63 (s, 1 C), 136.24 (s, 1 C), 137.00 (s, 1 C), 138.23 (s, 1 C), 141.91 (s, 1 C), 
147.53 (s, 1 C), 159.32 (s, 1 C), 163.00 (s, 1 C), 163.84 (s, 1 C). 
MS (70 eV, EI) m/z (%): 340 (100), 326 (11), 297 (14), 254 (12), 163 (5). 
IR ATR ν (cm-1): 2999, 2955, 2945, 2917, 2835, 1607, 1511, 1483, 1463, 1455, 1422, 1402, 
1370, 1289, 1242, 1173, 1144, 1109, 1027, 965, 829, 809, 792, 782, 757, 746, 731, 714, 666. 
HRMS (EI) for C23H19NO2 (341.1416) [M]+:340.1336. 
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Synthesis of 2-(4-fluorophenyl)-6,7-dimethoxy-4-methylquinoline (34j): 
 
 
A solution of 32g in THF (1.0 mmol, 2.0 equiv, 1.05 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35j (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34j as a slightly yellow solid. 
 
Isolated yield: with FeBr3: 82% (122 mg). 
                         with CoCl2: 67% (100 mg). 
Reaction time: 15 min. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 164 – 168 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.70 (s, 3 H), 4.05 (s, 3 H), 4.06 (s, 3 H), 7.12 - 7.23 (m, 
3 H), 7.54 (d, J=2.76 Hz, 2 H), 8.09 (dd, J=8.98, 5.39 Hz, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 19.26 (s, 1 C), 56.02 (s, 1 C), 56.17 (s, 1 C), 101.46 (s, 1 
C), 108.56 (s, 1 C), 115.64 (d, J=21.64 Hz, 1 C), 117.99 (s, 1 C), 122.38 (s, 1 C), 129.06 (d, 
J=8.54 Hz, 1 C), 135.88 (s, 1 C), 143.36 (s, 1 C), 144.79 (s, 1 C), 149.46 (s, 1 C), 152.36 (s, 1 
C), 153.96 (s, 1 C), 163.48 (d, J=247.96 Hz, 1 C). 
MS (70 eV, EI) m/z (%): 297 (100), 282 (14), 254 (24), 252 (6), 211 (10). 
IR ATR ν (cm-1): 2923, 2854, 2833, 1623, 1597, 1503, 1489, 1465, 1433, 1422, 1399, 1353, 
1260, 1246, 1208, 1189, 1166, 1150, 1096, 1065, 1034, 1014, 1000, 994, 910, 862, 850, 836, 
808, 771, 726, 668. 
HRMS (EI) for C18H16FNO2 (297.1165) [M]+:297.1165. 
 
 169 
Synthesis of 3-(4,6-dimethylpyrimidin-2-yl)-N,N-dimethylaniline (34k): 
 
 
A solution of 32s in THF (1.0 mmol, 2.0 equiv, 1.15 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 31h (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34k as a brownish solid. 
 
Isolated yield: with FeBr3: 78% (89 mg). 
                         with CoCl2: 63% (72 mg). 
Reaction time: 30 min. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 105 – 108 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.54 (s, 6 H), 3.05 (s, 6 H), 6.92 (s, 2 H), 7.35 (t, J=7.88 
Hz, 1 H), 7.77 - 7.92 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 24.18 (s, 1 C), 40.91 (s, 1 C), 112.49 (s, 1 C), 114.95 (s, 
1 C), 117.16 (s, 1 C), 117.79 (s, 1 C), 129.13 (s, 1 C), 138.86 (s, 1 C), 150.82 (s, 1 C), 164.71 
(s, 1 C), 166.57 (s, 1 C). 
MS (70 eV, EI) m/z (%): 227 (100), 212 (53), 184 (18), 114 (7), 43 (55). 
IR ATR ν (cm-1): 2986, 2918, 2887, 2800, 1600, 1586, 1570, 1539, 1494, 1486, 1436, 1414, 
1396, 1362, 1345, 1319, 1233, 1177, 1064, 996, 955, 864, 775, 766, 697. 
HRMS (EI) for C14H17N3 (227.1422) [M]+:227.1417. 
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Synthesis of 4,6-bis(3-((tert-butyldimethylsilyl)oxy)phenyl)pyrimidine (34l): 
 
 
A solution of 32p in THF (2.0 mmol, 4.0 equiv, 1.1 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 35k (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 
25 °C for 15 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 34l as a red liquid. 
 
Isolated yield: with FeBr3: 95% (234 mg). 
Reaction time: 15 min, using 4 equiv of Grignard reagent. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
MS (70 eV, EI) m/z (%): 492 (11), 436 (36), 435 (100), 393 (19), 379 (9), 189 (23). 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.27 (s, 12 H), 1.03 (s, 18 H), 7.01 (dd, J=7.87, 1.83 Hz, 
2 H), 7.40 (t, J=7.97 Hz, 2 H), 7.65 (d, J=1.83 Hz, 2 H), 7.72 (d, J=7.87 Hz, 2 H), 8.02 (s, 1 
H), 9.32 (s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -4.32 (s, 1 C), 18.24 (s, 1 C), 25.72 (s, 1 C), 112.98 (s, 1 
C), 118.89 (s, 1 C), 120.17 (s, 1 C), 122.56 (s, 1 C), 129.99 (s, 1 C), 138.58 (s, 1 C), 156.37 
(s, 1 C), 159.14 (s, 1 C), 164.47 (s, 1 C). 
IR ATR ν (cm-1): 2955, 2943, 2886, 2858, 1572, 1521, 1491, 1471, 1461, 1277, 1252, 1229, 
1199, 1001, 968, 939, 870, 833, 777, 734, 708, 687, 666. 
HRMS (EI) for C28H40N2O2Si2 (492.2628) [M]+:492.2615. 
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Synthesis of 4-(4-chloro-2-fluorophenyl)-2-(4-(dimethoxymethyl)phenyl)pyrimidine 
(34m): 
N
N
Cl
F
OMe
OMe
 
 
A solution of 32t in THF (1.0 mmol, 2.0 equiv, 0.9 M) was added dropwise to a suspension of 
or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 35l (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at  
25 °C for 15 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 34m as a white solid. 
 
Isolated yield: with CoCl2: 68% (122 mg). 
Reaction time: 15 min. 
Purification: purified by HPLC with a column Chromolith SemiPrep RP-18e, 100-10 nm;  
15 % H2O/85 % CH3CN; flow rate 8 ml/min. 
m.p.: 89 – 91 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.36 (s, 6 H), 5.49 (s, 1 H), 7.18 - 7.30 (m, 1 H), 7.34 
(dddd, J=8.48, 6.38, 2.00, 0.68 Hz, 1 H), 7.60 (d, J=8.19 Hz, 1 H), 7.66 - 7.81 (m, 1 H), 7.95 - 
8.09 (m, 1 H), 8.36 (td, J=8.38, 2.53 Hz, 1 H), 8.48 - 8.59 (m, 1 H), 8.65 - 8.76 (m, 1 H), 8.87 
(dd, J=17.45, 5.36 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 52.61 (s, 1 C), 102.69 (s, 1 C), 117.24 (d, J=21.77 Hz, 
1C), 125.39 (s, 1 C), 127.02 (s, 1 C), 128.11 (s, 1 C), 128.76 (s, 1 C), 129.88 (s, 1 C), 137.75 
(s, 1 C), 140.72 (s, 1 C), 142.91 (s, 1 C), 158.15 (s, 1 C), 159.27 (s, 1 C), 161.31 (d, J=255.47 
Hz, 1C), 163.38 (s, 1 C), 164.26 (s, 1 C). 
MS (70 eV, EI) m/z (%): 358 (1), 327 (100), 311 (18), 283 (8), 154 (1), 130(5). 
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IR ATR ν (cm-1): 2980, 2959, 2932, 2830, 1607, 1584, 1576, 1558, 1548, 1484, 1432, 1407, 
1380, 1348, 1286, 1207, 1189, 1099, 1078, 1050, 1018, 982, 900, 851, 822, 810, 786, 738, 
722, 712, 665. 
HRMS (EI) for C19H16ClFN2O2 (358.0884) [M]+:358.0872. 
 
Synthesis of 2-(4-chloro-2-fluorophenyl)-4-(4-(trifluoromethyl)phenyl)pyrimidine (34n): 
N
N
CF3
Cl
F
 
 
A solution of 32u in THF (1.0 mmol, 2.0 equiv, 1.0 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35m (0.5 mmol, 1.0 equiv) in tBuOMe 
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34n as a white solid. 
 
Isolated yield: with FeBr3: 61% (108 mg). 
                         with CoCl2: 60% (106 mg). 
Reaction time: 15 min. 
Solvent for purification: 4:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 120 – 122 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.24 - 7.32 (m, 2 H), 7.67 (d, J=5.28 Hz, 1 H), 7.79 (m, 
J=8.14 Hz, 2 H), 8.20 (t, J=8.36 Hz, 1 H), 8.30 (m, J=8.14 Hz, 2 H), 8.94 (d, J=5.28 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 114.93 (s, 1 C), 117.71 (d, J=26.19 Hz, 1 C), 123.86 (q, 
J=272.44, 1 C), 124.64 (d, J=3.99 Hz, 1 C), 124.92 (d, J=8.83 Hz, 1 C), 125.96 (q, J=3.70 Hz, 
1 C), 127.60 (s, 1 C), 132.71 (s, 1 C), 132.75 (s, 1 C), 132.81 (q, J=32.74 Hz, 1 C), 137.12 (d, 
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J= 10.25 Hz, 1 C), 139.83 (q, J=1.14 Hz, 1 C), 158.28 (s, 1 C), 161.33 (d, J=260.48 Hz, 1 C), 
162.60 (s, 1 C), 162.75 (s, 1 C), 162.82 (s, 1 C). 
MS (70 eV, EI) m/z (%): 354 (31), 352 (100), 197 (34), 170 (36), 157 (10). 
IR ATR ν (cm-1): 1607, 1576, 1558, 1550, 1488, 1414, 1374, 1323, 1308, 1285, 1278, 1218, 
1191, 1172, 1142, 1106, 1087, 1065, 1038, 1014, 902, 854, 838, 820, 792, 768, 718, 711. 
HRMS (EI) for C17H9ClF4N2 (352.0390) [M]+:352.0383. 
 
Synthesis of 2-(4-methoxyphenyl)-4,6-diphenyl-1,3,5-triazine (34o): 
 
 
A solution of 32i in THF (1.0 mmol, 2.0 equiv, 1.3 M) was added dropwise to a suspension of 
FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35n (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34o as a white solid. 
 
Isolated yield: with FeBr3: 81% (137 mg). 
                         with CoCl2: 79% (134 mg). 
Reaction time: 15 min. 
Solvent for purification: 10:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 144 – 146 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.94 (s, 3 H), 7.08 (d, J=8.79 Hz, 2 H), 7.39 - 7.81 (m, 6 
H), 8.62 - 9.07 (m, 6 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.45 (s, 1 C), 113.94 (s, 1 C), 128.55 (s, 1 C), 128.77 
(s, 1 C), 128.87 (s, 1 C), 130.85 (s, 1 C), 132.31 (s, 1 C), 136.40 (s, 1 C), 163.31 (s, 1 C), 
171.18 (s, 1 C), 171.38 (s, 1 C). 
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MS (70 eV, EI) m/z (%): 339 (63), 214 (44), 199 (35), 171 (12), 133 (41), 103 (24). 
IR ATR ν (cm-1): 3312, 3038, 3015, 2958, 2840, 2362, 2331, 1605, 1499, 1438, 1274, 1249, 
1183, 1040, 1012, 823, 809, 781, 770, 690. 
HRMS (EI) for C22H17N3O (339.1372) [M]+:339.1366. 
 
2-phenyl-4,6-di(pyrrolidin-1-yl)-1,3,5-triazine (34p): 
N
N
N
Ph
N
N
 
 
A solution of 32a in THF (1.0 mmol, 2.0 equiv, 1.7 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), 
and 35o (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 
50 °C for 12 h before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 34p as a white solid. 
 
Isolated yield: with FeBr3: 76% (112 mg). 
Reaction time: 12 h at 50 °C. 
Solvent for purification: 10:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 137 – 139 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.96 (ddd, J=6.28, 3.48, 3.26 Hz, 8 H), 3.61 (br. s., 4 
H), 3.72 (br. s., 4 H), 7.35 - 7.52 (m, 3 H), 8.38 - 8.50 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 25.35 (s, 1 C), 45.98 (s, 1 C), 127.97 (s, 1 C), 128.21 (s, 
1 C), 130.69 (s, 1 C), 138.07 (s, 1 C), 163.62 (s, 1 C), 169.50 (s, 1 C). 
MS (70 eV, EI) m/z (%): 295 (88), 267 (100), 253 (25), 239 (19), 226 (39), 197 (13). 
IR ATR ν (cm-1): 2969, 2871, 2361, 1557, 1540, 1507, 1491, 1471, 1454, 1383, 1338, 1293, 
1279, 1238, 1221, 1180, 1167, 1154, 1008, 863, 815, 795, 780, 702. 
HRMS (EI) for C17H21N5 (295.1797) [M]+:295.1792. 
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Synthesis of 2,4-diethoxy-6-(thiophen-2-yl)-1,3,5-triazine (34q): 
 
 
A solution of 32v in THF (1.0 mmol, 2.0 equiv, 0.8 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35p (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 12 h before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34q as a yellow solid. 
 
Isolated yield: with FeBr3: 84% (105 mg). 
                         with CoCl2: 79% (99 mg). 
Reaction time: 12 h. 
Solvent for purification: 10:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
m.p.: 79 – 81 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.33 - 1.55 (m, 6 H), 4.52 (q, J=7.08 Hz, 4 H), 7.14 (dd, 
J=4.97, 3.80 Hz, 1 H), 7.56 (dd, J=4.97, 1.27 Hz, 1 H), 8.14 (dd, J=3.80, 1.27 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 14.29 (s, 1 C), 64.22 (s, 1 C), 128.27 (s, 1 C), 131.71 (s, 
1 C), 132.29 (s, 1 C), 140.81 (s, 1 C), 170.59 (s, 1 C), 172.03 (s, 1 C). 
MS (70 eV, EI) m/z (%): 251 (6), 207 (6), 110 (10), 71 (35), 61 (14). 
IR ATR ν (cm-1): 3102, 2983, 2927, 1531, 1490, 1466, 1439, 1416, 1378, 1346, 1324, 1290, 
1233, 1218, 1121, 1100, 1078, 1044, 1034, 1008, 866, 841, 811, 754, 714, 692, 671. 
HRMS (EI) for C11H13N3O2S (251.0728) [M]+:251.0725. 
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Synthesis of 2-(4-(dimethoxymethyl)phenyl)-4,6-bis(ethylthio)-1,3,5-triazine (34r): 
 
 
A solution of 32t in THF (1.0 mmol, 2.0 equiv, 0.9 M) was added dropwise to a suspension of 
FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv), isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 
35q (0.5 mmol, 1.0 equiv) in tBuOMe (2.5 mL) at 25 °C. The suspension was stirred at 25 °C 
for 15 min before being quenched with NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 
and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 15 min, 
before being filtered through a pad of Celite®. After washing the pad of Celite® with CH2Cl2, 
NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic layer was 
dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which 
was purified by column chromatography to yield 34r as a colorless oil. 
 
Isolated yield: with FeBr3: 61% (107 mg). 
Reaction time: 15 min. 
Solvent for purification: 6:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.45 (t, J=7.46 Hz, 6 H), 3.22 (q, J=7.46 Hz, 4 H), 3.34 
(s, 6 H), 5.47 (s, 1 H), 7.56 (d, J=8.29 Hz, 2 H), 8.45 (d, J=8.57 Hz, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 14.39 (s, 1 C), 24.85 (s, 1 C), 52.63 (s, 1 C), 102.51 (s, 1 
C), 126.95 (s, 1 C), 128.88 (s, 1 C), 135.21 (s, 1 C), 142.59 (s, 1 C), 167.94 (s, 1 C), 181.30 
(s, 1 C). 
MS (70 eV, EI) m/z (%): 351 (43), 320 (53), 230 (6), 146 (11), 75 (11). 
IR ATR ν (cm-1): 2962, 2947, 2829, 1483, 1410, 1377, 1348, 1309, 1284, 1235, 1205, 1098, 
1051, 1018, 984, 971, 912, 898, 847, 832, 796, 751, 733, 690. 
HRMS (EI) for C16H21N3O2S2 (351.1075) [M]+:351.1061. 
 
Synthesis of 2-(benzo[b]thiophen-3-yl)-3-(trimethylsilyl)pyridine (34s): 
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A solution of 32w in THF (1.0 mmol, 2.0 equiv, 0.8 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35a (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 24 h before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34s as a yellow oil. 
 
Isolated yield: with FeBr3: 64% (90 mg). 
                         with CoCl2: 66% (93 mg). 
Reaction time: 24 h. 
Solvent for purification: 9:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.00 (s, 9 H), 7.28 - 7.42 (m, 4 H), 7.49 - 7.55 (m, 1 H), 
7.87 - 7.93 (m, 1 H), 7.99 (dt, J=7.74, 1.52 Hz, 1 H), 8.72 (dt, J=3.04, 1.52 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -0.15 (s, 1 C), 121.89 (s, 1 C), 122.43 (s, 1 C), 123.43 (s, 
1 C), 124.42 (s, 1 C), 124.55 (s, 1 C), 125.39 (s, 1 C), 135.44 (s, 1 C), 138.94 (s, 1 C), 139.48 
(s, 1 C), 139.68 (s, 1 C), 143.21 (s, 1 C), 149.46 (s, 1 C), 159.75 (s, 1 C). 
MS (70 eV, EI) m/z (%): 283 (36), 268 (100), 250 (10), 227 (21), 126 (14). 
IR ATR ν (cm-1): 3051, 3028, 2952, 2896, 1564, 1550, 1458, 1431, 1399, 1338, 1262, 1248, 
1221, 1041, 953, 833, 797, 782, 752, 731, 712, 696. 
HRMS (EI) for C16H17NSSi (283.0851) [M]+:283.0840. 
 
Synthesis of 2-(benzo[b]thiophen-2-yl)-3-(trimethylsilyl)pyridine (34t): 
 
 
A solution of 32x in THF (1.0 mmol, 2.0 equiv, 0.8 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35a (0.5 mmol, 1.0 equiv) in tBuOMe   
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(2.5 mL) at 25 °C. The suspension was stirred at 50 °C for 12 h (for FeBr3) or at 25 °C for   
12 h (for CoCl2) before being quenched with NaHCO3 sat. aq. The mixture was diluted with 
CH2Cl2 and an EDTA (1.0 M, H2O) solution was added. The mixture was stirred at 25 °C for 
15 min, before being filtered through a pad of Celite®. After washing the pad of Celite® with 
CH2Cl2, NaCl sat. aq. was added, and the mixture was extracted with CH2Cl2. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 34t as a yellow oil. 
 
Isolated yield: with FeBr3: 61% (86 mg). 
                         with CoCl2: 66% (93 mg). 
Reaction time: for FeBr3: 12 h at 50 °C. 
                          for CoCl2: 12 h at 25 °C. 
Solvent for purification: 4:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.23 (s, 9 H), 7.25 - 7.30 (m, 1 H), 7.35 - 7.41 (m, 2 H), 
7.42 (s, 1 H), 7.78 - 7.84 (m, 1 H), 7.86 - 7.91 (m, 1 H), 7.96 (dd, J=9.40, 1.11 Hz, 1 H), 8.66 
(dd, J=3.04, 1.11 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 0.28 (s, 1 C), 122.01 (s, 1 C), 122.29 (s, 1 C), 123.88 (s, 
1 C), 124.20 (s, 1 C), 124.37 (s, 1 C), 124.71 (s, 1 C), 134.24 (s, 1 C), 139.61 (s, 1 C), 140.62 
(s, 1 C), 143.54 (s, 1 C), 145.80 (s, 1 C), 149.23 (s, 1 C), 158.26 (s, 1 C). 
MS (70 eV, EI) m/z (%): 283 (32), 270 (10), 268 (100), 252 (8), 238 (19), 127 (7). 
IR ATR ν (cm-1): 3052, 3027, 2953, 2896, 1561, 1548, 1458, 1391, 1248, 1166, 1156, 1129, 
1041, 958, 835, 829, 798, 783, 743, 725, 709, 685. 
HRMS (EI) for C16H17NSSi (283.0851) [M]+:283.0837. 
 
Synthesis of 2-(4-methoxyphenyl)-4-((trimethylsilyl)ethynyl)pyridine (34u): 
N
TMS
OMe
 
 
A solution of 32i in THF (1.0 mmol, 2.0 equiv, 1.3 M) was added dropwise to a suspension of 
FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35r (0.5 mmol, 1.0 equiv) in tBuOMe   
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(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34u as a slightly yellow oil. 
 
Isolated yield: with FeBr3: 38% (53 mg). 
                         with CoCl2: 62% (87 mg). 
Reaction time: 30 min. 
Solvent for purification: 8:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.29 (s, 9 H), 3.86 (s, 3 H), 6.98 (dd, J=8.82, 1.19 Hz, 2 
H), 7.18 (dt, J=5.01, 1.43 Hz, 1 H), 7.70 (d, J=0.72 Hz, 1 H), 7.95 (dd, J=8.58, 1.19 Hz, 2 H), 
8.58 (d, J=5.01 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -0.26 (s, 1 C), 55.34 (s, 1 C), 99.26 (s, 1 C), 102.51 (s, 1 
C), 114.12 (s, 1 C), 122.00 (s, 1 C), 123.33 (s, 1 C), 128.17 (s, 1 C), 131.31 (s, 1 C), 131.72 
(s, 1 C), 149.43 (s, 1 C), 157.15 (s, 1 C), 160.68 (s, 1 C). 
MS (70 eV, EI) m/z (%): 281 (68), 266 (100), 251 (6), 223 (8), 133 (12). 
IR ATR ν (cm-1): 2958, 2900, 2837, 2160, 1609, 1592, 1578, 1535, 1514, 1466, 1422, 1385, 
1274, 1247, 1219, 1196, 1174, 1112, 1031, 890, 839, 826, 800, 758, 728, 700. 
HRMS (EI) for C17H19NOSi (281.1236) [M]+:281.1220. 
 
Synthesis of 3-(but-3-en-1-yl)-2-phenylpyridine (34v): 
 
 
A solution of 32a in THF (1.0 mmol, 2.0 equiv, 1.7 M) was added dropwise to a suspension 
of FeBr3 (4.4 mg, 0.015 mmol, 0.03 equiv) or CoCl2 (1.9 mg, 0.015 mmol, 0.03 equiv), 
isoquinoline (6.5 mg, 0.05 mmol, 0.10 equiv), and 35s (0.5 mmol, 1.0 equiv) in tBuOMe   
(2.5 mL) at 25 °C. The suspension was stirred at 25 °C for 1 h before being quenched with 
NaHCO3 sat. aq. The mixture was diluted with CH2Cl2 and an EDTA (1.0 M, H2O) solution 
was added. The mixture was stirred at 25 °C for 15 min, before being filtered through a pad of 
Celite®. After washing the pad of Celite® with CH2Cl2, NaCl sat. aq. was added, and the 
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mixture was extracted with CH2Cl2. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 34v as a colorless oil. 
 
Isolated yield: with FeBr3: 62% (65 mg). 
                         with CoCl2: 78% (81 mg). 
Reaction time: 1 h. 
Solvent for purification: 4:1 i-hexane/ethyl acetate + 0.5 % triethylamine. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.18 - 2.34 (m, 2 H), 2.71 - 2.83 (m, 2 H), 4.81 - 5.02 
(m, 2 H), 5.63 - 5.79 (m, 1 H), 7.21 - 7.28 (m, 1 H), 7.36 - 7.52 (m, 5 H), 7.61 (dd, J=7.88, 
1.80 Hz, 1 H), 8.53 (dd, J=4.70, 1.66 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 31.81 (s, 1 C), 34.57 (s, 1 C), 115.34 (s, 1 C), 122.13 (s, 
1 C), 127.84 (s, 1 C), 128.17 (s, 1 C), 128.78 (s, 1 C), 129.09 (s, 1 C), 134.60 (s, 1 C), 137.30 
(s, 1 C), 140.62 (s, 1 C), 146.97 (s, 1 C), 158.97 (s, 1 C). 
MS (70 eV, EI) m/z (%): 209 (42), 208 (51), 180 (15), 168 (25). 167 (100),  
IR ATR ν (cm-1): 3060, 3027, 2977, 2925, 2860, 1640, 1579, 1564, 1495, 1453, 1433, 1421, 
1019, 995, 912, 791, 749, 732, 699. 
HRMS (EI) for C15H15N (209.1204) [M]+:208.1126. 
 
 
7. Efficient Chromium(II)-Catalyzed Cross-Coupling Reactions 
Between Csp2-Centers 
7.1. Preparation of the Title Compounds Using TP4 
 
Synthesis of 2-phenylpyridine (33a): 
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 31a (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
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filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 33a as a colorless oil. 
 
Isolated yield: 90% (140 mg)  
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.23 (m, 1 H), 7.45 (m, 3 H), 7.75 (m, 2 H), 8.01 (m, 2 
H), 8.70 (d, J=4.7 Hz, 1 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 120.6, 122.1, 126.9, 128.7, 128.9, 136.8, 139.2, 149.5, 
157.4. 
MS (70 eV, EI) m/z (%): 155 (100) [M]+, 154 (60), 128 (10), 127 (10), 77 (9), 59 (10), 43 
(7). 
IR ATR ν (cm-1): 3062, 3036, 3008, 2927, 1586, 1580, 1564, 1468, 1449, 1424, 1293, 1152, 
1074, 1020, 988, 800, 737, 692. 
HRMS (EI) for C11H9N (155.1735) [M]+: 155.1731. 
 
Synthesis of 3-(but-3-en-1-yl)-2-phenylpyridine (34v): 
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35s (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 34v as a colorless oil. 
 
Isolated yield: 95% (199 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.18 - 2.32 (m, 2 H), 2.68 - 2.84 (m, 2 H), 4.86 - 5.00 
(m, 2 H), 5.63 - 5.80 (m, 1 H), 7.21 (dd, J=7.76, 4.77 Hz, 1 H), 7.32 - 7.54 (m, 5 H), 7.57 - 
7.64 (m, 1 H), 8.53 (dd, J=4.86, 1.31 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: 31.8, 34.6, 115.4, 122.1, 127.9, 128.2, 128.8, 134.6, 
137.3, 140.6, 147.0, 159.0. 
MS (70 eV, EI) m/z (%): 209 (42), 208 (51), 180 (15), 168 (25). 167 (100). 
IR ATR ν (cm-1): 3060, 3027, 2977, 2925, 2860, 1640, 1579, 1564, 1495, 1453, 1433, 1421, 
1019, 995, 912, 791, 749, 732, 699. 
HRMS (EI) for C15H15N (209.1204) [M]+:209.1191. 
 
Synthesis of 4-(3-(4-chlorophenyl)pyridin-2-yl)-N,N-dimethylaniline (34b): 
 
 
A solution of 32n in THF (1.2 mmol, 1.2 equiv, 1.2 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35b (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 90 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 34b as a slightly yellow oil. 
 
Isolated yield: 80% (247 mg). 
Reaction time: 90 min. 
Solvent for purification: dichloromethane/ethyl acetate 9:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.95 (s, 6 H), 6.59 (d, J=8.85 Hz, 2 H), 7.08 - 7.35 (m, 7 
H), 7.61 (dd, J=7.74, 1.66 Hz, 1 H), 8.65 (dd, J=4.70, 1.66 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 40.3, 111.6, 120.9, 127.5, 128.6, 130.8, 130.9, 132.9, 
133.9, 138.3, 139.3, 148.5, 150.1, 157.2. 
MS (70 eV, EI) m/z (%): 308 (100), 307 (45), 291 (19), 153 (9), 136 (12). 
IR ATR ν (cm-1): 3037, 2885, 2855, 2801, 1606, 1576, 1524, 1489, 1425, 1394, 1353, 1193, 
1168, 1090, 999, 945, 834, 821, 799, 778, 758, 728, 718, 704. 
HRMS (EI) for C19H17ClN2 (308.1080) [M]+: 308.1060. 
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Synthesis of 3-chloro-2-(4-(trifluoromethyl)phenyl)pyridine (37a): 
 
 
A solution of 32y in THF (1.2 mmol, 1.2 equiv, 0.9 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35t (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 37a as a white solid. 
 
Isolated yield: 76% (195 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
m.p.: 53.0-54.0 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.27 (dd, J=8.02, 4.70 Hz, 1 H), 7.69 - 7.78 (m, 2 H), 
7.79 - 7.92 (m, 3 H), 8.62 (dd, J=4.70, 1.66 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 123.7, 124.0 (q, J=272.1 Hz), 125.0 (q, J=3.9 Hz), 
129.8, 130.3, 130.8 (q, J=32.5 Hz), 138.3, 141.6, 147.8, 155.1. 
MS (70 eV, EI) m/z (%): 257 (46), 237 (28), 222 (98), 81 (13), 71 (16), 43 (100). 
IR ATR ν (cm-1): 3052, 1616, 1564, 1436, 1428, 1402, 1324, 1164, 1132, 1108, 1090, 1066, 
1040, 1026, 1012, 848, 792, 768, 758, 736, 690. 
HRMS (EI) for C12H7ClF3N (257.0219) [M]+: 257.0219. 
 
Synthesis of 4-(5-fluoropyridin-2-yl)phenyl pivalate (37b): 
 
 
A solution of 32l in THF (1.2 mmol, 1.2 equiv, 0.8 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35u (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
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concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 37b as a white solid. 
 
Isolated yield: 66% (180 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
m.p.: 76.6-76.8 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.38 (s, 9 H), 7.16 (m, 2 H), 7.46 (td, J=8.43, 3.32 Hz, 1 
H), 7.69 (dd, J=8.85, 4.42 Hz, 1 H), 7.95 (m, 2 H), 8.53 (d, J=2.76 Hz, 1 H) 
13C NMR (75 MHz, CDCl3) δ/ppm: 27.1, 39.1, 121.1, 121.2, 121.8, 123.5, 123.7, 127.8, 
135.8, 137.5, 137.8, 151.8, 152.9, 152.9, 157.1, 160.5, 176.9. 
MS (70 eV, EI) m/z (%): 273 (9), 190 (11), 189 (100), 160 (4), 159 (3). 
IR ATR ν (cm-1): 2982, 2966, 2932, 2908, 2890, 1750, 1742, 1600, 1470, 1416, 1396, 1382, 
1368, 1276, 1264, 1224, 1198, 1166, 1112, 1026, 1010, 974, 960, 942, 924, 898, 834, 826, 
810, 796, 750.  
HRMS (EI) for C16H16FNO2 (273.1165) [M]+: 273.1154. 
 
Synthesis of 2-(benzo[d][1,3]dioxol-5-yl)-6,7-dimethoxy-4-methylquinoline (37c): 
 
 
A solution of 32k in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35j (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 1 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 37c as a yellow solid. 
 
Isolated yield: 74% (239 mg). 
Reaction time: 1 h. 
Solvent for purification: i-hexane/ethyl acetate 3:1 (+0.5% NEt3). 
m.p.: 195-221 °C. 
 185 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.67 (s, 3 H), 4.04 (d, J=5.53 Hz, 6 H), 6.02 (s, 2 H), 
6.92 (d, J=8.29 Hz, 1 H), 7.13 (s, 1 H), 7.50 (d, J=5.81 Hz, 2 H), 7.59 (dd, J=8.16, 1.80 Hz, 1 
H), 7.65 (d, J=1.94 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 19.2, 56.0, 56.1, 101.2, 101.5, 107.7, 108.4, 108.6, 
117.9, 121.3, 122.2, 134.3, 143.0, 144.8, 148.2, 148.4, 149.3, 152.2, 154.5. 
MS (70 eV, EI) m/z (%): 323 (100), 308 (18), 280 (15), 278 (6), 161 (9). 
IR ATR ν (cm-1): 2922, 2898, 2834, 1618, 1604, 1592, 1494, 1486, 1476, 1466, 1450, 1432, 
1416, 1382, 1352, 1336, 1240, 1222, 1206, 1166, 1138, 1114, 1066, 1048, 1028, 998, 926, 
876, 862, 852, 834, 808. 
HRMS (EI) for C19H17NO4 (323.1158) [M]+: 323.1149. 
 
Synthesis of N,N-dimethyl-4-(2-phenylquinolin-4-yl)aniline (37d): 
N
N
 
 
A solution of 32n in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35v (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 37d as a red solid. 
 
Isolated yield: 78% (253 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
m.p.: 152.0-154.0 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.06 (s, 6 H), 6.89 (dd, J=8.71, 1.80 Hz, 2 H), 7.43 - 
7.59 (m, 6 H), 7.70 - 7.77 (m, 1 H), 7.83 (d, J=1.66 Hz, 1 H), 8.09 (d, J=8.29 Hz, 1 H), 8.19 - 
8.30 (m, 3 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 40.4, 112.2, 113.1, 119.1, 125.9, 126.1, 127.0, 127.6, 
128.8, 129.2, 129.3, 130.0, 130.6, 139.9, 148.9, 149.5, 150.6, 156.9. 
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MS (70 eV, EI) m/z (%): 324 (100), 323 (42), 307 (16), 280 (13), 240 (63), 225 (23), 161 
(15), 119 (14). 
IR ATR ν (cm-1): 2922, 2866, 2806, 1610, 1592, 1542, 1524, 1504, 1492, 1460, 1442, 1424, 
1414, 1402, 1356, 1226, 1196, 1162, 1138, 1120, 1064, 944, 818, 808, 788, 772, 762, 694, 
680. 
HRMS (EI) for C23H20N2 (324.1626) [M]+: 324.1621. 
 
Synthesis of 4,6-dimethyl-2-(4-(trifluoromethoxy)phenyl)pyrimidine (37e): 
 
 
A solution of 32z in THF (1.2 mmol, 1.2 equiv, 0.8 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 31h (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 2 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 37e as a white solid. 
 
Isolated yield: 71% (190 mg). 
Reaction time: 2 h. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
m.p.: 66.0-67.4 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 2.53 (s, 6 H), 6.93 (s, 1 H), 7.29 (d, J=8.29 Hz, 2 H), 
8.48 (d, J=8.57 Hz, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 24.1, 118.2, 120.5, 120.5 (q, J=257.6 Hz), 129.9, 136.6, 
150.9, 162.8, 166.9. 
MS (70 eV, EI) m/z (%): 269 (13), 268 (100), 253 (12), 189 (15), 187 (20). 
IR ATR ν (cm-1): 1602, 1582, 1544, 1504, 1434, 1368, 1288, 1256, 1196, 1148, 1102, 1030, 
1012, 958, 920, 874, 866, 852, 810, 786, 734, 680. 
HRMS (EI) for C13H11F3N2O (268.0823) [M]+: 268.0803. 
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Synthesis of 2-(3-((tert-butyldimethylsilyl)oxy)phenyl)-4-(4-(trifluoromethyl)-phenyl)-
pyrimidine (37f): 
N
N
CF3
OTBS
 
 
A solution of 32p in THF (1.2 mmol, 1.2 equiv, 1.0 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 35m (1 mmol,            
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before 
being quenched with brine and extracted with EtOAc. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield 37f as a slightly yellow oil. 
 
Isolated yield: 80% (366 mg)  
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.29 (s, 6 H), 1.05 (s, 9 H), 7.02 (dd, J=7.60, 2.07 Hz, 1 
H), 7.40 (t, J=7.88 Hz, 1 H), 7.63 (d, J=5.25 Hz, 1 H), 7.81 (m, J=8.02 Hz, 2 H), 8.08 (dd, 
J=2.21, 1.66 Hz, 1 H), 8.17 - 8.22 (m, J=7.78, 1.11, 0.81, 0.81 Hz, 1 H), 8.33 (m, J=8.02 Hz, 
2 H), 8.90 (d, J=5.25 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -4.3, 18.3, 25.7, 107.6, 108.4, 112.6, 114.8, 119.9, 121.4, 
122.9, 123.9 (q, J=272.6 Hz), 125.9 (q, J=3.9 Hz), 127.6, 129.6, 129.9, 132.4, 140.3, 156.1, 
156.7, 158.0, 162.5, 164.5. 
MS (70 eV, EI) m/z (%): 430 (7), 374 (26), 373 (100), 224 (4), 167 (23). 
IR ATR ν (cm-1): 2958, 2932, 2860, 1712, 1566, 1550, 1452, 1426, 1410, 1382, 1362, 1326, 
1284, 1272, 1256, 1220, 1168, 1146, 1128, 1094, 1070, 950, 838, 810, 784. 
HRMS (EI) for C23H25F3N2OSi (430.1688) [M]+: 430.1682. 
 
Synthesis of 2-(4-methoxyphenyl)pyrazine (37g): 
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A solution of 32i in THF (1.2 mmol, 1.2 equiv, 1.3 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 31j (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 37g as a white solid. 
 
Isolated yield: 72% (134 mg). 
Reaction time: 30 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
m.p.: 93.8-95.2 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.87 (s, 3 H), 6.98 - 7.07 (m, 2 H), 7.95 - 8.01 (m, 2 H), 
8.43 (d, J=2.49 Hz, 1 H), 8.58 (dd, J=2.49, 1.38 Hz, 1 H), 8.97 (d, J=1.38 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.4, 114.5, 128.3, 128.8, 141.5, 141.9, 144.0, 152.5, 
161.2. 
MS (70 eV, EI) m/z (%): 186 (19), 149 (7), 133 (7), 109 (6), 83 (8), 71 (8), 69 (24). 
IR ATR ν (cm-1): 2956, 2914, 2836, 1604, 1586, 1516, 1474, 1458, 1424, 1400, 1302, 1246, 
1178, 1148, 1108, 1078, 1034, 1014, 834, 818, 750. 
HRMS (EI) for C11H10N2O (186.0793) [M]+: 186.0785. 
 
Synthesis of Ethyl 2'-benzoyl-[1,1'-biphenyl]-3-carboxylate (41a): 
 
 
A solution of 39 in THF (1.2 mmol, 1.2 equiv, 0.8 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 38 (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 41a as a white solid. 
 
Isolated yield: 79% (261 mg). 
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Reaction time: 15 min. 
Solvent for purification: i-hexane/diethyl ether 9:1. 
m.p.: 65.1-66.7 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.98 (t, J=1.7 Hz, 1 H), 7.85 (dt, J=7.8, 1.5 Hz, 1 H), 
7.69 – 7.38 (m, 8 H), 7.32 - 7.23 (m, 3 H), 4.32 (q, J=7.2 Hz, 2 H), 1.33 (t, J=7.1 Hz, 3 H).  
13C NMR (75 MHz, CDCl3) δ/ppm: 198.3, 166.1, 140.3, 140.2, 138.9, 137.3, 133.3, 132.9, 
130.5, 130.5, 130.1, 129.9, 129.8, 128.9, 128.4, 128.2, 128.1, 127.4, 60.9, 14.2. 
MS (70 eV, EI) m/z (%): 330 (100), 285 (37), 257 (53), 253 (30), 207 (97), 152 (30), 105 
(83), 77 (45). 
IR ATR ν (cm-1): 3054, 2971, 2912, 1714, 1662, 1595, 1580, 1567, 1447, 1440, 1428, 1306, 
1283, 1264, 1238, 1180, 1167, 1153, 1120, 1112, 1106, 1075, 1054, 1033, 1023, 1000, 937, 
923, 894, 882, 861, 805, 768, 747, 712, 704, 695, 669. 
HRMS (EI) for C22H18O3 (330.1256) [M]+: 330.1247. 
 
Synthesis of 2'-benzoyl-[1,1'-biphenyl]-3-carbonitrile (41b):  
 
 
A solution of 40 in THF (0.7 mmol, 0.7 equiv, 0.5 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 38 (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 2 h before being quenched with 
brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 41b as colorless oil. 
 
Isolated yield: 71% (261 mg). 
Reaction time: 2 h. 
Solvent for purification: i-hexane/ethyl acetate 95:5. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.68 – 7.51 (m, 6H), 7.50 – 7.41 (m, 4H), 7.39 – 7.22 
(m, 3H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 197.8, 141.5, 138.9, 138.8, 137.2, 133.4, 133.3, 132.2, 
130.9, 130.8, 130.1, 129.9, 129.2, 129.0, 128.4, 128.0, 118.5, 112.5. 
MS (70 eV, EI) m/z (%): 283 (98), 282 (28), 206 (79), 151 (25), 105 (100), 77 (53). 
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IR ATR ν (cm-1): 3061, 3028, 2230, 1661, 1595, 1579, 1470, 1448, 1412, 1314, 1284, 1276, 
1264, 1177, 1152, 1110, 1074, 1026, 1000, 928, 905, 846, 802, 757, 727, 707, 690. 
HRMS (EI) for C20H13NO (283.0997) [M]+: 283.0988. 
 
Synthesis of phenyl(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methanone (41c):  
 
 
A solution of 32y in THF (1.2 mmol, 1.2 equiv, 0.9 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 38 (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 41c as colorless oil. 
 
Isolated yield: 93% (305 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 96:4. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.71 - 7.66 (m, 2 H), 7.65 - 7.43 (m, 7 H), 7.42 - 7.26 
(m, 4 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 198.1, 143.9, 139.9, 138.9, 137.3, 133.2, 130.6, 130.1, 
129.9, 129.4 (q, J=32.5 Hz), 129.3, 128.9, 128.3, 127.7, 125.2 (q, J=3.9 Hz), 124.1 (q, 
J=272.1 Hz). 
MS (70 eV, EI) m/z (%): 326 (100), 325 (27), 249 (91), 201 (34), 152 (24), 105 (74), 77 (42). 
IR ATR ν (cm-1): 3063, 1663, 1618, 1597, 1581, 1450, 1405, 1322, 1281, 1260, 1162, 1120, 
1114, 1068, 1020, 1006, 926, 843, 806, 764, 737, 709, 698. 
HRMS (EI) for C20H13F3O (326.0918) [M]+: 326.0904. 
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Synthesis of (4'-(dimethylamino)-[1,1'-biphenyl]-2-yl)(phenyl)methanone  (41d): 
 
 
A solution of 32n in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 38 (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 41d as an orange solid. 
 
Isolated yield: 94% (282 mg). 
Reaction conditions: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 97:3 (+ 4% Et3N). 
m.p.: 112.4-113.8 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.75 - 7.68 (m, 2 H), 7.58 - 7.45 (m, 3 H), 7.44 - 7.35 
(m, 2 H), 7.33 - 7.24 (m, 2 H), 7.21 - 7.14 (m, 2 H), 6.62 - 6.53 (m, 2 H), 2.87 (s, 6 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 199.3, 149.7, 141.2, 138.6, 137.5, 132.7, 130.2, 129.9, 
129.8, 129.8, 128.6, 128.1, 128.1, 126.0, 112.3, 40.4. 
MS (70 eV, EI) m/z (%): 302 (21), 301 (100), 300 (36), 77 (12). 
IR ATR ν (cm-1): 2924, 2854, 2802, 1663, 1611, 1594, 1580, 1570, 1525, 1479, 1447, 1349, 
1315, 1293, 1281, 1247, 1222, 1204, 1168, 1161, 1150, 1130, 1104, 1062, 1028, 945, 938, 
932, 921, 879, 823, 804, 775, 766, 726, 720, 703, 690, 676. 
HRMS (EI) for C21H19NO (301.1467) [M]+: 301.1452. 
 
Synthesis of (2-(benzo[b]thiophen-3-yl)phenyl)(phenyl)methanone (41e):  
 
 
A solution of 32w in THF (1.2 mmol, 1.2 equiv, 0.9 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 38 (1 mmol, 1.0 equiv) 
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in THF (5 mL) at 25 °C. The suspension was stirred at 50 °C for 2 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 41e as a red solid. 
 
Isolated yield: 89% (305 mg). 
Reaction conditions: 2 h, 50 °C. 
Solvent for purification: i-hexane/ethyl acetate 96:4. 
m.p.: 121.2-123.1 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.75 - 7.49 (m, 8 H), 7.38 - 7.20 (m, 3 H), 7.18 (s, 1 H), 
7.05 - 7.13 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 198.5, 140.1, 139.9, 138.3, 137.2, 135.6, 134.5, 132.4, 
130.4, 130.3, 129.1, 129.1, 127.8, 127.7, 126.0, 124.3, 124.3, 122.7, 122.5. 
MS (70 eV, EI) m/z (%): 314 (100), 313 (21), 285 (19), 234 (76), 165 (30), 105 (21), 77 (27). 
IR ATR ν (cm-1): 1663, 1593, 1577, 1448, 1424, 1316, 1285, 1270, 1255, 1210, 1183, 1163, 
1147, 1062, 944, 926, 836, 808, 764, 758, 733, 717, 704. 
HRMS (EI) for C21H14OS (314.0765) [M]+: 314.0755. 
 
Synthesis of [1,1'-biphenyl]-2-yl(6-chloropyridin-3-yl)methanone (43): 
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 42 (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 43 as white crystals. 
 
Isolated yield: 72% (211 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/diethyl ether 2:1. 
m.p.: 108.6-111.2 °C. 
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1H NMR (300 MHz, CDCl3) δ/ppm: 8.42 (dd, J=2.5, 0.6 Hz, 1 H), 7.81 (dd, J=8.3, 2.5 Hz, 1 
H), 7.68 - 7.48 (m, 4 H), 7.24 - 7.12 (m, 6 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 196.3, 154.8, 151.2, 141.2, 139.6, 138.9, 137.6, 131.8, 
131.4, 130.1, 129.1, 129.0, 128.6, 127.8, 127.7, 123.8. 
MS (70 eV, EI) m/z (%): 293 (97), 292 (100), 266 (11), 264 (26), 182 (10), 153 (30), 152 
(50), 151 (13), 140 (18). 
IR ATR ν (cm-1): 1671, 1594, 1576, 1564, 1478, 1460, 1448, 1433, 1376, 1363, 1289, 1276, 
1266, 1251, 1139, 1115, 1100, 1076, 1052, 1041, 1020, 1008, 970, 961, 926, 918, 884, 844, 
786, 774, 752, 744, 715, 699. 
HRMS (EI) for C18H12ClNO (293.0613) [M]+: 293.0569. 
 
Synthesis of thiophen-2-yl(2-(thiophen-3-yl)phenyl)methanone (46):  
 
 
A solution of 45 in THF (1.2 mmol, 1.2 equiv, 0.8 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 44 (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 46 as a brownish solid. 
 
Isolated yield: 90% (165 mg). 
Reaction conditions: 15 min. 
Solvent for purification: i-hexane/diethyl ether 9:1. 
m.p.: 68.8-70.2 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.65 - 7.47 (m, 4 H), 7.45 - 7.38 (m, 1 H), 7.28 - 7.17 
(m, 3 H), 7.09 (dd, J=4.8, 1.5 Hz, 1 H), 6.94 (dd, J=4.8, 3.7 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 190.8, 144.5, 140.5, 138.7, 135.2, 134.8, 134.7, 130.3, 
129.7, 128.2, 128.1, 127.9, 127.0, 125.9, 123.4. 
MS (70 eV, EI) m/z (%): 270 (100), 269 (33), 241 (32), 237 (85), 115 (31), 111 (38). 
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IR ATR ν (cm-1): 3094, 2923, 2853, 1628, 1595, 1567, 1511, 1481, 1443, 1407, 1366, 1354, 
1295, 1268, 1258, 1231, 1195, 1164, 1149, 1106, 1085, 1052, 1042, 1026, 889, 859, 842, 804, 
795, 779, 756, 748, 728, 723, 706, 697, 669. 
HRMS (EI) for C15H10OS2 (270.0173) [M]+: 270.0169. 
 
7.2. Preparation of the Title Compounds Using TP5 
 
Synthesis of [1,1'-biphenyl]-2-carbaldehyde (48a):  
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and imine 47 (1 mmol,     
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before 
being quenched with an aq. solution of HCl (2 M) and extracted with EtOAc. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 48a as a yellow oil. 
 
Isolated yield: 84% (152 mg). 
Reaction conditions: 15 min. 
Solvent for purification: i-hexane/diethyl ether 9:1. 
1H NMR (300 MHz, CDCl3) δ/ppm: 10.00 (d, J=0.8 Hz, 1 H), 8.04 (dd, J=7.7, 1.4 Hz, 1 H), 
7.64 (td, J=7.5, 1.5 Hz, 1 H), 7.52 - 7.43 (m, 5 H), 7.41 - 7.37 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 192.4, 146.0, 137.7, 133.7, 133.5, 130.8, 130.1, 128.4, 
128.1, 127.8, 127.6. 
MS (70 eV, EI) m/z (%): 182 (72), 181 (100), 154 (19), 153 (41), 152 (49), 76 (13). 
IR ATR ν (cm-1): 3060, 3028, 2845, 2752, 1688, 1655, 1596, 1498, 1473, 1453, 1437, 1392, 
1301, 1252, 1194, 1160, 1101, 1075, 1048, 1033, 1008, 919, 827, 778, 756, 745, 700. 
HRMS (EI) for C13H10O (182.0732) [M]+: 182.0701. 
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Synthesis of 4'-methoxy-[1,1'-biphenyl]-2-carbaldehyde (48b):  
 
 
A solution of 32i in THF (1.2 mmol, 1.2 equiv, 1.3 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and imine 47 (1 mmol,          
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before 
being quenched with an aq. solution of HCl (2 M) and extracted with EtOAc. The organic 
layer was dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, 
which was purified by column chromatography to yield 48b as a yellow oil. 
 
Isolated yield: 69% (152 mg). 
Reaction conditions: 15 min. 
Solvent for purification: i-hexane/diethyl ether 95:5. 
1H NMR (300 MHz, CDCl3) δ/ppm: 10.00 (t, J=0.7 Hz, 1 H), 8.00 (dt, J=7.8, 0.7 Hz, 1 H), 
7.65 - 7.57 (m, 1 H), 7.49 - 7.40 (m, 2 H), 7.34 - 7.25 (m, 2 H), 7.04 - 6.97 (m, 2 H), 3.87 (d, 
J=0.8 Hz, 3 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 192.6, 159.7, 145.6, 133.8, 133.5, 131.3, 130.8, 130.0, 
127.6, 127.3, 113.9, 55.4. 
MS (70 eV, EI) m/z (%): 212 (100), 211 (30), 197 (20), 181 (27), 169 (59), 168 (19), 152 
(21), 140 (20), 139 (51), 115 (57). 
IR ATR ν (cm-1): 3031, 2957, 2935, 2837, 2750, 1688, 1657, 1609, 1596, 1578, 1514, 1474, 
1449, 1442, 1391, 1297, 1271, 1243, 1192, 1177, 1160, 1112, 1100, 1047, 1033, 1016, 1000, 
833, 803, 763, 742, 713. 
HRMS (EI) for C14H12O2: (212.0837) [M]+: 212.0838. 
 
Synthesis of 2-(thiophen-3-yl)benzaldehyde (48c):  
 
 
A solution of 45 in THF (1.2 mmol, 1.2 equiv, 0.8 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and imine 47 (1 mmol,          
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1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 16 h before being 
quenched with an aq. solution of HCl (2 M) and extracted with EtOAc. The organic layer was 
dried with MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which 
was purified by column chromatography to yield 48c as a yellow oil. 
 
Isolated yield: 75% (140 mg). 
Reaction conditions: 16 h. 
Solvent for purification: i-hexane/diethyl ether 95:5. 
1H NMR (300 MHz, CDCl3) δ/ppm: 10.10 (d, J=0.6 Hz, 1 H), 8.03 - 7.97 (m, 1 H), 7.65 - 
7.58 (m, 1 H), 7.51 - 7.42 (m, 3 H), 7.29 (dd, J=2.9, 1.2 Hz, 1 H), 7.21 - 7.17 (m, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 192.3, 140.4, 138.3, 134.0, 133.6, 130.6, 129.3, 127.8, 
127.6, 126.3, 125.0. 
MS (70 eV, EI) m/z (%): 188 (100), 160 (100), 159 (24), 158 (21), 116 (20), 115 (85), 43 
(31). 
IR ATR ν (cm-1): 3099, 2847, 2750, 1683, 1596, 1570, 1474, 1447, 1406, 1389, 1362, 1270, 
1243, 1194, 1160, 1100, 1082, 1047, 1028, 859, 830, 813, 792, 756, 731, 684, 653. 
HRMS (EI) for C11H8OS: (188.0296) [M]+: 188.0300. 
 
7.3. Preparation of the Title Compounds Using TP6 
 
Synthesis of (E)-N,N-dimethyl-4-(oct-1-en-1-yl)aniline (50a): 
 
 
A solution of 32n in THF (1.5 mmol, 1.5 equiv, 1.2 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and alkenyl iodide 49         
(1 mmol, 1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min 
before being quenched with brine and extracted with EtOAc. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield 50a as a slightly yellow oil. 
 
Isolated yield: 70% (162 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 9:1. 
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1H NMR (300 MHz, CDCl3) δ/ppm: 0.84 - 0.96 (m, 3 H), 1.23 - 1.52 (m, 8 H), 2.10 - 2.26 
(m, 2 H), 2.95 (s, 6 H), 5.97 - 6.10 (m, 1 H), 6.30 (d, J=16.03 Hz, 1 H), 6.66 - 6.74 (m, 2 H), 
7.21 - 7.29 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 14.1, 22.7, 28.9, 29.7, 31.8, 33.1, 40.7, 112.8, 126.7, 
127.2, 129.4, 149.6. 
MS (70 eV, EI) m/z (%): 232 (15), 231 (100), 161 (26), 160 (40), 145 (14), 134 (30). 
IR ATR ν (cm-1): 2954, 2923, 2871, 2852, 2801, 1610, 1519, 1480, 1466, 1454, 1444, 1348, 
1221, 1187, 1164, 1129, 1061, 961, 947, 831, 801, 725. 
HRMS (EI) for C16H25N (231.1987) [M]+: 231.1964. 
 
Synthesis of (E)-1-methoxy-4-(oct-1-en-1-yl)benzene (50b): 
 
 
A solution of 32i in THF (1.5 mmol, 1.5 equiv, 1.3 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and alkenyl iodide 49 (1 mmol, 
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before 
being quenched with brine and extracted with EtOAc. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield 50b as a colorless oil. 
 
Isolated yield: 75% (164 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 20:1. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.87 - 0.99 (m, 3 H), 1.28 - 1.52 (m, 8 H), 2.14 - 2.27 
(m, 2 H), 3.81 (s, 3 H), 6.04 - 6.17 (m, 1 H), 6.29 - 6.39 (m, 1 H), 6.85 (m, 2 H), 7.29 (m, 2 
H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 14.1, 22.7, 28.9, 29.5, 31.8, 33.0, 55.3, 113.9, 126.9, 
129.0, 129.1, 130.8, 158.6. 
MS (70 eV, EI) m/z (%): 218 (27), 148 (14), 147 (100), 134 (19), 121 (24), 115 (10), 91 (16).  
IR ATR ν (cm-1): 2955, 2924, 2871, 2854, 2836, 1608, 1510, 1465, 1441, 1287, 1244, 1174, 
1105, 1037, 963, 840, 803, 758, 724. 
HRMS (EI) for C15H22O (218.1671) [M]+: 218.1666. 
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Synthesis of (E)-tert-butyldimethyl(3-(oct-1-en-1-yl)phenoxy)silane (50c): 
 
 
A solution of 32p in THF (1.5 mmol, 1.5 equiv, 1.0 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and alkenyl iodide 49         
(1 mmol, 1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min 
before being quenched with brine and extracted with EtOAc. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield 50c as a colorless oil. 
 
Isolated yield: 80% (255 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.22 (s, 6 H), 0.87 - 0.97 (m, 3 H), 1.02 (s, 9 H), 1.22 - 
1.58 (m, 8 H), 2.22 (q, J=7.28 Hz, 2 H), 6.15 - 6.26 (m, 1 H), 6.30 - 6.38 (m, 1 H), 6.70 (dd, 
J=8.02, 2.21 Hz, 1 H), 6.94 - 7.00 (m, 1 H), 7.12 - 7.28 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -4.4, 14.1, 18.2, 22.6, 25.7, 28.9, 29.3, 31.8, 33.0, 117.5, 
118.5, 119.1, 120.1, 129.5, 131.3, 139.5, 155.8. 
MS (70 eV, EI) m/z (%): 318 (13), 262 (20), 261 (100), 163 (9), 151 (6). 
IR ATR ν (cm-1): 2956, 2928, 2857, 1597, 1578, 1490, 1472, 1464, 1439, 1277, 1252, 1170, 
1156, 1001, 965, 939, 916, 876, 837, 778, 713, 688, 665.  
HRMS (EI) for C20H34OSi (318.2379) [M]+: 318.2376. 
 
Synthesis of (E)-1-(dimethoxymethyl)-4-(oct-1-en-1-yl)benzene (50d): 
 
 
A solution of 32t in THF (1.5 mmol, 1.5 equiv, 0.9 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and alkenyl iodide 49 (1 mmol, 
1.0 equiv) in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before 
being quenched with brine and extracted with EtOAc. The organic layer was dried with 
MgSO4, filtered, and concentrated in vacuo to yield the crude compound, which was purified 
by column chromatography to yield 50d as a colorless oil. 
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Isolated yield: 69% (181 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 20:1. 
1H NMR (300 MHz, DMSO) δ/ppm: 0.81 - 0.87 (m, 3 H), 1.23 - 1.32 (m, 6 H), 1.36 - 1.45 
(m, 2 H), 2.15 (q, J=6.63 Hz, 2 H), 3.32 (s, 6 H), 5.33 (s, 1 H), 6.24 - 6.39 (m, 2 H), 7.28 (m, 
2 H), 7.36 (m, 2 H). 
13C NMR (75 MHz, DMSO) δ/ppm: 14.4, 22.5, 28.8, 29.2, 31.6, 32.9, 52.8, 102.9, 125.9, 
127.2, 129.6, 131.7, 137.1, 137.9. 
MS (70 eV, EI) m/z (%): 216 (24), 133 (11), 132 (100), 131 (30), 117 (66), 91 (24). 
IR ATR ν (cm-1): 2954, 2927, 2856, 1689, 1609, 1577, 1466, 1422, 1379, 1286, 1268, 1208, 
1170, 1107, 1016, 893, 856, 828, 804, 790, 762, 733, 724, 702. 
HRMS (EI) for C17H26O2 (262.1933) [M]+: 262.1916. 
 
7.4. Preparation of the Title Compounds Using TP7 and TP8 
 
Synthesis of 4-chloro-2-phenylpyridine (52a): 
 
N
Cl
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51a (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52a as a slightly yellow oil. 
 
Isolated yield: 80% (152 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
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1H NMR (300 MHz, CDCl3) δ/ppm: 7.21 - 7.29 (m, 1 H), 7.41 - 7.57 (m, 3 H), 7.74 (dd, 
J=1.94, 0.55 Hz, 1 H), 7.90 - 8.08 (m, 2 H), 8.59 (dd, J=5.25, 0.55 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 120.83 (s, 1 C), 122.27 (s, 1 C), 126.98 (s, 1 C), 128.85 
(s, 1 C), 129.60 (s, 1 C), 138.10 (s, 1 C), 144.74 (s, 1 C), 150.46 (s, 1 C), 158.98 (s, 1 C): 
MS (70 eV, EI) m/z (%): 189 (51) [M]+, 188 (14), 154 (27), 127 (12), 70 (11), 43 (100). 
IR ATR ν (cm-1): 3044, 2358, 1571, 1549, 1497, 1462, 1442, 1382, 1112, 1096, 1072, 
1053, 872, 823, 802, 771, 728, 703, 690, 668, 659. 
HRMS (EI) for C11H8ClN (189.0345) [M]+: 189.0337. 
 
Synthesis of 3-chloro-2-phenylpyridine (52b): 
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51b (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52b as a slightly yellow oil. 
 
Isolated yield: 76% (144 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.22 (dd, J=8.02, 4.70 Hz, 1 H), 7.43 - 7.53 (m, 3 H), 
7.72 - 7.84 (m, 3 H), 8.61 (dd, J=4.70, 1.38 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 123.02 (s, 1 C), 128.02 (s, 1 C), 128.81 (s, 1 C), 129.32 
(s, 1 C), 130.16 (s, 1 C), 138.06 (s, 1 C), 138.19 (s, 1 C), 147.55 (s, 1 C), 156.58 (s, 1 C). 
MS (70 eV, EI) m/z (%): 189 (22), 154 (50), 61 (18), 43 (100). 
IR ATR ν (cm-1): 3057, 3042, 2362, 1570, 1553, 1496, 1450, 1431, 1415, 1222, 1181, 1131, 
1089, 1075, 1031, 1016, 1002, 974, 918, 794, 786, 761, 737, 694, 681, 668, 659, 654. 
HRMS (EI) for C11H8ClN (189.0345) [M]+: 189.0344. 
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Synthesis of 5-chloro-2-phenylpyridine (52c): 
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51c (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52c as white crystals. 
 
Isolated yield: 87% (165 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
m.p.: 65.8-67.8 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.42 - 7.52 (m, 3 H), 7.66 - 7.69 (m, 1 H), 7.71 - 7.74 
(m, 1 H), 7.95 - 8.01 (m, 2 H), 8.65 (dd, J=2.34, 0.78 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 121.11 (s, 1 C), 126.79 (s, 1 C), 128.85 (s, 1 C), 129.28 
(s, 1 C), 130.59 (s, 1 C), 136.45 (s, 1 C), 138.16 (s, 1 C), 148.46 (s, 1 C), 155.53 (s, 1 C). 
MS (70 eV, EI) m/z (%): 191 (33), 189 (100), 154 (41), 127 (13). 
IR ATR ν (cm-1): 3062, 3037, 2360, 1574, 1554, 1460, 1456, 1442, 1436, 1419, 1365, 1290, 
1136, 1112, 1074, 1022, 1007, 991, 979, 929, 920, 853, 834, 774, 755, 730, 707, 690, 676, 
672, 668, 663, 658, 655, 653. 
HRMS (EI) for C11H8ClN (189.0345) [M]+: 189.0340. 
 
Synthesis of 4-chloro-3-(1,3-dioxolan-2-yl)-2-phenylpyridine (52d): 
N
Cl
O
O
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51d (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being 
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quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52d as a white solid. 
 
Isolated yield: 67% (175 mg). 
Reaction time: 30 min. 
Solvent for purification: i-hexane/ethyl acetate 4:1 (+0.5% NEt3). 
m.p.: 59.3-61.0 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.85 - 4.02 (m, 2 H), 4.02 - 4.20 (m, 2 H), 5.97 (s, 1 H), 
7.30 - 7.67 (m, 6 H), 8.54 (d, J=5.25 Hz, 1 H) 
13C NMR (75 MHz, CDCl3) δ/ppm: 65.82 (s, 1 C), 101.38 (s, 1 C), 124.97 (s, 1 C), 127.46 
(s, 1 C), 128.02 (s, 1 C), 128.54 (s, 1 C), 129.43 (s, 1 C), 139.06 (s, 1 C), 145.17 (s, 1 C), 
149.86 (s, 1 C), 162.12 (s, 1 C). 
MS (70 eV, EI) m/z (%): 218 (30), 216 (89), 191 (33), 189 (100), 183 (26), 154 (47). 
IR ATR ν (cm-1): 2971, 2894, 2362, 1559, 1552, 1452, 1446, 1379, 1222, 1171, 1103, 1057, 
1018, 973, 962, 938, 922, 862, 844, 838, 810, 792, 771, 763, 724, 707, 702, 685, 673, 668, 
661, 656, 653. 
HRMS (EI) for C14H12ClNO2 (261.0557) [M]+: 261.0554. 
 
Synthesis of 4-chloro-2-phenyl-3-(((tetrahydro-2H-pyran-2-yl)oxy)methyl)pyridine 
(52e): 
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51e (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52e as a colorless oil. 
 
Isolated yield: 76% (231 mg). 
Reaction time: 30 min. 
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Solvent for purification: i-hexane/ethyl acetate 4:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.52 - 1.92 (m, 6 H), 3.46 - 3.55 (m, 1 H), 3.79 - 3.90 
(m, 1 H), 4.39 (d, J=10.50 Hz, 1 H), 4.77 (t, J=3.04 Hz, 1 H), 4.83 (d, J=10.50 Hz, 1 H), 7.36 
(d, J=5.25 Hz, 1 H), 7.41 - 7.51 (m, 3 H), 7.62 - 7.71 (m, 2 H), 8.52 (d, J=5.25 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 18.92 (s, 1 C), 25.41 (s, 1 C), 30.41 (s, 1 C), 61.69 (s, 1 
C), 64.56 (s, 1 C), 99.00 (s, 1 C), 123.55 (s, 1 C), 128.10 (s, 1 C), 128.67 (s, 1 C), 129.17 (s, 1 
C), 129.32 (s, 1 C), 139.39 (s, 1 C), 146.82 (s, 1 C), 149.27 (s, 1 C), 162.12 (s, 1 C). 
MS (70 eV, EI) m/z (%): 219 (16), 204 (30), 202 (100), 167 (14), 85 (33). 
IR ATR ν (cm-1): 2940, 2894, 2362, 2338, 1560, 1548, 1496, 1452, 1438, 1410, 1378, 1348, 
1200, 1182, 1174, 1131, 1118, 1103, 1076, 1068, 1055, 1037, 1022, 1001, 989, 962, 938, 922, 
905, 890, 869, 843, 837, 818, 816, 810, 793, 779, 757, 732, 730, 724, 700, 686, 668, 653. 
HRMS (EI) for C17H18ClNO2 (303.1026) [M]+: 303.0949. 
 
Synthesis of 3-chloro-1-phenylisoquinoline (52f): 
N
Cl
 
 
A solution of 32a in THF (1.2 mmol, 1.2 equiv, 1.7 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51f (1 mmol, 1.0 equiv) 
in CPME (5 mL) at 25 °C. The suspension was stirred at 25 °C for 1 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52f as a slightly yellow solid. 
 
Isolated yield: 71% (170 mg). 
Reaction time: 1 h. 
Solvent for purification: i-hexane/ethyl acetate 3:1 (+0.5% NEt3). 
m.p.: 75.9-77.9 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.47 - 7.60 (m, 4 H), 7.67 - 7.75 (m, 4 H), 7.79 - 7.84 
(m, 1 H), 8.10 (d, J=8.57 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: 118.89 (s, 1 C), 125.49 (s, 1 C), 126.25 (s, 1 C), 127.34 
(s, 1 C), 127.79 (s, 1 C), 128.41 (s, 1 C), 129.07 (s, 1 C), 130.04 (s, 1 C), 130.90 (s, 1 C), 
138.21 (s, 1 C), 138.96 (s, 1 C), 144.76 (s, 1 C), 161.49 (s, 1 C). 
MS (70 eV, EI) m/z (%): 239 (100), 202 (71), 176 (18), 151 (15), 101 (17). 
IR ATR ν (cm-1): 3054, 3028, 2363, 2331, 1616, 1572, 1570, 1560, 1558, 1542, 1489, 1443, 
1430, 1396, 1385, 1376, 1359, 1319, 1307, 1269, 1215, 1147, 1077, 1069, 1028, 999, 978, 
974, 964, 922, 874, 854, 850, 799, 766, 757, 749, 724, 698, 677, 668, 658, 653. 
HRMS (EI) for C15H10ClN (239.0502) [M]+: 239.0477. 
 
Synthesis of 2-(benzo[d][1,3]dioxol-5-yl)-6-chloroquinoline (52g): 
 
 
A solution of 32k in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51g (1 mmol, 1.0 equiv) 
in CPME (5 mL) at 25 °C. The suspension was stirred at 25 °C for 1 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52g as a white solid. 
 
Isolated yield: 82% (232 mg). 
Reaction time: 1 h. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
m.p.: 159.2-160.9 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 6.05 (s, 2 H), 6.95 (d, J=8.02 Hz, 1 H), 7.64 (ddd, 
J=8.71, 2.35, 2.21 Hz, 2 H), 7.70 - 7.83 (m, 3 H), 8.06 (dd, J=8.71, 2.63 Hz, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 101.41 (s, 1 C), 107.77 (s, 1 C), 108.48 (s, 1 C), 119.32 
(s, 1 C), 121.74 (s, 1 C), 126.06 (s, 1 C), 127.49 (s, 1 C), 130.50 (s, 1 C), 131.10 (s, 1 C), 
131.61 (s, 1 C), 133.58 (s, 1 C), 135.68 (s, 1 C), 146.52 (s, 1 C), 148.45 (s, 1 C), 149.03 (s, 1 
C), 156.78 (s, 1 C). 
MS (70 eV, EI) m/z (%): 283 (100), 225 (14), 190 (25), 44 (20). 
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IR ATR ν (cm-1): 2903, 2366, 2336, 1593, 1548, 1507, 1499, 1481, 1455, 1438, 1351, 1329, 
1293, 1287, 1256, 1241, 1214, 1190, 1145, 1120, 1111, 1072, 1036, 948, 936, 924, 913, 894, 
881, 861, 830, 824, 815, 809, 788, 775, 724, 706, 653. 
HRMS (EI) for C16H10ClNO2 (283.0400) [M]+: 283.0389. 
 
Synthesis of 5-chloro-2-(3-methoxyphenyl)pyridine (52h): 
 
 
A solution of 53 in THF (1.2 mmol, 1.2 equiv, 1.2 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51c (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52h as a white powder. 
 
Isolated yield: 71% (156 mg). 
Reaction time: 30 min. 
Solvent for purification: i-hexane/Et2O 9:1 (+0.5% NEt3). 
m.p.: 60.2-62.8 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.90 (s, 3 H), 6.99 (dd, J=8.16, 2.63 Hz, 1 H), 7.39 (t, 
J=8.02 Hz, 1 H), 7.49 - 7.59 (m, 2 H), 7.64 - 7.75 (m, 2 H), 8.64 (d, J=2.49 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.38 (s, 1 C), 111.97 (s, 1 C), 115.28 (s, 1 C), 119.13 
(s, 1 C), 121.23 (s, 1 C), 129.82 (s, 1 C), 130.69 (s, 1 C), 136.41 (s, 1 C), 139.63 (s, 1 C), 
148.40 (s, 1 C), 155.30 (s, 1 C), 160.11 (s, 1 C). 
MS (70 eV, EI) m/z (%): 219 (66), 190 (50), 176 (11), 154 (50), 141 (36), 113 (17). 
IR ATR ν (cm-1): 3002, 2956, 2834, 2360, 2331, 1608, 1586, 1575, 1554, 1471, 1459, 1430, 
1370, 1365, 1302, 1292, 1227, 1219, 1208, 1182, 1176, 1168, 1111, 1053, 1035, 1010, 894, 
889, 885, 876, 858, 855, 848, 840, 836, 824, 791, 755, 749, 689, 668. 
HRMS (EI) for C12H10ClNO (219.0451) [M]+: 219.0435. 
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Synthesis of 7-chloro-2-(3-methoxyphenyl)quinoline (52i): 
NCl
OMe
 
 
A solution of 53 in THF (1.2 mmol, 1.2 equiv, 1.2 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51h (1 mmol, 1.0 equiv) in 
CPME (5 mL) at 25 °C. The suspension was stirred at 25 °C for 2 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52i as a white solid. 
 
Isolated yield: 72% (194 mg). 
Reaction time: 2 h. 
Solvent for purification: i-hexane/ethyl acetate 9:1 (+0.5% NEt3). 
m.p.: 66.2-67.5 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.94 (s, 3 H), 7.04 (ddd, J=6.91, 1.66, 1.38 Hz, 1 H), 
7.41 - 7.51 (m, 2 H), 7.68 - 7.80 (m, 3 H), 7.86 (d, J=8.29 Hz, 1 H), 8.12 - 8.22 (m, 2 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 55.41 (s, 1 C), 112.71 (s, 1 C), 115.69 (s, 1 C), 119.15 
(s, 1 C), 119.96 (s, 1 C), 125.58 (s, 1 C), 127.28 (s, 1 C), 128.62 (s, 1 C), 128.70 (s, 1 C), 
129.83 (s, 1 C), 135.44 (s, 1 C), 136.49 (s, 1 C), 140.59 (s, 1 C), 148.56 (s, 1 C), 157.95 (s, 1 
C), 160.16 (s, 1 C). 
MS (70 eV, EI) m/z (%): 269 (71), 268 (100), 239 (45), 204 (12), 190 (16). 
IR ATR ν (cm-1): 2940, 2920, 2830, 2359, 1611, 1597, 1587, 1557, 1545, 1483, 1469, 1456, 
1436, 1329, 1308, 1292, 1278, 1241, 1218, 1188, 1183, 1157, 1152, 1133, 1087, 1069, 1046, 
1037, 997, 927, 880, 871, 849, 837, 806, 778, 766, 692, 674, 668, 659. 
HRMS (EI) for C16H12ClNO (269.0607) [M]+: 268.0524. 
 
Synthesis of 2-(benzo[d][1,3]dioxol-5-yl)-4-chloropyridine (52j):  
 
 
A solution of 32k in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51a (1 mmol, 1.0 equiv) 
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in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52j as a white solid. 
 
Isolated yield: 77% (179 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
m.p.: 108.5-111.0 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 6.03 (s, 2 H), 6.90 (d, J=8.02 Hz, 1 H), 7.19 (dd, 
J=5.25, 1.94 Hz, 1 H), 7.45 - 7.53 (m, 2 H), 7.63 (d, J=1.94 Hz, 1 H), 8.53 (d, J=5.25 Hz, 1 
H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 101.42 (s, 1 C), 107.34 (s, 1 C), 108.48 (s, 1 C), 120.17 
(s, 1 C), 121.16 (s, 1 C), 121.78 (s, 1 C), 132.50 (s, 1 C), 144.63 (s, 1 C), 148.37 (s, 1 C), 
148.97 (s, 1 C), 150.27 (s, 1 C), 158.41 (s, 1 C). 
MS (70 eV, EI) m/z (%): 233 (100), 140 (19), 113 (13). 
IR ATR ν (cm-1): 2894, 2359, 1573, 1550, 1500, 1493, 1462, 1442, 1378, 1351, 1278, 1257, 
1216, 1114, 1108, 1037, 934, 888, 869, 865, 861, 834, 815, 811, 780, 734, 719, 717, 701, 686, 
684, 668. 
HRMS (EI) for C12H8ClNO2 (233.0244) [M]+: 233.0244. 
 
Synthesis of 4-(6-chloroquinolin-2-yl)-N,N-dimethylaniline (52k):  
 
 
A solution of 32n in THF (1.2 mmol, 1.2 equiv, 1.2 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51g (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 3 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52k as a beige solid. 
 
Isolated yield: 71% (199 mg). 
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Reaction time: 3 h. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
m.p.: 188.0-188.8 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.06 (s, 6 H), 6.84 (d, J=9.12 Hz, 2 H), 7.61 (dd, 
J=8.98, 2.35 Hz, 1 H), 7.75 (d, J=2.49 Hz, 1 H), 7.84 (d, J=8.85 Hz, 1 H), 7.97 - 8.15 (m, 4 
H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 40.29 (s, 1 C), 112.18 (s, 1 C), 119.01 (s, 1 C), 126.04 
(s, 1 C), 126.94 (s, 1 C), 127.19 (s, 1 C), 128.43 (s, 1 C), 130.16 (s, 1 C), 130.75 (s, 1 C), 
130.84 (s, 1 C), 135.31 (s, 1 C), 146.76 (s, 1 C), 151.48 (s, 1 C), 157.50 (s, 1 C). 
MS (70 eV, EI) m/z (%): 282 (100), 281 (47), 266 (9), 238 (11). 
IR ATR ν (cm-1): 2915, 2830, 2366, 1613, 1597, 1539, 1484, 1470, 1457, 1437, 1330, 1310, 
1288, 1279, 1240, 1231, 1220, 1202, 1188, 1168, 1157, 1152, 1133, 1067, 1062, 1046, 1037, 
949, 941, 930, 882, 871, 849, 838, 825, 809, 794, 778, 767, 760, 757, 693, 681, 675, 668. 
HRMS (EI) for C17H15ClN2 (282.0924) [M]+: 282.0921. 
 
Synthesis of 5-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)-1-methyl-1H-indole (52l): 
 
 
A solution of 32r in THF (1.2 mmol, 1.2 equiv, 1.0 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51i (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 50 °C for 1 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52l as a beige solid. 
 
Isolated yield: 56% (174 mg). 
Reaction conditions: 1 h, 50 °C. 
Solvent for purification: i-hexane/ethyl acetate 6:1 (+0.5% NEt3). 
m.p.: 83.9-85.9 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.85 (s, 3 H), 6.60 (d, J=3.04 Hz, 1 H), 7.13 (d, J=3.04 
Hz, 1 H), 7.44 (d, J=8.57 Hz, 1 H), 7.68 (dd, J=8.85, 1.66 Hz, 1 H), 8.08 (dd, J=18.94, 2.07 
Hz, 2 H), 8.87 (d, J=1.94 Hz, 1 H). 
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13C NMR (75 MHz, CDCl3) δ/ppm: 32.95 (s, 1 C), 102.06 (s, 1 C), 108.91 (s, 1 C), 122.76 
(s, 1 C), 122.95 (q, J=272.73 Hz), 123.04 (s, 1 C), 125.07 (q, J=33.59 Hz), 128.10 (s, 1 C), 
128.21 (s, 1 C), 129.87 (s, 1 C), 130.06 (s, 1 C), 135.18 (q, J=3.42 Hz, 1 C), 137.21 (s, 1 C), 
144.00 (q, J=3.99 Hz, 1 C), 161.15 (s, 1 C). 
MS (70 eV, EI) m/z (%): 310 (100), 275 (16), 111 (13), 97 (16), 85 (15). 
IR ATR ν (cm-1): 2923, 2853, 2357, 1596, 1485, 1455, 1443, 1437, 1325, 1310, 1293, 1288, 
1280, 1271, 1243, 1232, 1220, 1202, 1188, 1181, 1153, 1133, 1118, 1109, 1093, 1066, 1027, 
1004, 1003, 949, 941, 937, 931, 916, 899, 887, 884, 871, 848, 839, 825, 814, 809, 793, 783, 
771, 766, 758, 752, 735, 730, 724, 718, 708, 693, 681, 676, 668, 660, 652. 
HRMS (EI) for C15H10ClF3N2 (310.0485) [M]+: 310.0472. 
 
Synthesis of 2-(3-((tert-butyldimethylsilyl)oxy)phenyl)-3-chloropyridine (52m):  
 
 
A solution of 32p in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51b (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52m as a colorless oil. 
 
Isolated yield: 82% (262 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/Et2O 9:1. 
1H NMR (300 MHz, CDCl3) δ/ppm: 0.24 (s, 6 H), 1.01 (s, 9 H), 6.93 (dt, J=7.26, 2.18 Hz, 1 
H), 7.17 - 7.25 (m, 2 H), 7.28 - 7.38 (m, 2 H), 7.79 (dd, J=8.02, 1.66 Hz, 1 H), 8.59 (dd, 
J=4.56, 1.52 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: -4.38 (s, 1 C), 18.18 (s, 1 C), 25.69 (s, 1 C), 120.53 (s, 1 
C), 121.07 (s, 1 C), 122.34 (s, 1 C), 123.01 (s, 1 C), 129.11 (s, 1 C), 130.14 (s, 1 C), 138.03 
(s, 1 C), 139.47 (s, 1 C), 147.47 (s, 1 C), 155.20 (s, 1 C), 156.36 (s, 1 C). 
MS (70 eV, EI) m/z (%): 319 (13), 264 (38), 262 (100), 226 (9). 
 210 
IR ATR ν (cm-1): 2955, 2928, 2857, 2360, 2338, 1602, 1581, 1570, 1486, 1471, 1462, 1439, 
1419, 1415, 1406, 1306, 1272, 1259, 1251, 1243, 1227, 1199, 1130, 1029, 1001, 937, 884, 
830, 816, 791, 778, 760, 723, 696, 685, 677, 668, 662. 
HRMS (EI) for C17H22ClNOSi (319.1159) [M]+: 319.1154. 
 
Synthesis of 2-(4-(1,3-dioxolan-2-yl)phenyl)-3-chloro-5-(trifluoromethyl)pyridine (52n): 
 
 
A solution of 54 in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51i (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52n as a white powder. 
 
Isolated yield: 71% (233 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 8:1 (+0.5% NEt3). 
m.p.: 72.4-74.0 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 4.02 - 4.22 (m, 4 H), 5.92 (s, 1 H), 7.63 (m, 2 H), 7.80 
(m, 2 H), 8.05 (d, J=1.36 Hz, 1 H), 8.85 (dd, J=2.05, 0.88 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 65.34 (s, 1 C), 103.22 (s, 1 C), 122.70 (q, J=272.93 Hz), 
126.12 (q, J=33.59 Hz), 126.28 (s, 1 C), 129.47 (s, 1 C), 130.25 (s, 1 C), 135.30 (q, J=3.65 
Hz), 137.68 (s, 1 C), 139.47 (s, 1 C), 144.21 (q, J=4.03 Hz), 159.49 (q, J=1.54 Hz). 
MS (70 eV, EI) m/z (%): 329 (19), 328 (69), 286 (16), 271 (14), 257 (100), 222 (81), 73 (62). 
IR ATR ν (cm-1): 2899, 2361, 2339, 1599, 1380, 1324, 1309, 1216, 1153, 1119, 1093, 1081, 
1069, 1028, 1014, 988, 981, 970, 957, 941, 911, 858, 843, 835, 824, 768, 735, 731, 695, 685. 
HRMS (EI) for C15H11ClF3NO2 (329.0430) [M]+: 328.0355. 
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Synthesis of 2-(4-(1,3-dioxolan-2-yl)phenyl)-4-chloro-3-(((tetrahydro-2H-pyran-2-
yl)oxy)methyl)pyridine (52o):  
 
 
A solution of 54 in THF (1.2 mmol, 1.2 equiv, 1.1 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51e (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52o as a colorless oil. 
 
Isolated yield: 66% (248 mg). 
Reaction conditions: 30 min. 
Solvent for purification: i-hexane/ethyl acetate 3:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.51 - 1.90 (m, 6 H), 3.45 - 3.60 (m, 1 H), 3.78 - 3.95 
(m, 1 H), 3.99 - 4.22 (m, 4 H), 4.37 (d, J=10.78 Hz, 1 H), 4.73 - 4.91 (m, 2 H), 5.90 (s, 1 H), 
7.36 (d, J=5.25 Hz, 1 H), 7.57 (m, 2 H), 7.71 (m, 2 H), 8.52 (d, J=5.25 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 18.95 (s, 1 C), 25.39 (s, 1 C), 30.44 (s, 1 C), 61.80 (s, 1 
C), 64.54 (s, 1 C), 65.25 (s, 1 C), 99.02 (s, 1 C), 103.38 (s, 1 C), 123.64 (s, 1 C), 126.23 (s, 1 
C), 129.26 (s, 1 C), 129.35 (s, 1 C), 138.47 (s, 1 C), 140.15 (s, 1 C), 146.86 (s, 1 C), 149.33 
(s, 1 C), 161.64 (s, 1 C). 
MS (70 eV, EI) m/z (%): 291 (25), 274 (40), 230 (13), 202 (36), 166 (16), 73 (100). 
IR ATR ν (cm-1): 2941, 2884, 2366, 2334, 1561, 1548, 1446, 1412, 1385, 1363, 1349, 1200, 
1182, 1130, 1117, 1078, 1064, 1053, 1036, 1023, 989, 966, 941, 905, 890, 880, 869, 824, 816, 
788, 775, 754, 729, 712, 710, 707, 693, 689, 687, 685, 681, 675, 668, 659, 658, 654. 
HRMS (EI) for C20H22ClNO4 (375.1237) [M]+: 374.1157. 
 
Synthesis of 4-chloro-3-(1,3-dioxolan-2-yl)-2-(4-fluorophenyl)pyridine (52p):  
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A solution of 32g in THF (1.2 mmol, 1.2 equiv, 1.0 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51d (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being 
quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52p as white crystals. 
 
Isolated yield: 79% (221 mg). 
Reaction conditions: 30 min. 
Solvent for purification: i-hexane/ethyl acetate 4:1 (+0.5% NEt3). 
m.p.: 76.2-79.0 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 3.88 - 4.13 (m, 4 H), 5.95 (s, 1 H), 7.06 - 7.20 (m, 2 H), 
7.36 (d, J=5.25 Hz, 1 H), 7.45 - 7.60 (m, 2 H), 8.52 (d, J=5.25 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 65.80 (s, 1 C), 101.26 (s, 1 C), 114.84 (s, 1 C), 115.13 
(s, 1 C), 124.99 (s, 1 C), 127.50 (s, 1 C), 131.28 (s, 1 C), 131.39 (s, 1 C), 135.19 (s, 1 C), 
135.24 (s, 1 C), 145.28 (s, 1 C), 149.84 (s, 1 C), 161.03 (s, 1 C), 161.35 (s, 1 C), 164.64 (s, 1 
C): 
MS (70 eV, EI) m/z (%): 236 (29), 234 (84), 220 (11), 207 (100), 183 (42), 171 (22), 144 
(17). 
IR ATR ν (cm-1): 2983, 2899, 2360, 2344, 1603, 1564, 1556, 1511, 1457, 1381, 1234, 1224, 
1213, 1179, 1159, 1154, 1102, 1096, 1057, 1019, 1013, 984, 971, 958, 940, 883, 846, 832, 
821, 776, 726, 720, 691, 668. 
HRMS (EI) for C14H11ClFNO2 (279.0462) [M]+: 278.0372. 
 
Synthesis of 4-chloro-2-(4-(trifluoromethyl)phenyl)pyridine (52q):  
 
 
A solution of 32y in THF (1.2 mmol, 1.2 equiv, 1.0 M) was added dropwise to a suspension 
of anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51a (1 mmol, 1.0 equiv) 
in THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being 
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quenched with brine and extracted with EtOAc. The organic layer was dried with MgSO4, 
filtered, and concentrated in vacuo to yield the crude compound, which was purified by 
column chromatography to yield 52q as white crystals. 
 
Isolated yield: 92% (237 mg). 
Reaction conditions: 30 min. 
Solvent for purification: i-hexane/diethyl ether 9:1. 
m.p.: 44.9-46.6 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.31 (dd, J=5.25, 1.11 Hz, 1 H), 7.69 - 7.80 (m, 3 H), 
8.05 - 8.16 (m, 2 H), 8.62 (d, J=5.25 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 121.17 (s, 1 C), 123.10 (s, 1 C), 124.03 (q, J=272.35 
Hz), 125.78 (q, J=3.65 Hz), 127.27 (s, 1 C), 131.41 (q, J=32.54 Hz), 141.37 (q, J=1.40 Hz), 
145.02 (s, 1 C), 150.70 (s, 1 C), 157.34 (s, 1 C). 
MS (70 eV, EI) m/z (%): 257 (100), 222 (50), 202 (12), 188 (15), 43 (47). 
IR ATR ν (cm-1): 2366, 2334, 1617, 1572, 1549, 1380, 1323, 1315, 1265, 1168, 1105, 1095, 
1069, 1047, 1013, 988, 977, 956, 849, 840, 829, 818, 785, 765, 750, 739, 728, 706, 690, 668, 
662. 
HRMS (EI) for C12H7ClF3N: (257.0219) [M]+: 257.0211. 
 
Synthesis of 6-chloro-2-(4-chloro-3-(trifluoromethyl)phenyl)quinoline (52r):  
 
 
A solution of 55 in THF (1.2 mmol, 1.2 equiv, 1.0 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51g (1 mmol, 1.0 equiv) in 
CPME (5 mL) at 25 °C. The suspension was stirred at 25 °C for 1 h before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52r as a white powder. 
 
Isolated yield: 87% (299 mg). 
Reaction conditions: 1 h. 
Solvent for purification: i-hexane/ethyl acetate 12:1 (+0.5% NEt3). 
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m.p.: 118.8-121.7 °C. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.62 - 7.73 (m, 2 H), 7.82 (d, J=2.21 Hz, 1 H), 7.87 (d, 
J=8.57 Hz, 1 H), 8.10 (d, J=8.85 Hz, 1 H), 8.17 (d, J=8.29 Hz, 1 H), 8.26 (dd, J=8.29, 2.21 
Hz, 1 H), 8.54 (d, J=2.21 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 118.89 (s, 1 C), 122.84 (q, J=273.30 Hz), 126.16 (s, 1 
C), 126.52 (q, J=5.41 Hz), 127.89 (s, 1 C), 128.73, 128.94 (q, J=31.60 Hz), 131.05 (s, 1 C), 
131.34 (s, 1 C), 131.91 (s, 1 C), 132.68 (s, 1 C), 133.48 (q, J=1.71 Hz), 136.31 (s, 1 C), 
137.86 (s, 1 C), 146.53 (s, 1 C), 154.52 (s, 1 C). 
MS (70 eV, EI) m/z (%): 341 (100), 308 (10), 306 (28), 286 (14), 272 (12). 
IR ATR ν (cm-1): 2926, 2860, 2360, 2331, 1595, 1476, 1411, 1328, 1321, 1315, 1276, 1259, 
1251, 1236, 1164, 1155, 1133, 1123, 1113, 1075, 1056, 1034, 948, 904, 899, 874, 848, 827, 
811, 781, 775, 729, 675, 668, 664, 658. 
HRMS (EI) for C16H8Cl2F3N: (340.9986) [M]+: 340.9969. 
 
Synthesis of 3-chloro-2-(4-chloro-3-(trifluoromethyl)phenyl)-5-(trifluoromethyl)pyridine 
(52s): 
 
 
A solution of 55 in THF (1.2 mmol, 1.2 equiv, 1.0 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51i (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 30 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52s as a colorless oil. 
 
Isolated yield: 66% (239 mg). 
Reaction time: 30 min. 
Solvent for purification: i-hexane/ethyl acetate 15:1. 
1H NMR (300 MHz, CDCl3) δ/ppm: 7.65 (d, J=8.02 Hz, 1 H), 7.95 (dd, J=8.57, 2.21 Hz, 1 
H), 8.09 (d, J=1.94 Hz, 1 H), 8.17 (d, J=1.94 Hz, 1 H), 8.88 (s, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 122.47 (q, J=273.20 Hz), 122.57 (q, J=273.48 Hz), 
126.92 (q, J=33.94 Hz), 128.57 (q, J=31.70 Hz), 128.87 (q, J=5.33 Hz), 130.22, 131.32, 
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133.64, 133.89 (q, J=1.68 Hz), 135.60, 135.65 (q, J=3.65 Hz), 144.50 (q, J=3.93 Hz), 157.10 
(q, J=1.68 Hz). 
MS (70 eV, EI) m/z (%): 359 (81), 339 (14), 324 (100), 304 (17), 290 (12). 
IR ATR ν (cm-1): 2362, 2342, 1602, 1487, 1456, 1413, 1380, 1329, 1315, 1295, 1278, 1260, 
1238, 1214, 1127, 1113, 1099, 1079, 1038, 1031, 910, 873, 836, 813, 766, 737, 718, 665. 
HRMS (EI) for C13H5Cl2F6N (358.9703) [M]+: 358.9690. 
 
Synthesis of ethyl 3-(3-chloro-5-(trifluoromethyl)pyridin-2-yl)benzoate (52t): 
 
 
A solution of 39 in THF (1.2 mmol, 1.2 equiv, 0.6 M) was added dropwise to a suspension of 
anhydrous CrCl2 (3.7 mg, 0.03 mmol, 0.03 equiv; 97% purity) and 51i (1 mmol, 1.0 equiv) in 
THF (5 mL) at 25 °C. The suspension was stirred at 25 °C for 15 min before being quenched 
with brine and extracted with EtOAc. The organic layer was dried with MgSO4, filtered, and 
concentrated in vacuo to yield the crude compound, which was purified by column 
chromatography to yield 52t as a slightly yellow oil. 
 
Isolated yield: 70% (231 mg). 
Reaction time: 15 min. 
Solvent for purification: i-hexane/ethyl acetate 9:1 (+0.5% NEt3). 
1H NMR (300 MHz, CDCl3) δ/ppm: 1.41 (t, J=7.19 Hz, 3 H), 4.42 (q, J=7.19 Hz, 2 H), 7.59 
(t, J=7.88 Hz, 1 H), 7.96 (dt, J=7.74, 1.52 Hz, 1 H), 8.07 (d, J=2.21 Hz, 1 H), 8.18 (dt, 
J=7.95, 1.42 Hz, 1 H), 8.46 (t, J=1.80 Hz, 1 H), 8.87 (d, J=1.11 Hz, 1 H). 
13C NMR (75 MHz, CDCl3) δ/ppm: 14.30 (s, 1 C), 61.22 (s, 1 C), 122.62 (q, J=272.92 Hz), 
126.44 (q, J=33.66 Hz), 128.34 (s, 1 C), 130.31 (s, 1 C), 130.58 (s, 1 C), 130.65 (s, 1 C), 
130.69 (s, 1 C), 133.56 (s, 1 C), 135.37 (q, J=3.65 Hz), 137.17 (s, 1 C), 144.33 (q, J=3.39 Hz), 
158.92 (q, J=1.40 Hz), 165.98 (s, 1 C). 
MS (70 eV, EI) m/z (%): 329 (33), 301 (22), 284 (100), 257 (55), 221 (15). 
IR ATR ν (cm-1): 2982, 2367, 2335, 1718, 1717, 1600, 1368, 1322, 1312, 1285, 1249, 1223, 
1214, 1160, 1131, 1093, 1082, 1075, 1036, 1020, 1001, 912, 847, 820, 741, 710, 693, 668, 
662. 
HRMS (EI) for C15H11ClF3NO2 (329.0430) [M]+: 329.0419. 
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